TREA

Herbicidal compositions containing N-(1,3,4-oxadiazol-2-yl)-aryl carboxylic acid amides

Follow

Information

  • Patent Grant
  • 10111435
  • Patent Number
    10,111,435
  • Date Filed
    Wednesday, October 22, 2014
    10 years ago
  • Date Issued
    Tuesday, October 30, 2018
    6 years ago
Information
Abstract
What are described are herbicidal compositions comprising active ingredients from the group of the N-(1,3,4-oxadiazol-2-yl)arylcarboxamides and further herbicides and optionally safeners. These herbicidal compositions are particularly suitable for use against harmful plants in crops of useful plants.
Description
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a § 371 National Stage Application of PCT/EP2014/072645, filed Oct. 22, 2014, which claims priority to European 13190182.9 filed Oct. 25, 2013.


BACKGROUND

Field of the Invention


The present invention relates to agrochemically active herbicidal compositions, to processes for production thereof and to the use thereof for control of harmful plants.


Description of Related Art


WO 2012/126932 A1 discloses particular N-(1,3,4-oxadiazol-2-yl)arylcarboxamides having herbicidal properties. However, these active ingredients do not always exhibit sufficient efficacy against harmful plants and/or some of them are not fully compatible with some important crop plants such as cereal species, corn or rice.


SUMMARY

It is therefore an object of the present invention to provide herbicidal compositions in which efficacy against harmful plants and/or selectivity of the abovementioned herbicides with respect to important crop plants is increased. This object is achieved by the inventive herbicidal compositions described hereinafter, comprising particular N-(1,3,4-oxadiazol-2-yl)arylcarboxamides, further herbicides and optionally safeners.


The present invention provides herbicidal compositions comprising (A) one or more compounds of the formula (I) (component A) or salts thereof




embedded image



in which the substituents are defined as follows:


A is N or CY,


R is hydrogen, (C1-C6)-alkyl, R1O—(C1-C6)-alkyl, CH2R6, (C3-C7)-cycloalkyl, halo-(C1-C6)-alkyl, (C2-C6)-alkenyl, halo-(C2-C6)-alkenyl, (C2-C6)-alkynyl, halo-(C2-C6)-alkynyl, OR1, NHR1, methoxycarbonyl, ethoxycarbonyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, methylcarbonyl, trifluoromethylcarbonyl, dimethylamino, acetylamino, methylsulfenyl, methylsulfinyl, methylsulfonyl, or heteroaryl, heterocyclyl, benzyl or phenyl each substituted by s radicals from the group of halogen, nitro, cyano, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, S(O)n—(C1-C6)-alkyl, (C1-C6)-alkoxy, halo-(C1-C6)-alkoxy, (C1-C6)-alkoxy-(C1-C4)-alkyl,


X is nitro, halogen, cyano, formyl, thiocyanato, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, (C2-C6)-alkenyl, halo-(C2-C6)-alkenyl, (C2-C6)-alkynyl, halo-(C3-C6)-alkynyl, (C3-C6)-cycloalkyl, halo-(C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, halo-(C3-C6)-cycloalkyl-(C1-C6)-alkyl, COR1, COOR1, OCOOR1, NR1COOR1, C(O)N(R1)2, NR1C(O)N(R1)2, OC(O)N(R1)2, C(O)NR1OR1, OR1, OCOR1, OSO2R2, S(O)nR2, SO2OR1, SO2N(R1)2, NR1SO2R2, NR1COR1, (C1-C6)-alkyl-S(O)nR2, (C1-C6)-alkyl-OR1, (C1-C6)-alkyl-OCOR1, (C1-C6)-alkyl-OSO2R2, (C1-C6)-alkyl-CO2R1, (C1-C6)-alkyl-SO2OR1, (C1-C6)-alkyl-CON(R1)2, (C1-C6)-alkyl-SO2N(R1)2, (C1-C6)-alkyl-NR1COR1, (C1-C6)-alkyl-NR1SO2R2, NR1R2, P(O)(OR5)2, CH2P(O)(OR5)2, (C1-C6)-alkylheteroaryl, (C1-C6)-alkylheterocyclyl, where the two latter radicals are each by s halogen, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, S(O)n—(C1-C6)-alkyl, (C1-C6)-alkoxy, halo-(C1-C6)-alkoxy radicals, and where heterocyclyl bears n oxo groups,


Y is hydrogen, nitro, halogen, cyano, thiocyanato, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, (C2-C6)-alkenyl, halo-(C2-C6)-alkenyl, (C2-C6)-alkynyl, halo-(C2-C6)-alkynyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkenyl, halo-(C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, halo-(C3-C6)-cycloalkyl-(C1-C6)-alkyl, COR1, COOR1, OCOOR1, NR1COOR1, C(O)N(R1)2, NR1C(O)N(R1)2, OC(O)N(R1)2, CO(NOR1)R1, NR1SO2R2, NR1COR1, OR1, OSO2R2, S(O)nR2, SO2OR1, SO2N(R1)2, (C1-C6)-alkyl-S(O)nR2, (C1-C6)-alkyl-OR1, (C1-C6)-alkyl-OCOR1, (C1-C6)-alkyl-OSO2R2, (C1-C6)-alkyl-CO2R1, (C1-C6)-alkyl-CN, (C1-C6)-alkyl-SO2OR1, (C1-C6)-alkyl-CON(R1)2, (C1-C6)-alkyl-SO2N(R1)2, (C1-C6)-alkyl-NR1COR1, (C1-C6)-alkyl-NR1SO2R2, N(R1)2, P(O)(OR5)2, CH2P(O)(OR5)2, (C1-C6)-alkylphenyl, (C1-C6)-alkylheteroaryl, (C1-C6)-alkylheterocyclyl, phenyl, heteroaryl or heterocyclyl, where the 6 latter radicals are each substituted by s radicals from the group of halogen, nitro, cyano, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, S(O)n—(C1-C6)-alkyl, (C1-C6)-alkoxy, halo-(C1-C6)-alkoxy, (C1-C6)-alkoxy-(C1-C4)-alkyl and cyanomethyl, and where heterocyclyl bears n oxo groups,


Z is hydrogen, halogen, cyano, thiocyanato, (C1-C6)-alkyl, (C1-C6)-alkoxy, halo-(C1-C6)-alkyl, (C2-C6)-alkenyl, halo-(C2-C6)-alkenyl, (C2-C6)-alkynyl, halo-(C2-C6)-alkynyl, (C3-C6)-cycloalkyl, halo-(C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, halo-(C3-C6)-cycloalkyl-(C1-C6)-alkyl, COR1, COOR1, OCOOR1, NR1COOR1, C(O)N(R1)2, NR1C(O)N(R1)2, OC(O)N(R1)2, C(O)NR1OR1, OSO2R2, S(O)nR2, SO2OR1, SO2N(R1)2, NR1SO2R2, NR1COR1, (C1-C6)-alkyl-S(O)nR2, (C1-C6)-alkyl-OR1, (C1-C6)-alkyl-OCOR1, (C1-C6)-alkyl-OSO2R2, (C1-C6)-alkyl-CO2R1, (C1-C6)-alkyl-SO2OR1, (C1-C6)-alkyl-CON(R1)2, (C1-C6)-alkyl-SO2N(R1)2, (C1-C6)-alkyl-NR1COR1, (C1-C6)-alkyl-NR1SO2R2, N(R1)2, P(O)(OR5)2, heteroaryl, heterocyclyl or phenyl, where the last three radicals are each substituted by s radicals from the group of halogen, nitro, cyano, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, S(O)n—(C1-C6)-alkyl, (C1-C6)-alkoxy and halo-(C1-C6)-alkoxy, and where heterocyclyl bears n oxo groups,


R1 is hydrogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkenyl, (C3-C6)-halocycloalkyl, (C1-C6)-alkyl-O—(C1-C6)-alkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, phenyl, phenyl-(C1-C6)-alkyl, heteroaryl, (C1-C6)-alkylheteroaryl, heterocyclo, (C1-C6)-alkylheterocyclyl, (C1-C6)-alkyl-O-heteroaryl, (C1-C6)-alkyl-O-heterocyclyl, (C1-C6)-alkyl-NR3-heteroaryl, (C1-C6)-alkyl-NR3-heterocyclyl, where the 21 latter radicals are substituted by s radicals from the group consisting of cyano, halogen, nitro, thiocyanato, OR3, S(O)nR4, N(R3)2, NR3OR3, COR3, OCOR3, SCOR4, NR3COR3, NR3SO2R4, CO2R3, COSR4, CON(R3)2 and (C1-C4)-alkoxy-(C2-C6)-alkoxycarbonyl, and where heterocyclyl bears n oxo groups,


R2 is (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkenyl, (C3-C6)-halocycloalkyl, (C1-C6)-alkyl-O—(C1-C6)-alkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, phenyl, phenyl-(C1-C6)-alkyl, heteroaryl, (C1-C6)-alkylheteroaryl, heterocyclyl, (C1-C6)-alkylheterocyclyl, (C1-C6)-alkyl-O-heteroaryl, (C1-C6)-alkyl-O-heterocyclyl, (C1-C6)-alkyl-NR3-heteroaryl, (C1-C6)-alkyl-NR3-heterocyclyl, where the 21 latter radicals are substituted by s radicals from the group consisting of cyano, halogen, nitro, thiocyanato, OR3, S(O)nR4, N(R3)2, NR3OR3, COR3, OCOR3, SCOR4, NR3COR3, NR3SO2R4, CO2R3, COSR4, CON(R3)2 and (C1-C4)-alkoxy-(C2-C6)-alkoxycarbonyl, and where heterocyclyl bears n oxo groups,


R3 is hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C3-C6)-cycloalkyl or (C3-C6)-cycloalkyl-(C1-C6)-alkyl,


R4 is (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl,


R5 is methyl or ethyl,


R6 is acetoxy, acetamido, N-methylacetamido, benzoyloxy, benzamido, N-methylbenzamido, methoxycarbonyl, ethoxycarbonyl, benzoyl, methylcarbonyl, piperidinylcarbonyl, morpholinylcarbonyl, trifluoromethylcarbonyl, aminocarbonyl, methylaminocarbonyl, dimethylaminocarbonyl, (C1-C6)-alkoxy, (C3-C6)-cycloalkyl, or heteroaryl, heterocyclyl or phenyl each substituted by s radicals from the group of methyl, ethyl, methoxy, trifluoromethyl and halogen,


n is 0, 1 or 2,


s is 0, 1, 2 or 3,


and


(B) one or more herbicides (component B) selected from groups (B1) to (B11):


B1 1,3-diketo compounds comprising


prohexadione, prohexadione-calcium, trinexapac-ethyl, alloxydim, alloxydim-sodium, butroxydim, clethodim, cycloxydim, ketospiradox, profoxydim, sethoxydim, tepraloxydim, tralkoxydim, mesotrione, sulcotrione, tefuryltrione, tembotrione, bicyclopyrone, pinoxaden,


B2 (sulfon)amides comprising


beflubutamide, bromobutide, dimethenamide, dimethenamide-P, diphenamide, napropamide, pethoxamid, N-[3-chloro-4-(1-methylethyl)-phenyl]-2-methylpentanamide, propyzamide, diflufenican, etobenzanid, flufenacet, mefenacet, mefluidide, picolinafen, propanil, N-phenylphthalamic acid, acetochlor, alachlor, amidochlor, butachlor, butenachlor, dimethachlor, metazachlor, metolachlor, S-metolachlor, pretilachlor, propachlor, propisochlor, (2-chloro-6′-ethyl-N-isopropoxymethylaceto-o-toluidide), thenylchlor, asulam, carbaryl, carbetamide, chlorpropham, desmedipham, phenmedipham, propham, butylate, cycloate, dimepiperate, EPTC, esprocarb, methasulfocarb, molinate, orbencarb, pebulate, prosulfocarb, pyributicarb, thiobencarb, tri-allate, vernolate, amidosulfuron, azimsulfuron, bensulfuron, bensulfuron-methyl, chlorimuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron-methyl-sodium, foramsulfuron, halosulfuron-methyl, imazosulfuron, iodosulfuron, iodosulfuron-methyl-sodium, mesosulfuron, mesosulfuron-methyl, metazosulfuron, methiopyrsulfuron, metsulfuron, metsulfuron-methyl, monosulfuron, monosulfuron-ester, nicosulfuron, orthosulfamuron, oxasulfuron, primisulfuron-methyl, propyrisulfuron, prosulfuron, pyrazosulfuron, pyrazosulfuron-ethyl, rimsulfuron, sulfometuron, sulfometuron-methyl, sulfosulfuron, thifensulfuron, thifensulfuron-methyl, triasulfuron, tribenuron, tribenuron-methyl, trifloxysulfuron, trifloxysulfuron (sodium), triflusulfuron, triflusulfuron-methyl, tritosulfuron, (benzoic acid, 2-[[[[[4-methoxy-6-(methylthio)-2-pyrimidinyl]amino]carbonyl]amino]sulfonyl]methyl ester), flucarbazone, flucarbazone-sodium, ipfencarbazone, propoxycarbazone, propoxycarbazone-sodium, thiencarbazone, thiencarbazone-methyl, cloransulam, cloransulam-methyl, diclosulam, florasulam, flumetsulam, metosulam, penoxsulam, pyroxsulam, 3-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-1-methyl-4-(5-methyl-5,6-dihydro-1,4,2-dioxazin-3-yl)-1H-pyrazole-5-sulfonamide,


B3 arylnitriles comprising


bromoxynil, bromoxynil-butyrate, bromoxynil-potassium, bromoxynil-heptanoate, bromoxynil-octanoate, detosyl-pyrazolate (DTP), dichlobenil, ioxynil, ioxynil-octanoate, ioxynil-potassium, ioxynil-sodium, pyraclonil,


B4 azoles comprising


benzofenap, pyrazolynate (pyrazolate), pyrazoxyfen, pyroxasulfone, topramezone, pyrasulfotole, 3-(3-chloro-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-1-methyl-5-(trifluoromethyl)-1H-pyrazole, 3-(3-iodo-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-1-methyl-5-(trifluoromethyl)-1H-pyrazole, 1-ethyl-3-(3-fl uoro-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-5-(trifluoromethyl)-1H-pyrazole, pyraflufen, pyraflufen-ethyl, fenoxasulfone, isouron, isoxaben, isoxaflutole, imazamethabenz, imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropyl-ammonium, imazaquin, imazaquin-ammonium, imazethapyr, imazethapyr-immonium, azafenidin, oxadiargyl, oxadiazon, amicarbazone, carfentrazone, carfentrazone-ethyl, sulfentrazone, amitrole, paclobutrazol, uniconazole, uniconazole-P, cafenstrole, fentrazamide,


B5 other herbicides comprising


allidochlor, aminocyclopyrachlor, aminocyclopyrachlor-potassium, aminocyclopyrachlor-methyl, N-acetylthiazolidine-4-carboxylic acid, aminopyralid, ammonium pelargonate, ammonium sulfamate, aviglycine, benazolin, benazolin-ethyl, benfluralin, benfuresate, bentazone, benzobicyclon, 6-benzylaminopurine, brassinolide, bromofenoxim, butralin, chlorfenac, chlorfenac-sodium, chlorfenprop, chlorflurenol, chlorflurenol-methyl, chloridazon, chlormequat chloride, chlorphthalim, chlorthal-dimethyl, cinidon, cinidon-ethyl, cinmethylin, clofencet, clomazone, cloxyfonac, cyanamide, cyclanilide, cyclopyrimorate, 6-isopentylaminopurine, kinetin, zeatin, dalapon, daminozide, dazomet, n-decanol, difenzoquat metilsulfate, 2,6-diisopropylnaphthalene, dikegulac, dikegulac-sodium, dimethipin, dinitramine, dinoterb, diquat, diquat dibromide, dithiopyr, DNOC, endothal, endothal-dipotassium, endothal-disodium, endothal-mono(N,N-dimethylalkylammonium), ethafluralin, ethofumesate, ethylchlozate, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, fluchloralin, flufenpyr, flufenpyr-ethyl, flumetralin, flumichlorac, flumiclorac-pentyl, flumioxazin, flupropanate, flurenol, flurenol-butyl, flurenol-dimethylammonium-methyl, fluridone, flurochloridone, flurtamone, fluthiacet, fluthiacet-methyl, gibberillic acid, halauxifen, indanofan, isoprothiolane, maleic hydrazide, mepiquat chloride, metam, methiozolin, methylarsonic acid, 1-methylcyclopropene, methyl isothiocyanate, nitrophenolate mixture, nonanoic acid, norflurazon, oleic acid, oryzalin, oxaziclomefone, paraquat, paraquat dichloride, pendimethalin, pentachlorophenol, pentoxazone, petroleum oils, prodiamine, n-propyl dihydrojasmonate, pyridafol, pyridate, quinoclamine, sintofen, TCA, TCA sodium, tecnazene, thiazopyr, triacontanol, triafamone, trifluralin, urea sulfate,


B6 (het)arylcarboxylic acids comprising


chloramben, dicamba, 2,3,6-TBA, clopyralid, fluroxypyr, fluroxypyr-meptyl, inabenfide, picloram, triclopyr, quinclorac, quinmerac, indol-3-ylacetic acid, 4-indol-3-yl-butyric acid, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthyloxyacetic acid,


B7 organic phosphorus compounds comprising


anilofos, bensulide, bilanafos, bilanafos-sodium, butamifos, clacyfos, fosamine, glufosinate, glufosinate salts, glufosinate-ammonium, glufosinate-sodium, glufosinate-P, L-glufosinate-ammonium, L-glufosinate-sodium, glyphosate, glyphosate salts, glyphosate-isopropyl-ammonium, glyphosate-ammonium, glyphosate-dimethylammonium, glyphosate-trimesium (=sulfosate), glyphosate-diammonium, glyphosate-potassium, glyphosate-sodium, piperophos, ethephon, tribufos,


B8 phenyl ethers comprising


acifluorfen-sodium, aclonifen, fluoroglycofen, fluoroglycofen-ethyl, fomesafen, fomesafen-sodium, halosafen, lactofen, oxyfluorfen, acifluorfen, bifenox, ethoxyfen-ethyl, clomeprop, cloprop, dichlorprop, dichlorprop-P, mecoprop, mecoprop-sodium, mecoprop-butotyl, mecoprop-P, mecoprop-P-butotyl, mecoprop-P-dimethylammonium, mecoprop-P-2-ethylhexyl, mecoprop-P-patassium, 4-CPA, 2,4-D, 2,4-D-butotyl, 2,4-D-butyl, 2,4-D-dimethylammonium, 2,4-D-diolamine, 2,4-D-ethyl, 2,4-D-2-ethylhexyl, 2,4-D-isobutyl, 2,4-D-isooctyl, 2,4-D-isopropylammonium, 2,4-D-potassium, 2,4-D-triisopropanolammonium, 2,4-D-trolamine, MCPA, MCPA-butotyl, MCPA-dimethylammonium, MCPA-2-ethylhexyl, MCPA-isopropylammonium, MCPA-potassium, MCPA-sodium, 2,4-DB, MCPB, MCPB-methyl, MCPB-ethyl-sodium, clodinafop-ethyl, clodinafop-propargyl, cyhalofop, cyhalofop-butyl, diclofop, diclofop-P, diclofop-methyl, diclofop-P-methyl, fenoxaprop, fenoxaprop-P, fenoxaprop-P-ethyl, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, haloxyfop, haloxyfop-P, metamifop, propaquizafop quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl,


B9 pyrimidines, comprising


ancymidol, flurprimidol, pyrimisulfan, bispyribac, bispyribac-sodium, pyribenzoxim, pyriminobac, pyriminobac-methyl, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyriftalid, pyrithiobac, pyrithiobac-sodium, bromacil, butafenacil, lenacil, saflufenacil, terbacil, tifenacil, 2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1 (2H)-yl]-N-[methyl(1-methylethyl)sulfamoyl]benzamide, ethyl [(3-{2-chloro-5-[2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1 (2H)-yl]-4-fluorophenoxy}pyridin-2-yl)oxy]acetate,


B10 (thio)ureas comprising


cumyluron, chlorbromuron, chlorotoluron, daimuron, diflufenzopyr, diflufenzopyr-sodium, dimefuron, diuron, fluometuron, forchlorfenuron, isoproturon, karbutilate, linuron, metobromuron, metoxuron, monolinuron, neburon, siduron, terbucarb, thidiazuron, tebuthiuron, methabenzthiazuron,


B11 triazines comprising


triaziflam, indaziflam, atrazine, cyanazine, cyprazine, propazine, simazine, terbumeton, terbuthylazine, trietazine, prometon, ametryn, dimethametryn, prometryn, simetryn, terbutryn, ethiozin, hexazinon, metamitron, metribuzin.







DETAIL DESCRIPTION OF A PREFERRED EMBODIMENT

In a further embodiment, these herbicidal compositions comprise (C) one or more safeners (component C) from the group consisting of benoxacor (C1), cloquintocet-mexyl (C2), cyprosulfamide (C3), dichlormid (C4), fenclorim (C5), fenchlorazole (C6), furilazole (C7), isoxadifen-ethyl (C8), mefenpyr-diethyl (C9), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS 71526-07-3) (C10), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (CAS 52836-31-4) (C11), 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}sulfonyl)benzamide (CAS 129531-12-0) (C12).


Components B) and C) are known, for example, from “The Pesticide Manual”, 16th edition, 2012, The British Crop Protection Council and the Royal Soc. of Chemistry.


The inventive herbicidal compositions may comprise or be used together with additional further components, for example other kinds of active crop protection ingredients and/or additives and/or formulation auxiliaries customary in crop protection.


The herbicides (A), (B) and optionally the safeners (C) can be applied in a known manner, for example together (for example as a co-formulation or as a tank-mix) or else at different times in short succession (splitting), for example to the plants, plant parts, plant seeds or the area on which the plants grow. It is possible, for example, to apply the individual active ingredients or the herbicide-safener combination in several portions (sequential application), for example by pre-emergence applications followed by post-emergence applications, or by early post-emergence applications followed by post-emergence applications at an intermediate or late stage. Preference is given to the joint or immediately successive application of the active ingredients in the respective combination. It is also possible to use the individual active ingredients or the herbicide-safener combination for seed treatment.


Preference is given to those inventive compositions which comprise, as herbicide (A), compounds of the general formula (I) and salts thereof in which


A is N or CY,


R is hydrogen, (C1-C6)-alkyl, (C3-C7)-cycloalkyl, halo-(C1-C6)-alkyl, (C3-C7)-cycloalkylmethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, acetylmethyl, methoxymethyl, methoxyethyl, benzyl, pyrazin-2-yl, furan-2-yl, tetrahydrofuran-2-yl, morpholine, dimethylamino, or phenyl substituted by s radicals from the group of methyl, methoxy, trifluoromethyl and halogen;


X is nitro, halogen, cyano, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, OR1, S(O)nR2, (C1-C6)-alkyl-S(O)nR2, (C1-C6)-alkyl-OR1, (C1-C6)-alkyl-CON(R1)2, (C1-C6)-alkyl-SO2N(R1)2, (C1-C6)-alkyl-NR1COR1, (C1-C6)-alkyl-NR1SO2R2, (C1-C6)-alkylheteroaryl, (C1-C6)-alkylheterocyclyl, where the two latter radicals are each substituted by s halogen, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, S(O)n—(C1-C6)-alkyl, (C1-C6)-alkoxy, halo-(C1-C6)-alkoxy radicals, and where heterocyclyl bears n oxo groups,


Y hydrogen, nitro, halogen, cyano, (C1-C6)-alkyl, (C1-C6)-haloalkyl, OR1, S(O)nR2, SO2N(R1)2, N(R1)2, NR1SO2R2, NR1COR1, (C1-C6)-alkyl-S(O)nR2, (C1-C6)-alkyl-OR1, (C1-C6)-alkyl-CON(R1)2, (C1-C6)-alkyl-SO2N(R1)2, (C1-C6)-alkyl-NR1COR1, (C1-C6)-alkyl-NR1SO2R2, (C1-C6)-alkylphenyl, (C1-C6)-alkylheteroaryl, (C1-C6)-alkylheterocyclyl, phenyl, heteroaryl or heterocyclyl, where the 6 latter radicals are each substituted by s radicals from the group consisting of halogen, nitro, cyano, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, S(O)n—(C1-C6)-alkyl, (C1-C6)-alkoxy, halo-(C1-C6)-alkoxy, (C1-C6)-alkoxy-(C1-C4)-alkyl and cyanomethyl, and where heterocyclyl bears n oxo groups,


Z is halogen, cyano, nitro, methyl, halo-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, S(O)nR2, 1,2,4-triazol-1-yl, pyrazol-1-yl, or


Z may also be hydrogen if Y is the S(O)nR2 radical,


R1 is hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, (C1-C6)-alkyl-O—(C1-C6)-alkyl, phenyl, phenyl-(C1-C6)-alkyl, heteroaryl, (C1-C6)-alkylheteroaryl, heterocyclyl, (C1-C6)-alkylheterocyclyl, (C1-C6)-alkyl-O-heteroaryl, (C1-C6)-alkyl-O-heterocyclyl, (C1-C6)-alkyl-NR3-heteroaryl or (C1-C6)-alkyl-NR3-heterocyclyl, where the 16 latter radicals are substituted by s radicals from the group consisting of cyano, halogen, nitro, OR3, S(O)nR4, N(R3)2, NR3OR3, COR3, OCOR3, NR3COR3, NR3SO2R4, COO2R3, CON(R3)2 and (C1-C4)-alkoxy-(C2-C6)-alkoxycarbonyl, and where heterocyclyl bears n oxo groups,


R2 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl or (C3-C6)-cycloalkyl-(C1-C6)-alkyl, where these three aforementioned radicals are each substituted by s radicals from the group consisting of halogen and OR3,


R3 is hydrogen or (C1-C6)-alkyl,


R4 is (C1-C6)-alkyl,


n is 0, 1 or 2,


s is 0, 1, 2 or 3.


Particular preference is given to inventive compositions which comprise, as herbicide (A), compounds of the general formula (I) and salts thereof in which


A is N or CY,


R is hydrogen, (C1-C4)-alkyl, cyclopropyl, halo-(C1-C4)-alkyl, (C3-C6)-cycloalkylmethyl, methoxymethyl, methoxyethyl, benzyl,


X is nitro, halogen, cyano, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, cyclopropyl, OR1, S(O)nR2, (C1-C6)-alkyl-S(O)nR2, (C1-C5)-alkyl-OR1, (C1-C2)-alkylheteroaryl, (C1-C2)-alkylheterocyclyl, where the two latter radicals are each substituted by s halogen, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, S(O)n—(C1-C6)-alkyl, (C1-C6)-alkoxy, halo-(C1-C6)-alkoxy radicals, and where heterocyclyl bears n oxo groups,


Y hydrogen, nitro, halogen, cyano, (C1-C6)-alkyl, (C1-C6)-haloalkyl, OR1, S(O)nR2, SO2N(R1)2, N(R1)2, NR1SO2R2, NR1COR1, (C1-C6)-alkyl-S(O)nR2, (C1-C6)-alkyl-OR1, (C1-C6)-alkyl-CON(R1)2, (C1-C6)-alkyl-SO2N(R1)2, (C1-C6)-alkyl-NR1COR1, (C1-C6)-alkyl-NR1SO2R2, (C1-C6)-alkylphenyl, (C1-C6)-alkylheteroaryl, (C1-C6)-alkylheterocyclyl, phenyl, heteroaryl or heterocyclyl, where the 6 latter radicals are each substituted by s radicals from the group consisting of halogen, nitro, cyano, (C1-C6)-alkyl, halo-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, S(O)n—(C1-C6)-alkyl, (C1-C6)-alkoxy, halo-(C1-C6)-alkoxy, (C1-C6)-alkoxy-(C1-C4)-alkyl and cyanomethyl, and where heterocyclyl bears n oxo groups,


Z is halogen, cyano, nitro, methyl, halo-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, S(O)nR2, 1,2,4-triazol-1-yl, pyrazol-1-yl, or


R1 is hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, (C1-C6)-alkyl-O—(C1-C6)-alkyl, phenyl, phenyl-(C1-C6)-alkyl, heteroaryl, (C1-C6)-alkylheteroaryl, heterocyclyl, (C1-C6)-alkylheterocyclyl, (C1-C6)-alkyl-O-heteroaryl, (C1-C6)-alkyl-O-heterocyclyl, (C1-C6)-alkyl-NR3-heteroaryl or (C1-C6)-alkyl-NR3-heterocyclyl, where the 16 latter radicals are substituted by s radicals from the group consisting of cyano, halogen, nitro, OR3, S(O)nR4, N(R3)2, NR3OR3, COR3, OCOR3, NR3COR3, NR3SO2R4, CO2R3, CON(R3)2 and (C1-C4)-alkoxy-(C2-C6)-alkoxycarbonyl, and where heterocyclyl bears n oxo groups,


R2 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl or (C3-C6)-cycloalkyl-(C1-C6)-alkyl, where these three aforementioned radicals are each substituted by s radicals from the group consisting of halogen and OR3,


R3 is hydrogen or (C1-C6)-alkyl,


R4 is (C1-C6)-alkyl,


n is 0, 1 or 2,


s is 0, 1, 2 or 3.


In the formula (I) and all the formulae which follow, alkyl radicals having more than two carbon atoms may be straight-chain or branched. Alkyl radicals are, for example, methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls such as n-hexyl, i-hexyl and 1,3-dimethylbutyl. Analogously, alkenyl is, for example, allyl, 1-methylprop-2-en-1-yl, 2-methylprop-2-en-1-yl, but-2-en-1-yl, but-3-en-1-yl, 1-methylbut-3-en-1-yl and 1-methylbut-2-en-1-yl. Alkynyl is, for example, propargyl, but-2-yn-1-yl, but-3-ynl-yl, 1-methylbut-3-yn-1-yl. The multiple bond may be in any position in each unsaturated radical. Cycloalkyl is a carbocyclic saturated ring system having three to six carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. Analogously, cycloalkenyl is a monocyclic alkenyl group having three to six carbon ring members, for example cyclopropenyl, cyclobutenyl, cyclopentenyl and cyclohexenyl, where the double bond may be in any position.


Halogen is fluorine, chlorine, bromine or iodine.


Heterocyclyl is a saturated, partly saturated or fully unsaturated cyclic radical which contains 3 to 6 ring atoms, of which 1 to 4 are from the group of oxygen, nitrogen and sulfur, and which may additionally be fused by a benzo ring. For example, heterocyclyl is piperidinyl, pyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl and oxetanyl.


Heteroaryl is an aromatic cyclic radical which contains 3 to 6 ring atoms, of which 1 to 4 are from the group of oxygen, nitrogen and sulfur, and which may additionally be fused by a benzo ring. Heteroaryl represents, for example, benzimidazol-2-yl, furanyl, imidazolyl, isoxazolyl, isothiazolyl, oxazolyl, pyrazinyl, pyrimidinyl, pyridazinyl, pyridinyl, benzisoxazolyl, thiazolyl, pyrrolyl, pyrazolyl, thiophenyl, 1,2,3-oxadiazolyl, 1,2,4-oxadiazolyl, 1,2,5-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,4-triazolyl, 1,2,3-triazolyl, 1,2,5-triazolyl, 1,3,4-triazolyl, 1,2,4-triazolyl, 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,3-thiadiazolyl, 1,2,5-thiadiazolyl, 2H-1,2,3,4-tetrazolyl, 1H-1,2,3,4-tetrazolyl, 1,2,3,4-oxatriazolyl, 1,2,3,5-oxatriazolyl, 1,2,3,4-thiatriazolyl and 1,2,3,5-thiatriazolyl.


When a group is polysubstituted by radicals, this means that this group is substituted by one or more identical or different radicals from those mentioned. The same applies to the formation of ring systems by different atoms and elements. At the same time, the scope of the claims shall exclude those compounds known by the person skilled in the art to be chemically unstable under standard conditions.


The present invention also provides herbicidal compositions comprising stereoisomers and mixtures thereof which are encompassed by formula (I) or by the formulae of component B. Such compounds of the formula (I) or of the formulae of component B contain, for example, one or more asymmetrically substituted carbon atoms or sulfoxides. The possible stereoisomers defined by the specific three-dimensional shape thereof, such as enantiomers and diastereomers, are all encompassed by the formula (I) or by components (B) and (C); especially also the racemic mixtures and—where enantiomers are possible—both enantiomers and especially the respective biologically active enantiomer. The individual stereoisomers can be obtained by customary methods from mixtures of the stereoisomers or else be prepared by stereoselective reactions in combination with the use of stereochemically pure starting materials or auxiliaries.


Examples of compounds very particularly preferred as herbicide (A) are listed in the tables which follow.


In these tables, the abbreviations used mean:

















Et = ethyl
Me = methyl
n-Pr = n-propyl
i-Pr = isopropyl


c-Pr = cyclopropyl
Ph = phenyl
Ac = acetyl
i-Bu = isobutyl
















TABLE 1







Compounds of the general formula (I) in which A is CY




embedded image
















Ex. no.
R
X
Y
Z





A1-1
Me
Cl
CH2OCH2CF3
SO2Me


A1-2
c-Pr
Cl
SO2Me
CF3


A1-3
CH2OMe
Me
SO2Me
CF3


A1-4
Me
Me
OEt
SO2Me


A1-5
Me
Cl
OEt
SO2Me


A1-6
Me
Cl
SEt
CF3


A1-7
Me
Cl
SO2Et
CF3


A1-8
Et
Me
SO2Me
CF3


A1-9
Me
Cl
SOMe
c-Pr


A1-10
Me
Cl
5-cyano-4,5-dihydro-
SO2Et





1,2-oxazol-3-yl



A1-11
CH2OMe
Me
SMe
CF3


A1-12
Et
Cl
SO2Me
CF3


A1-13
Me
Me
SO2Me
CF3


A1-14
Me
Cl
SOMe
CF3


A1-15
CH2OEt
Cl
SO2Me
CF3


A1-16
Me
Cl
2H-1,2,3-triazol-2-yl
SO2Me


A1-17
Me
Cl
O—CH2CH2SMe
Cl


A1-18
Me
Cl
OCH2CH2OCF3
SO2Et


A1-19
Me
Cl
OCH2CF3
SO2Me


A1-20
Me
Cl
SO2Me
Me


A1-21
Me
CH2OMe
SO2Me
CF3


A1-22
Me
Cl
OCH2CH2OEt
SO2Et


A1-23
Me
Cl
OCH2CH2Cl
SO2Et


A1-24
Et
Cl
5-cyano-4,5-dihydro-
SO2Et





1,2-oxazol-3-yl



A1-25
Me
Me
SMe
CF3


A1-26
Me
Cl
OCH2CH2Cl
SO2Me


A1-27
Me
Cl
OCH2CH2CH2SMe
Cl


A1-28
Me
Cl
SCH2-c-Pr
CF3


A1-29
CH2F
Me
SO2Me
CF3


A1-30
Me
Cl
O-propargyl
SO2Me


A1-31
Me
Cl
1H-1,2,3-triazol-1-yl
CF3


A1-32
H
Cl
CH2OCH2CF3
SO2Me


A1-33
Me
Cl
3-Br-1H-pyrazol-1-yl
SO2Me


A1-34
c-Pr
Me
SOMe
CF3


A1-35
Et
Cl
SO2Me
SO2Me


A1-36
Me
Cl
SO2Me
CF3


A1-37
Me
Me
4,5-dihydro-1,2-oxazol-3-yl
SO2Me


A1-38
Me
Me
1H-pyrazol-1-yl
SO2Me


A1-39
Me
Cl
O—nPr
SO2Me


A1-40
Me
Cl
OCH2CH2CH2OMe
SO2Et


A1-41
Me
Cl
O—nPr
SO2Et


A1-42
CH2OMe
Cl
SOMe
CF3


A1-43
CH2OMe
Cl
SO2Me
CF3


A1-44
Me
Cl
5-ethyl-4,5-dihydro-1,2-
Cl





oxazol-3-yl



A1-45
Me
Me
N(Me)CHO
CF3


A1-46
Me
Cl
N(CO)-pyrrolidine
Cl


A1-47
CF3
Me
SO2Me
SO2Me


A1-48
Me
Me
4-OMe-1H-pyrazol-1-yl
SO2Me


A1-49
Me
Me
1H-1,2,3-triazol-1-yl
SO2Me


A1-50
Me
Cl
OCH2CH2CH2OMe
SO2Me


A1-51
Me
Cl
OCHF2
SO2Me


A1-52
Me
Me
1H-pyrazol-1-yl
CF3


A1-53
Me
Cl
OCH2CH2CH2SCF3
SO2Me


A1-54
CHF2
Me
SO2Me
CF3


A1-55
Me
Cl
1H-pyrazol-1-yl
CF3


A1-56
Me
Cl
OCH2—cPr
SO2Me


A1-57
Me
Cl
OCH2CH2F
SO2Me


A1-58
Me
Me
SMe
C2F5


A1-59
Me
Cl
OMe
SO2Me


A1-60
Me
Me
SOMe
CF3


A1-61
Me
Br
1H-pyrazol-1-yl
C2F5
















TABLE 2







Compounds of the general formula (I) in which A is nitrogen




embedded image















Ex. no.
R
X
Z





A2-1
Me
Me
CF3


A2-2
pyrazin-2-yl
Cl
CF3


A2-3
Me
Br
CF3


A2-4
Me
Cl
CF3









Preferred herbicides of group B1 are clethodim, sethoxydim, tepraloxydim, mesotrione, sulcotrione, tefuryltrione, tembotrione, bicyclopyrone, pinoxaden, tralkoxydim. Particularly preferred herbicides of group B1 are clethodim (B1-1), sulcotrione (B1-2), tefuryltrione (B1-3), tembotrione (B1-4), bicyclopyrone (B1-5), pinoxaden (B1-6).


Preferred herbicides of group B2 are dimethenamide, dimethenamide-P, napropamide, pethoxamid, propyzamide, diflufenican, flufenacet, mefenacet, picolinafen, propanil, acetochlor, alachlor, butachlor, metazachlor, metolachlor, S-metolachlor, pretilachlor, thenylchlor, asulam, carbetamide, desmedipham, phenmedipham, esprocarb, molinate, prosulfocarb, thiobencarb, amidosulfuron, chlorimuron-ethyl, cyclosulfamuron, ethoxysulfuron, flupyrsulfuron-methyl-sodium, foramsulfuron, iodosulfuron-methyl-sodium, mesosulfuron-methyl, nicosulfuron, orthosulfamuron, prosulfuron, pyrazosulfuron-ethyl, rimsulfuron, trifloxysulfuron (sodium), flucarbazone-sodium, propoxycarbazone-sodium, thiencarbazone-methyl, florasulam, metosulam, penoxsulam, metsulfuron-methyl, sulfosulfuron, thifensulfuron-methyl, tribenuron-methyl, tritosulfuron, pyroxsulam.


Particularly preferred herbicides of group B2 are dimethenamide-P (B2-1), napropamide (B2-2), diflufenican (B2-3), flufenacet (B2-4), mefenacet (B2-5), acetochlor (B2-6), metazachlor (B2-7), S-metolachlor (B2-8), asulam (B2-9), desmedipham (B2-10), phenmedipham (B2-11), molinate (B2-12), prosulfocarb (B2-13), amidosulfuron (B2-14), ethoxysulfuron (B2-15), foramsulfuron (B2-16), iodosulfuron-methyl-sodium (B2-17), mesosulfuron-methyl (B2-18), flucarbazone-sodium (B2-19), propoxycarbazone-sodium (B2-20), thiencarbazone-methyl (B2-21), florasulam (B2-22), metosulam (B2-23), metsulfuron-methyl (B2-24), sulfosulfuron (B2-25), thifensulfuron-methyl (B2-26), tribenuron-methyl (B2-27), tritosulfuron (B2-28), pyroxsulam (B2-29).


Preferred herbicides of group B3 are bromoxynil (B3-1) and ioxynil (B3-2).


Preferred herbicides of group B4 are benzofenap, topramezone, pyrasulfotole, isoxaflutole, imazamox, imazethapyr, oxadiargyl, oxadiazon, amicarbazone, carfentrazone-ethyl, sulfentrazone, uniconazole, cafenstrole, fentrazamide, 3-(3-chloro-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-1-methyl-5-(trifluoromethyl)-1H-pyrazole, 3-(3-iodo-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-1-methyl-5-(trifluoromethyl)-1H-pyrazole, 1-ethyl-3-(3-fluoro-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-5-(trifluoromethyl)-1H-pyrazole, pyraflufen-ethyl.


Particularly preferred herbicides of group B4 are pyrasulfotole (B4-1), isoxaflutole (B4-2), oxadiargyl (B4-3), oxadiazon (B4-4), amicarbazone (B4-5), fentrazamide (B4-6), 3-(3-chloro-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-1-methyl-5-(trifluoromethyl)-1H-pyrazole (B4-7), 3-(3-iodo-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-1-methyl-5-(trifluoromethyl)-1H-pyrazole (B4.8), 1-ethyl-3-(3-fluoro-5-{[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]oxy}phenoxy)-5-(trifluoromethyl)-1H-pyrazole (B4-9), pyraflufen-ethyl (B4-10), imazamox (B4-11).


Preferred herbicides of group B5 are aminopyralid, benazolin, benfuresate, bentazone, cinidon-ethyl, clomazone, diquat dibromide, ethofumesate, flumiclorac-pentyl, flumioxazin, flurtamone, oxaziclomefone, pendimethalin, pyridate and trifluralin. Particularly preferred herbicides of group B5 are aminopyralid (B5-1), benfuresate (B5-2), ethofumesate (B5-3), flurtamone (B5-4) and oxaziclomefone (B5-5). Preferred herbicides of group B6 are dicamba (B6-1), clopyralid (B6-2), fluroxypyr (B6-3), picloram (B6-4), triclopyr (B6-5), quinclorac (B6-6).


Preferred herbicides of group B7 are anilofos (B7-1), glufosinate-ammonium (B7-2), L-glufosinate-ammonium (B7-3), glyphosate (B7-4), glyphosate-isopropyl-ammonium (B7-5), glyphosate-ammonium (B7-6), glyphosate-trimesium (=sulfosate (B7-7)), glyphosate-diammonium (B7-7), glyphosate-potassium (B7-8).


Preferred herbicides of group B8 are acifluorfen-sodium, aclonifen, fluoroglycofen-ethyl, oxyfluorfen, bifenox, dichlorprop-P, mecoprop-P, 2,4-D, MCPA, clodinafop-propargyl, cyhalofop-butyl, diclofop-methyl, diclofop-P-methyl, fenoxaprop-P-ethyl, fluazifop-P-butyl, quizalofop-P.


Particularly preferred herbicides of group B8 are aclonifen (B8-1), diclofop-methyl (B8-2), diclofop-P-methyl (B8-3), fenoxaprop-P-ethyl (B8-4), MCPA (B8-5), 2,4-D (B8-6), clodinafop-ethyl (B8-7).


Preferred herbicides of group B9 are bispyribac (sodium), pyriftalid, bromacil, lenacil, 2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1 (2H)-yl]-N-[methyl(1-methylethyl)sulfamoyl]benzamide. Particularly preferred herbicides of group B9 are bispyribac (sodium) (B9-1), bromacil (B9-2).


Preferred herbicides of group B10 are cumyluron (B10-1), daimuron (B10-2), diuron (B10-3), isoproturon (B10-4), diflufenzopyr (B10-5).


Preferred herbicides of group B11 are atrazine, simazine, terbuthylazine, ametryn, terbutryn, metamitron, metribuzin.


Particularly preferred herbicides of group B11 are metamitron (B11-1), metribuzin (B11-2), terbuthylazine (B11-2).


Examples of preferred compositions of herbicides (A) and herbicides (B) are given below.


(A1-1)+(B1-1), (A1-1)+(B1-2), (A1-1)+(B1-3), (A1-1)+(B1-4), (A1-1)+(B1-5), (A1-1)+(B1-6), (A1-1)+(B2-1), (A1-1)+(B2-2), (A1-1)+(B2-3), (A1-1)+(B2-4), (A1-1)+(B2-5), (A1-1)+(B2-6), (A1-1)+(B2-7), (A1-1)+(B2-8), (A1-1)+(B2-9), (A1-1)+(B2-10), (A1-1)+(B2-11), (A1-1)+(B2-12), (A1-1)+(B2-13), (A1-1)+(B2-14), (A1-1)+(B2-15), (A1-1)+(B2-16), (A1-1)+(B2-17), (A1-1)+(B2-18), (A1-1)+(B2-19), (A1-1)+(B2-20), (A1-1)+(B2-21), (A1-1)+(B2-22), (A1-1)+(B2-23), (A1-1)+(B2-24), (A1-1)+(B2-25), (A1-1)+(B2-26), (A1-1)+(B2-27), (A1-1)+(B2-28), (A1-1)+(B2-29), (A1-1)+(B3-1), (A1-1)+(B3-2), (A1-1)+(B4-1), (A1-1)+(B4-2), (A1-1)+(B4-3), (A1-1)+(B4-4), (A1-1)+(B4-5), (A1-1)+(B4-6), (A1-1)+(B4-7), (A1-1)+(B4-8), (A1-1)+(B4-9), (A1-1)+(B4-10), (A1-1)+(B4-11), (A1-1)+(B5-1), (A1-1)+(B5-2), (A1-1)+(B5-3), (A1-1)+(B5-4), (A1-1)+(B5-5), (A1-1)+(B6-1), (A1-1)+(B6-2), (A1-1)+(B6-3), (A1-1)+(B6-4), (A1-1)+(B6-5), (A1-1)+(B6-6), (A1-1)+(B7-1), (A1-1)+(B7-2), (A1-1)+(B7-3), (A1-1)+(B7-4), (A1-1)+(B7-5), (A1-1)+(B7-6), (A1-1)+(B7-7)), (A1-1)+(B7-7), (A1-1)+(B7-8), (A1-1)+(B8-1), (A1-1)+(B8-2), (A1-1)+(B8-3), (A1-1)+(B8-4), (A1-1)+(B8-5), (A1-1)+(B8-6), (A1-1)+(B8-7), (A1-1)+(B9-1), (A1-1)+(B9-2), (A1-1)+(B10-1), (A1-1)+(B10-2), (A1-1)+(B10-3), (A1-1)+(B10-4), (A1-1)+(B10-5), (A1-1)+(B11-1), (A1-1)+(B11-2), (A1-1)+(B11-2),


(A1-2)+(B1-1), (A1-2)+(B1-2), (A1-2)+(B1-3), (A1-2)+(B1-4), (A1-2)+(B1-5), (A1-2)+(B1-6), (A1-2)+(B2-1), (A1-2)+(B2-2), (A1-2)+(B2-3), (A1-2)+(B2-4), (A1-2)+(B2-5), (A1-2)+(B2-6), (A1-2)+(B2-7), (A1-2)+(B2-8), (A1-2)+(B2-9), (A1-2)+(B2-10), (A1-2)+(B2-11), (A1-2)+(B2-12), (A1-2)+(B2-13), (A1-2)+(B2-14), (A1-2)+(B2-15), (A1-2)+(B2-16), (A1-2)+(B2-17), (A1-2)+(B2-18), (A1-2)+(B2-19), (A1-2)+(B2-20), (A1-2)+(B2-21), (A1-2)+(B2-22), (A1-2)+(B2-23), (A1-2)+(B2-24), (A1-2)+(B2-25), (A1-2)+(B2-26), (A1-2)+(B2-27), (A1-2)+(B2-28), (A1-2)+(B2-29), (A1-2)+(B3-1), (A1-2)+(B3-2), (A1-2)+(B4-1), (A1-2)+(B4-2), (A1-2)+(B4-3), (A1-2)+(B4-4), (A1-2)+(B4-5), (A1-2)+(B4-6), (A1-2)+(B4-7), (A1-2)+(B4-8), (A1-2)+(B4-9), (A1-2)+(B4-10), (A1-2)+(B4-11), (A1-2)+(B5-1), (A1-2)+(B5-2), (A1-2)+(B5-3), (A1-2)+(B5-4), (A1-2)+(B5-5), (A1-2)+(B6-1), (A1-2)+(B6-2), (A1-2)+(B6-3), (A1-2)+(B6-4), (A1-2)+(B6-5), (A1-2)+(B6-6), (A1-2)+(B7-1), (A1-2)+(B7-2), (A1-2)+(B7-3), (A1-2)+(B7-4), (A1-2)+(B7-5), (A1-2)+(B7-6), (A1-2)+(B7-7)), (A1-2)+(B7-7), (A1-2)+(B7-8), (A1-2)+(B8-1), (A1-2)+(B8-2), (A1-2)+(B8-3), (A1-2)+(B8-4), (A1-2)+(B8-5), (A1-2)+(B8-6), (A1-2)+(B8-7), (A1-2)+(B9-1), (A1-2)+(B9-2), (A1-2)+(B10-1), (A1-2)+(B10-2), (A1-2)+(B10-3), (A1-2)+(B10-4), (A1-2)+(B10-5), (A1-2)+(B11-1), (A1-2)+(B11-2), (A1-2)+(B11-2),


(A1-3)+(B1-1), (A1-3)+(B1-2), (A1-3)+(B1-3), (A1-3)+(B1-4), (A1-3)+(B1-5), (A1-3)+(B1-6), (A1-3)+(B2-1), (A1-3)+(B2-2), (A1-3)+(B2-3), (A1-3)+(B2-4), (A1-3)+(B2-5), (A1-3)+(B2-6), (A1-3)+(B2-7), (A1-3)+(B2-8), (A1-3)+(B2-9), (A1-3)+(B2-10), (A1-3)+(B2-11), (A1-3)+(B2-12), (A1-3)+(B2-13), (A1-3)+(B2-14), (A1-3)+(B2-15), (A1-3)+(B2-16), (A1-3)+(B2-17), (A1-3)+(B2-18), (A1-3)+(B2-19), (A1-3)+(B2-20), (A1-3)+(B2-21), (A1-3)+(B2-22), (A1-3)+(B2-23), (A1-3)+(B2-24), (A1-3)+(B2-25), (A1-3)+(B2-26), (A1-3)+(B2-27), (A1-3)+(B2-28), (A1-3)+(B2-29), (A1-3)+(B3-1), (A1-3)+(B3-2), (A1-3)+(B4-1), (A1-3)+(B4-2), (A1-3)+(B4-3), (A1-3)+(B4-4), (A1-3)+(B4-5), (A1-3)+(B4-6), (A1-3)+(B4-7), (A1-3)+(B4-8), (A1-3)+(B4-9), (A1-3)+(B4-10), (A1-3)+(B4-11), (A1-3)+(B5-1), (A1-3)+(B5-2), (A1-3)+(B5-3), (A1-3)+(B5-4), (A1-3)+(B5-5), (A1-3)+(B6-1), (A1-3)+(B6-2), (A1-3)+(B6-3), (A1-3)+(B6-4), (A1-3)+(B6-5), (A1-3)+(B6-6), (A1-3)+(B7-1), (A1-3)+(B7-2), (A1-3)+(B7-3), (A1-3)+(B7-4), (A1-3)+(B7-5), (A1-3)+(B7-6), (A1-3)+(B7-7)), (A1-3)+(B7-7), (A1-3)+(B7-8), (A1-3)+(B8-1), (A1-3)+(B8-2), (A1-3)+(B8-3), (A1-3)+(B8-4), (A1-3)+(B8-5), (A1-3)+(B8-6), (A1-3)+(B8-7), (A1-3)+(B9-1), (A1-3)+(B9-2), (A1-3)+(B10-1), (A1-3)+(B10-2), (A1-3)+(B10-3), (A1-3)+(B10-4), (A1-3)+(B10-5), (A1-3)+(B11-1), (A1-3)+(B11-2), (A1-3)+(B11-2),


(A1-4)+(B1-1), (A1-4)+(B1-2), (A1-4)+(B1-3), (A1-4)+(B1-4), (A1-4)+(B1-5), (A1-4)+(B1-6), (A1-4)+(B2-1), (A1-4)+(B2-2), (A1-4)+(B2-3), (A1-4)+(B2-4), (A1-4)+(B2-5), (A1-4)+(B2-6), (A1-4)+(B2-7), (A1-4)+(B2-8), (A1-4)+(B2-9), (A1-4)+(B2-10), (A1-4)+(B2-11), (A1-4)+(B2-12), (A1-4)+(B2-13), (A1-4)+(B2-14), (A1-4)+(B2-15), (A1-4)+(B2-16), (A1-4)+(B2-17), (A1-4)+(B2-18), (A1-4)+(B2-19), (A1-4)+(B2-20), (A1-4)+(B2-21), (A1-4)+(B2-22), (A1-4)+(B2-23), (A1-4)+(B2-24), (A1-4)+(B2-25), (A1-4)+(B2-26), (A1-4)+(B2-27), (A1-4)+(B2-28), (A1-4)+(B2-29), (A1-4)+(B3-1), (A1-4)+(B3-2), (A1-4)+(B4-1), (A1-4)+(B4-2), (A1-4)+(B4-3), (A1-4)+(B4-4), (A1-4)+(B4-5), (A1-4)+(B4-6), (A1-4)+(B4-7), (A1-4)+(B4-8), (A1-4)+(B4-9), (A1-4)+(B4-10), (A1-4)+(B4-11), (A1-4)+(B5-1), (A1-4)+(B5-2), (A1-4)+(B5-3), (A1-4)+(B5-4), (A1-4)+(B5-5), (A1-4)+(B6-1), (A1-4)+(B6-2), (A1-4)+(B6-3), (A1-4)+(B6-4), (A1-4)+(B6-5), (A1-4)+(B6-6), (A1-4)+(B7-1), (A1-4)+(B7-2), (A1-4)+(B7-3), (A1-4)+(B7-4), (A1-4)+(B7-5), (A1-4)+(B7-6), (A1-4)+(B7-7)), (A1-4)+(B7-7), (A1-4)+(B7-8), (A1-4)+(B8-1), (A1-4)+(B8-2), (A1-4)+(B8-3), (A1-4)+(B8-4), (A1-4)+(B8-5), (A1-4)+(B8-6), (A1-4)+(B8-7), (A1-4)+(B9-1), (A1-4)+(B9-2), (A1-4)+(B10-1), (A1-4)+(B10-2), (A1-4)+(B10-3), (A1-4)+(B10-4), (A1-4)+(B10-5), (A1-4)+(B11-1), (A1-4)+(B11-2), (A1-4)+(B11-2),


(A1-5)+(B1-1), (A1-5)+(B1-2), (A1-5)+(B1-3), (A1-5)+(B1-4), (A1-5)+(B1-5), (A1-5)+(B1-6), (A1-5)+(B2-1), (A1-5)+(B2-2), (A1-5)+(B2-3), (A1-5)+(B2-4), (A1-5)+(B2-5), (A1-5)+(B2-6), (A1-5)+(B2-7), (A1-5)+(B2-8), (A1-5)+(B2-9), (A1-5)+(B2-10), (A1-5)+(B2-11), (A1-5)+(B2-12), (A1-5)+(B2-13), (A1-5)+(B2-14), (A1-5)+(B2-15), (A1-5)+(B2-16), (A1-5)+(B2-17), (A1-5)+(B2-18), (A1-5)+(B2-19), (A1-5)+(B2-20), (A1-5)+(B2-21), (A1-5)+(B2-22), (A1-5)+(B2-23), (A1-5)+(B2-24), (A1-5)+(B2-25), (A1-5)+(B2-26), (A1-5)+(B2-27), (A1-5)+(B2-28), (A1-5)+(B2-29), (A1-5)+(B3-1), (A1-5)+(B3-2), (A1-5)+(B4-1), (A1-5)+(B4-2), (A1-5)+(B4-3), (A1-5)+(B4-4), (A1-5)+(B4-5), (A1-5)+(B4-6), (A1-5)+(B4-7), (A1-5)+(B4-8), (A1-5)+(B4-9), (A1-5)+(B4-10), (A1-5)+(B4-11), (A1-5)+(B5-1), (A1-5)+(B5-2), (A1-5)+(B5-3), (A1-5)+(B5-4), (A1-5)+(B5-5), (A1-5)+(B6-1), (A1-5)+(B6-2), (A1-5)+(B6-3), (A1-5)+(B6-4), (A1-5)+(B6-5), (A1-5)+(B6-6), (A1-5)+(B7-1), (A1-5)+(B7-2), (A1-5)+(B7-3), (A1-5)+(B7-4), (A1-5)+(B7-5), (A1-5)+(B7-6), (A1-5)+(B7-7)), (A1-5)+(B7-7), (A1-5)+(B7-8), (A1-5)+(B8-1), (A1-5)+(B8-2), (A1-5)+(B8-3), (A1-5)+(B8-4), (A1-5)+(B8-5), (A1-5)+(B8-6), (A1-5)+(B8-7), (A1-5)+(B9-1), (A1-5)+(B9-2), (A1-5)+(B10-1), (A1-5)+(B10-2), (A1-5)+(B10-3), (A1-5)+(B10-4), (A1-5)+(B10-5), (A1-5)+(B11-1), (A1-5)+(B11-2), (A1-5)+(B11-2),


(A1-6)+(B1-1), (A1-6)+(B1-2), (A1-6)+(B1-3), (A1-6)+(B1-4), (A1-6)+(B1-5), (A1-6)+(B1-6), (A1-6)+(B2-1), (A1-6)+(B2-2), (A1-6)+(B2-3), (A1-6)+(B2-4), (A1-6)+(B2-5), (A1-6)+(B2-6), (A1-6)+(B2-7), (A1-6)+(B2-8), (A1-6)+(B2-9), (A1-6)+(B2-10), (A1-6)+(B2-11), (A1-6)+(B2-12), (A1-6)+(B2-13), (A1-6)+(B2-14), (A1-6)+(B2-15), (A1-6)+(B2-16), (A1-6)+(B2-17), (A1-6)+(B2-18), (A1-6)+(B2-19), (A1-6)+(B2-20), (A1-6)+(B2-21), (A1-6)+(B2-22), (A1-6)+(B2-23), (A1-6)+(B2-24), (A1-6)+(B2-25), (A1-6)+(B2-26), (A1-6)+(B2-27), (A1-6)+(B2-28), (A1-6)+(B2-29), (A1-6)+(B3-1), (A1-6)+(B3-2), (A1-6)+(B4-1), (A1-6)+(B4-2), (A1-6)+(B4-3), (A1-6)+(B4-4), (A1-6)+(B4-5), (A1-6)+(B4-6), (A1-6)+(B4-7), (A1-6)+(B4-8), (A1-6)+(B4-9), (A1-6)+(B4-10), (A1-6)+(B4-11), (A1-6)+(B5-1), (A1-6)+(B5-2), (A1-6)+(B5-3), (A1-6)+(B5-4), (A1-6)+(B5-5), (A1-6)+(B6-1), (A1-6)+(B6-2), (A1-6)+(B6-3), (A1-6)+(B6-4), (A1-6)+(B6-5), (A1-6)+(B6-6), (A1-6)+(B7-1), (A1-6)+(B7-2), (A1-6)+(B7-3), (A1-6)+(B7-4), (A1-6)+(B7-5), (A1-6)+(B7-6), (A1-6)+(B7-7)), (A1-6)+(B7-7), (A1-6)+(B7-8), (A1-6)+(B8-1), (A1-6)+(B8-2), (A1-6)+(B8-3), (A1-6)+(B8-4), (A1-6)+(B8-5), (A1-6)+(B8-6), (A1-6)+(B8-7), (A1-6)+(B9-1), (A1-6)+(B9-2), (A1-6)+(B10-1), (A1-6)+(B10-2), (A1-6)+(B10-3), (A1-6)+(B10-4), (A1-6)+(B10-5), (A1-6)+(B11-1), (A1-6)+(B11-2), (A1-6)+(B11-2),


(A1-7)+(B1-1), (A1-7)+(B1-2), (A1-7)+(B1-3), (A1-7)+(B1-4), (A1-7)+(B1-5), (A1-7)+(B1-6), (A1-7)+(B2-1), (A1-7)+(B2-2), (A1-7)+(B2-3), (A1-7)+(B2-4), (A1-7)+(B2-5), (A1-7)+(B2-6), (A1-7)+(B2-7), (A1-7)+(B2-8), (A1-7)+(B2-9), (A1-7)+(B2-10), (A1-7)+(B2-11), (A1-7)+(B2-12), (A1-7)+(B2-13), (A1-7)+(B2-14), (A1-7)+(B2-15), (A1-7)+(B2-16), (A1-7)+(B2-17), (A1-7)+(B2-18), (A1-7)+(B2-19), (A1-7)+(B2-20), (A1-7)+(B2-21), (A1-7)+(B2-22), (A1-7)+(B2-23), (A1-7)+(B2-24), (A1-7)+(B2-25), (A1-7)+(B2-26), (A1-7)+(B2-27), (A1-7)+(B2-28), (A1-7)+(B2-29), (A1-7)+(B3-1), (A1-7)+(B3-2), (A1-7)+(B4-1), (A1-7)+(B4-2), (A1-7)+(B4-3), (A1-7)+(B4-4), (A1-7)+(B4-5), (A1-7)+(B4-6), (A1-7)+(B4-7), (A1-7)+(B4-8), (A1-7)+(B4-9), (A1-7)+(B4-10), (A1-7)+(B4-11), (A1-7)+(B5-1), (A1-7)+(B5-2), (A1-7)+(B5-3), (A1-7)+(B5-4), (A1-7)+(B5-5), (A1-7)+(B6-1), (A1-7)+(B6-2), (A1-7)+(B6-3), (A1-7)+(B6-4), (A1-7)+(B6-5), (A1-7)+(B6-6), (A1-7)+(B7-1), (A1-7)+(B7-2), (A1-7)+(B7-3), (A1-7)+(B7-4), (A1-7)+(B7-5), (A1-7)+(B7-6), (A1-7)+(B7-7)), (A1-7)+(B7-7), (A1-7)+(B7-8), (A1-7)+(B8-1), (A1-7)+(B8-2), (A1-7)+(B8-3), (A1-7)+(B8-4), (A1-7)+(B8-5), (A1-7)+(B8-6), (A1-7)+(B8-7), (A1-7)+(B9-1), (A1-7)+(B9-2), (A1-7)+(B10-1), (A1-7)+(B10-2), (A1-7)+(B10-3), (A1-7)+(B10-4), (A1-7)+(B10-5), (A1-7)+(B11-1), (A1-7)+(B11-2), (A1-7)+(B11-2),


(A1-8)+(B1-1), (A1-8)+(B1-2), (A1-8)+(B1-3), (A1-8)+(B1-4), (A1-8)+(B1-5), (A1-8)+(B1-6), (A1-8)+(B2-1), (A1-8)+(B2-2), (A1-8)+(B2-3), (A1-8)+(B2-4), (A1-8)+(B2-5), (A1-8)+(B2-6), (A1-8)+(B2-7), (A1-8)+(B2-8), (A1-8)+(B2-9), (A1-8)+(B2-10), (A1-8)+(B2-11), (A1-8)+(B2-12), (A1-8)+(B2-13), (A1-8)+(B2-14), (A1-8)+(B2-15), (A1-8)+(B2-16), (A1-8)+(B2-17), (A1-8)+(B2-18), (A1-8)+(B2-19), (A1-8)+(B2-20), (A1-8)+(B2-21), (A1-8)+(B2-22), (A1-8)+(B2-23), (A1-8)+(B2-24), (A1-8)+(B2-25), (A1-8)+(B2-26), (A1-8)+(B2-27), (A1-8)+(B2-28), (A1-8)+(B2-29), (A1-8)+(B3-1), (A1-8)+(B3-2), (A1-8)+(B4-1), (A1-8)+(B4-2), (A1-8)+(B4-3), (A1-8)+(B4-4), (A1-8)+(B4-5), (A1-8)+(B4-6), (A1-8)+(B4-7), (A1-8)+(B4-8), (A1-8)+(B4-9), (A1-8)+(B4-10), (A1-8)+(B4-11), (A1-8)+(B5-1), (A1-8)+(B5-2), (A1-8)+(B5-3), (A1-8)+(B5-4), (A1-8)+(B5-5), (A1-8)+(B6-1), (A1-8)+(B6-2), (A1-8)+(B6-3), (A1-8)+(B6-4), (A1-8)+(B6-5), (A1-8)+(B6-6), (A1-8)+(B7-1), (A1-8)+(B7-2), (A1-8)+(B7-3), (A1-8)+(B7-4), (A1-8)+(B7-5), (A1-8)+(B7-6), (A1-8)+(B7-7)), (A1-8)+(B7-7), (A1-8)+(B7-8), (A1-8)+(B8-1), (A1-8)+(B8-2), (A1-8)+(B8-3), (A1-8)+(B8-4), (A1-8)+(B8-5), (A1-8)+(B8-6), (A1-8)+(B8-7), (A1-8)+(B9-1), (A1-8)+(B9-2), (A1-8)+(B10-1), (A1-8)+(B10-2), (A1-8)+(B10-3), (A1-8)+(B10-4), (A1-8)+(B10-5), (A1-8)+(B11-1), (A1-8)+(B11-2), (A1-8)+(B11-2),


(A1-9)+(B1-1), (A1-9)+(B1-2), (A1-9)+(B1-3), (A1-9)+(B1-4), (A1-9)+(B1-5), (A1-9)+(B1-6), (A1-9)+(B2-1), (A1-9)+(B2-2), (A1-9)+(B2-3), (A1-9)+(B2-4), (A1-9)+(B2-5), (A1-9)+(B2-6), (A1-9)+(B2-7), (A1-9)+(B2-8), (A1-9)+(B2-9), (A1-9)+(B2-10), (A1-9)+(B2-11), (A1-9)+(B2-12), (A1-9)+(B2-13), (A1-9)+(B2-14), (A1-9)+(B2-15), (A1-9)+(B2-16), (A1-9)+(B2-17), (A1-9)+(B2-18), (A1-9)+(B2-19), (A1-9)+(B2-20), (A1-9)+(B2-21), (A1-9)+(B2-22), (A1-9)+(B2-23), (A1-9)+(B2-24), (A1-9)+(B2-25), (A1-9)+(B2-26), (A1-9)+(B2-27), (A1-9)+(B2-28), (A1-9)+(B2-29), (A1-9)+(B3-1), (A1-9)+(B3-2), (A1-9)+(B4-1), (A1-9)+(B4-2), (A1-9)+(B4-3), (A1-9)+(B4-4), (A1-9)+(B4-5), (A1-9)+(B4-6), (A1-9)+(B4-7), (A1-9)+(B4-8), (A1-9)+(B4-9), (A1-9)+(B4-10), (A1-9)+(B4-11), (A1-9)+(B5-1), (A1-9)+(B5-2), (A1-9)+(B5-3), (A1-9)+(B5-4), (A1-9)+(B5-5), (A1-9)+(B6-1), (A1-9)+(B6-2), (A1-9)+(B6-3), (A1-9)+(B6-4), (A1-9)+(B6-5), (A1-9)+(B6-6), (A1-9)+(B7-1), (A1-9)+(B7-2), (A1-9)+(B7-3), (A1-9)+(B7-4), (A1-9)+(B7-5), (A1-9)+(B7-6), (A1-9)+(B7-7)), (A1-9)+(B7-7), (A1-9)+(B7-8), (A1-9)+(B8-1), (A1-9)+(B8-2), (A1-9)+(B8-3), (A1-9)+(B8-4), (A1-9)+(B8-5), (A1-9)+(B8-6), (A1-9)+(B8-7), (A1-9)+(B9-1), (A1-9)+(B9-2), (A1-9)+(B10-1), (A1-9)+(B10-2), (A1-9)+(B10-3), (A1-9)+(B10-4), (A1-9)+(B10-5), (A1-9)+(B11-1), (A1-9)+(B11-2), (A1-9)+(B11-2),


(A1-10)+(B1-1), (A1-10)+(B1-2), (A1-10)+(B1-3), (A1-10)+(B1-4), (A1-10)+(B1-5), (A1-10)+(B1-6), (A1-10)+(B2-1), (A1-10)+(B2-2), (A1-10)+(B2-3), (A1-10)+(B2-4), (A1-10)+(B2-5), (A1-10)+(B2-6), (A1-10)+(B2-7), (A1-10)+(B2-8), (A1-10)+(B2-9), (A1-10)+(B2-10), (A1-10)+(B2-11), (A1-10)+(B2-12), (A1-10)+(B2-13), (A1-10)+(B2-14), (A1-10)+(B2-15), (A1-10)+(B2-16), (A1-10)+(B2-17), (A1-10)+(B2-18), (A1-10)+(B2-19), (A1-10)+(B2-20), (A1-10)+(B2-21), (A1-10)+(B2-22), (A1-10)+(B2-23), (A1-10)+(B2-24), (A1-10)+(B2-25), (A1-10)+(B2-26), (A1-10)+(B2-27), (A1-10)+(B2-28), (A1-10)+(B2-29), (A1-10)+(B3-1), (A1-10)+(B3-2), (A1-10)+(B4-1), (A1-10)+(B4-2), (A1-10)+(B4-3), (A1-10)+(B4-4), (A1-10)+(B4-5), (A1-10)+(B4-6), (A1-10)+(B4-7), (A1-10)+(B4-8), (A1-10)+(B4-9), (A1-10)+(B4-10), (A1-10)+(B4-11), (A1-10)+(B5-1), (A1-10)+(B5-2), (A1-10)+(B5-3), (A1-10)+(B5-4), (A1-10)+(B5-5), (A1-10)+(B6-1), (A1-10)+(B6-2), (A1-10)+(B6-3), (A1-10)+(B6-4), (A1-10)+(B6-5), (A1-10)+(B6-6), (A1-10)+(B7-1), (A1-10)+(B7-2), (A1-10)+(B7-3), (A1-10)+(B7-4), (A1-10)+(B7-5), (A1-10)+(B7-6), (A1-10)+(B7-7)), (A1-10)+(B7-7), (A1-10)+(B7-8), (A1-10)+(B8-1), (A1-10)+(B8-2), (A1-10)+(B8-3), (A1-10)+(B8-4), (A1-10)+(B8-5), (A1-10)+(B8-6), (A1-10)+(B8-7), (A1-10)+(B9-1), (A1-10)+(B9-2), (A1-10)+(B10-1), (A1-10)+(B10-2), (A1-10)+(B10-3), (A1-10)+(B10-4), (A1-10)+(B10-5), (A1-10)+(B11-1), (A1-10)+(B11-2), (A1-10)+(B11-2),


(A1-11)+(B1-1), (A1-11)+(B1-2), (A1-11)+(B1-3), (A1-11)+(B1-4), (A1-11)+(B1-5), (A1-11)+(B1-6), (A1-11)+(B2-1), (A1-11)+(B2-2), (A1-11)+(B2-3), (A1-11)+(B2-4), (A1-11)+(B2-5), (A1-11)+(B2-6), (A1-11)+(B2-7), (A1-11)+(B2-8), (A1-11)+(B2-9), (A1-11)+(B2-10), (A1-11)+(B2-11), (A1-11)+(B2-12), (A1-11)+(B2-13), (A1-11)+(B2-14), (A1-11)+(B2-15), (A1-11)+(B2-16), (A1-11)+(B2-17), (A1-11)+(B2-18), (A1-11)+(B2-19), (A1-11)+(B2-20), (A1-11)+(B2-21), (A1-11)+(B2-22), (A1-11)+(B2-23), (A1-11)+(B2-24), (A1-11)+(B2-25), (A1-11)+(B2-26), (A1-11)+(B2-27), (A1-11)+(B2-28), (A1-11)+(B2-29), (A1-11)+(B3-1), (A1-11)+(B3-2), (A1-11)+(B4-1), (A1-11)+(B4-2), (A1-11)+(B4-3), (A1-11)+(B4-4), (A1-11)+(B4-5), (A1-11)+(B4-6), (A1-11)+(B4-7), (A1-11)+(B4-8), (A1-11)+(B4-9), (A1-11)+(B4-10), (A1-11)+(B4-11), (A1-11)+(B5-1), (A1-11)+(B5-2), (A1-11)+(B5-3), (A1-11)+(B5-4), (A1-11)+(B5-5), (A1-11)+(B6-1), (A1-11)+(B6-2), (A1-11)+(B6-3), (A1-11)+(B6-4), (A1-11)+(B6-5), (A1-11)+(B6-6), (A1-11)+(B7-1), (A1-11)+(B7-2), (A1-11)+(B7-3), (A1-11)+(B7-4), (A1-11)+(B7-5), (A1-11)+(B7-6), (A1-11)+(B7-7)), (A1-11)+(B7-7), (A1-11)+(B7-8), (A1-11)+(B8-1), (A1-11)+(B8-2), (A1-11)+(B8-3), (A1-11)+(B8-4), (A1-11)+(B8-5), (A1-11)+(B8-6), (A1-11)+(B8-7), (A1-11)+(B9-1), (A1-11)+(B9-2), (A1-11)+(B10-1), (A1-11)+(B10-2), (A1-11)+(B10-3), (A1-11)+(B10-4), (A1-11)+(B10-5), (A1-11)+(B11-1), (A1-11)+(B11-2), (A1-11)+(B11-2),


(A1-12)+(B1-1), (A1-12)+(B1-2), (A1-12)+(B1-3), (A1-12)+(B1-4), (A1-12)+(B1-5), (A1-12)+(B1-6), (A1-12)+(B2-1), (A1-12)+(B2-2), (A1-12)+(B2-3), (A1-12)+(B2-4), (A1-12)+(B2-5), (A1-12)+(B2-6), (A1-12)+(B2-7), (A1-12)+(B2-8), (A1-12)+(B2-9), (A1-12)+(B2-10), (A1-12)+(B2-11), (A1-12)+(B2-12), (A1-12)+(B2-13), (A1-12)+(B2-14), (A1-12)+(B2-15), (A1-12)+(B2-16), (A1-12)+(B2-17), (A1-12)+(B2-18), (A1-12)+(B2-19), (A1-12)+(B2-20), (A1-12)+(B2-21), (A1-12)+(B2-22), (A1-12)+(B2-23), (A1-12)+(B2-24), (A1-12)+(B2-25), (A1-12)+(B2-26), (A1-12)+(B2-27), (A1-12)+(B2-28), (A1-12)+(B2-29), (A1-12)+(B3-1), (A1-12)+(B3-2), (A1-12)+(B4-1), (A1-12)+(B4-2), (A1-12)+(B4-3), (A1-12)+(B4-4), (A1-12)+(B4-5), (A1-12)+(B4-6), (A1-12)+(B4-7), (A1-12)+(B4-8), (A1-12)+(B4-9), (A1-12)+(B4-10), (A1-12)+(B4-11), (A1-12)+(B5-1), (A1-12)+(B5-2), (A1-12)+(B5-3), (A1-12)+(B5-4), (A1-12)+(B5-5), (A1-12)+(B6-1), (A1-12)+(B6-2), (A1-12)+(B6-3), (A1-12)+(B6-4), (A1-12)+(B6-5), (A1-12)+(B6-6), (A1-12)+(B7-1), (A1-12)+(B7-2), (A1-12)+(B7-3), (A1-12)+(B7-4), (A1-12)+(B7-5), (A1-12)+(B7-6), (A1-12)+(B7-7)), (A1-12)+(B7-7), (A1-12)+(B7-8), (A1-12)+(B8-1), (A1-12)+(B8-2), (A1-12)+(B8-3), (A1-12)+(B8-4), (A1-12)+(B8-5), (A1-12)+(B8-6), (A1-12)+(B8-7), (A1-12)+(B9-1), (A1-12)+(B9-2), (A1-12)+(B10-1), (A1-12)+(B10-2), (A1-12)+(B10-3), (A1-12)+(B10-4), (A1-12)+(B10-5), (A1-12)+(B11-1), (A1-12)+(B11-2), (A1-12)+(B11-2),


(A1-13)+(B1-1), (A1-13)+(B1-2), (A1-13)+(B1-3), (A1-13)+(B1-4), (A1-13)+(B1-5), (A1-13)+(B1-6), (A1-13)+(B2-1), (A1-13)+(B2-2), (A1-13)+(B2-3), (A1-13)+(B2-4), (A1-13)+(B2-5), (A1-13)+(B2-6), (A1-13)+(B2-7), (A1-13)+(B2-8), (A1-13)+(B2-9), (A1-13)+(B2-10), (A1-13)+(B2-11), (A1-13)+(B2-12), (A1-13)+(B2-13), (A1-13)+(B2-14), (A1-13)+(B2-15), (A1-13)+(B2-16), (A1-13)+(B2-17), (A1-13)+(B2-18), (A1-13)+(B2-19), (A1-13)+(B2-20), (A1-13)+(B2-21), (A1-13)+(B2-22), (A1-13)+(B2-23), (A1-13)+(B2-24), (A1-13)+(B2-25), (A1-13)+(B2-26), (A1-13)+(B2-27), (A1-13)+(B2-28), (A1-13)+(B2-29), (A1-13)+(B3-1), (A1-13)+(B3-2), (A1-13)+(B4-1), (A1-13)+(B4-2), (A1-13)+(B4-3), (A1-13)+(B4-4), (A1-13)+(B4-5), (A1-13)+(B4-6), (A1-13)+(B4-7), (A1-13)+(B4-8), (A1-13)+(B4-9), (A1-13)+(B4-10), (A1-13)+(B4-11), (A1-13)+(B5-1), (A1-13)+(B5-2), (A1-13)+(B5-3), (A1-13)+(B5-4), (A1-13)+(B5-5), (A1-13)+(B6-1), (A1-13)+(B6-2), (A1-13)+(B6-3), (A1-13)+(B6-4), (A1-13)+(B6-5), (A1-13)+(B6-6), (A1-13)+(B7-1), (A1-13)+(B7-2), (A1-13)+(B7-3), (A1-13)+(B7-4), (A1-13)+(B7-5), (A1-13)+(B7-6), (A1-13)+(B7-7)), (A1-13)+(B7-7), (A1-13)+(B7-8), (A1-13)+(B8-1), (A1-13)+(B8-2), (A1-13)+(B8-3), (A1-13)+(B8-4), (A1-13)+(B8-5), (A1-13)+(B8-6), (A1-13)+(B8-7), (A1-13)+(B9-1), (A1-13)+(B9-2), (A1-13)+(B10-1), (A1-13)+(B10-2), (A1-13)+(B10-3), (A1-13)+(B10-4), (A1-13)+(B10-5), (A1-13)+(B11-1), (A1-13)+(B11-2), (A1-13)+(B11-2),


(A1-14)+(B1-1), (A1-14)+(B1-2), (A1-14)+(B1-3), (A1-14)+(B1-4), (A1-14)+(B1-5), (A1-14)+(B1-6), (A1-14)+(B2-1), (A1-14)+(B2-2), (A1-14)+(B2-3), (A1-14)+(B2-4), (A1-14)+(B2-5), (A1-14)+(B2-6), (A1-14)+(B2-7), (A1-14)+(B2-8), (A1-14)+(B2-9), (A1-14)+(B2-10), (A1-14)+(B2-11), (A1-14)+(B2-12), (A1-14)+(B2-13), (A1-14)+(B2-14), (A1-14)+(B2-15), (A1-14)+(B2-16), (A1-14)+(B2-17), (A1-14)+(B2-18), (A1-14)+(B2-19), (A1-14)+(B2-20), (A1-14)+(B2-21), (A1-14)+(B2-22), (A1-14)+(B2-23), (A1-14)+(B2-24), (A1-14)+(B2-25), (A1-14)+(B2-26), (A1-14)+(B2-27), (A1-14)+(B2-28), (A1-14)+(B2-29), (A1-14)+(B3-1), (A1-14)+(B3-2), (A1-14)+(B4-1), (A1-14)+(B4-2), (A1-14)+(B4-3), (A1-14)+(B4-4), (A1-14)+(B4-5), (A1-14)+(B4-6), (A1-14)+(B4-7), (A1-14)+(B4-8), (A1-14)+(B4-9), (A1-14)+(B4-10), (A1-14)+(B4-11), (A1-14)+(B5-1), (A1-14)+(B5-2), (A1-14)+(B5-3), (A1-14)+(B5-4), (A1-14)+(B5-5), (A1-14)+(B6-1), (A1-14)+(B6-2), (A1-14)+(B6-3), (A1-14)+(B6-4), (A1-14)+(B6-5), (A1-14)+(B6-6), (A1-14)+(B7-1), (A1-14)+(B7-2), (A1-14)+(B7-3), (A1-14)+(B7-4), (A1-14)+(B7-5), (A1-14)+(B7-6), (A1-14)+(B7-7)), (A1-14)+(B7-7), (A1-14)+(B7-8), (A1-14)+(B8-1), (A1-14)+(B8-2), (A1-14)+(B8-3), (A1-14)+(B8-4), (A1-14)+(B8-5), (A1-14)+(B8-6), (A1-14)+(B8-7), (A1-14)+(B9-1), (A1-14)+(B9-2), (A1-14)+(B10-1), (A1-14)+(B10-2), (A1-14)+(B10-3), (A1-14)+(B10-4), (A1-14)+(B10-5), (A1-14)+(B11-1), (A1-14)+(B11-2), (A1-14)+(B11-2),


(A1-15)+(B1-1), (A1-15)+(B1-2), (A1-15)+(B1-3), (A1-15)+(B1-4), (A1-15)+(B1-5), (A1-15)+(B1-6), (A1-15)+(B2-1), (A1-15)+(B2-2), (A1-15)+(B2-3), (A1-15)+(B2-4), (A1-15)+(B2-5), (A1-15)+(B2-6), (A1-15)+(B2-7), (A1-15)+(B2-8), (A1-15)+(B2-9), (A1-15)+(B2-10), (A1-15)+(B2-11), (A1-15)+(B2-12), (A1-15)+(B2-13), (A1-15)+(B2-14), (A1-15)+(B2-15), (A1-15)+(B2-16), (A1-15)+(B2-17), (A1-15)+(B2-18), (A1-15)+(B2-19), (A1-15)+(B2-20), (A1-15)+(B2-21), (A1-15)+(B2-22), (A1-15)+(B2-23), (A1-15)+(B2-24), (A1-15)+(B2-25), (A1-15)+(B2-26), (A1-15)+(B2-27), (A1-15)+(B2-28), (A1-15)+(B2-29), (A1-15)+(B3-1), (A1-15)+(B3-2), (A1-15)+(B4-1), (A1-15)+(B4-2), (A1-15)+(B4-3), (A1-15)+(B4-4), (A1-15)+(B4-5), (A1-15)+(B4-6), (A1-15)+(B4-7), (A1-15)+(B4-8), (A1-15)+(B4-9), (A1-15)+(B4-10), (A1-15)+(B4-11), (A1-15)+(B5-1), (A1-15)+(B5-2), (A1-15)+(B5-3), (A1-15)+(B5-4), (A1-15)+(B5-5), (A1-15)+(B6-1), (A1-15)+(B6-2), (A1-15)+(B6-3), (A1-15)+(B6-4), (A1-15)+(B6-5), (A1-15)+(B6-6), (A1-15)+(B7-1), (A1-15)+(B7-2), (A1-15)+(B7-3), (A1-15)+(B7-4), (A1-15)+(B7-5), (A1-15)+(B7-6), (A1-15)+(B7-7)), (A1-15)+(B7-7), (A1-15)+(B7-8), (A1-15)+(B8-1), (A1-15)+(B8-2), (A1-15)+(B8-3), (A1-15)+(B8-4), (A1-15)+(B8-5), (A1-15)+(B8-6), (A1-15)+(B8-7), (A1-15)+(B9-1), (A1-15)+(B9-2), (A1-15)+(B10-1), (A1-15)+(B10-2), (A1-15)+(B10-3), (A1-15)+(B10-4), (A1-15)+(B10-5), (A1-15)+(B11-1), (A1-15)+(B11-2), (A1-15)+(B11-2),


(A1-16)+(B1-1), (A1-16)+(B1-2), (A1-16)+(B1-3), (A1-16)+(B1-4), (A1-16)+(B1-5), (A1-16)+(B1-6), (A1-16)+(B2-1), (A1-16)+(B2-2), (A1-16)+(B2-3), (A1-16)+(B2-4), (A1-16)+(B2-5), (A1-16)+(B2-6), (A1-16)+(B2-7), (A1-16)+(B2-8), (A1-16)+(B2-9), (A1-16)+(B2-10), (A1-16)+(B2-11), (A1-16)+(B2-12), (A1-16)+(B2-13), (A1-16)+(B2-14), (A1-16)+(B2-15), (A1-16)+(B2-16), (A1-16)+(B2-17), (A1-16)+(B2-18), (A1-16)+(B2-19), (A1-16)+(B2-20), (A1-16)+(B2-21), (A1-16)+(B2-22), (A1-16)+(B2-23), (A1-16)+(B2-24), (A1-16)+(B2-25), (A1-16)+(B2-26), (A1-16)+(B2-27), (A1-16)+(B2-28), (A1-16)+(B2-29), (A1-16)+(B3-1), (A1-16)+(B3-2), (A1-16)+(B4-1), (A1-16)+(B4-2), (A1-16)+(B4-3), (A1-16)+(B4-4), (A1-16)+(B4-5), (A1-16)+(B4-6), (A1-16)+(B4-7), (A1-16)+(B4-8), (A1-16)+(B4-9), (A1-16)+(B4-10), (A1-16)+(B4-11), (A1-16)+(B5-1), (A1-16)+(B5-2), (A1-16)+(B5-3), (A1-16)+(B5-4), (A1-16)+(B5-5), (A1-16)+(B6-1), (A1-16)+(B6-2), (A1-16)+(B6-3), (A1-16)+(B6-4), (A1-16)+(B6-5), (A1-16)+(B6-6), (A1-16)+(B7-1), (A1-16)+(B7-2), (A1-16)+(B7-3), (A1-16)+(B7-4), (A1-16)+(B7-5), (A1-16)+(B7-6), (A1-16)+(B7-7)), (A1-16)+(B7-7), (A1-16)+(B7-8), (A1-16)+(B8-1), (A1-16)+(B8-2), (A1-16)+(B8-3), (A1-16)+(B8-4), (A1-16)+(B8-5), (A1-16)+(B8-6), (A1-16)+(B8-7), (A1-16)+(B9-1), (A1-16)+(B9-2), (A1-16)+(B10-1), (A1-16)+(B10-2), (A1-16)+(B10-3), (A1-16)+(B10-4), (A1-16)+(B10-5), (A1-16)+(B11-1), (A1-16)+(B11-2), (A1-16)+(B11-2),


(A1-17)+(B1-1), (A1-17)+(B1-2), (A1-17)+(B1-3), (A1-17)+(B1-4), (A1-17)+(B1-5), (A1-17)+(B1-6), (A1-17)+(B2-1), (A1-17)+(B2-2), (A1-17)+(B2-3), (A1-17)+(B2-4), (A1-17)+(B2-5), (A1-17)+(B2-6), (A1-17)+(B2-7), (A1-17)+(B2-8), (A1-17)+(B2-9), (A1-17)+(B2-10), (A1-17)+(B2-11), (A1-17)+(B2-12), (A1-17)+(B2-13), (A1-17)+(B2-14), (A1-17)+(B2-15), (A1-17)+(B2-16), (A1-17)+(B2-17), (A1-17)+(B2-18), (A1-17)+(B2-19), (A1-17)+(B2-20), (A1-17)+(B2-21), (A1-17)+(B2-22), (A1-17)+(B2-23), (A1-17)+(B2-24), (A1-17)+(B2-25), (A1-17)+(B2-26), (A1-17)+(B2-27), (A1-17)+(B2-28), (A1-17)+(B2-29), (A1-17)+(B3-1), (A1-17)+(B3-2), (A1-17)+(B4-1), (A1-17)+(B4-2), (A1-17)+(B4-3), (A1-17)+(B4-4), (A1-17)+(B4-5), (A1-17)+(B4-6), (A1-17)+(B4-7), (A1-17)+(B4-8), (A1-17)+(B4-9), (A1-17)+(B4-10), (A1-17)+(B4-11), (A1-17)+(B5-1), (A1-17)+(B5-2), (A1-17)+(B5-3), (A1-17)+(B5-4), (A1-17)+(B5-5), (A1-17)+(B6-1), (A1-17)+(B6-2), (A1-17)+(B6-3), (A1-17)+(B6-4), (A1-17)+(B6-5), (A1-17)+(B6-6), (A1-17)+(B7-1), (A1-17)+(B7-2), (A1-17)+(B7-3), (A1-17)+(B7-4), (A1-17)+(B7-5), (A1-17)+(B7-6), (A1-17)+(B7-7)), (A1-17)+(B7-7), (A1-17)+(B7-8), (A1-17)+(B8-1), (A1-17)+(B8-2), (A1-17)+(B8-3), (A1-17)+(B8-4), (A1-17)+(B8-5), (A1-17)+(B8-6), (A1-17)+(B8-7), (A1-17)+(B9-1), (A1-17)+(B9-2), (A1-17)+(B10-1), (A1-17)+(B10-2), (A1-17)+(B10-3), (A1-17)+(B10-4), (A1-17)+(B10-5), (A1-17)+(B11-1), (A1-17)+(B11-2), (A1-17)+(B11-2),


(A1-18)+(B1-1), (A1-18)+(B1-2), (A1-18)+(B1-3), (A1-18)+(B1-4), (A1-18)+(B1-5), (A1-18)+(B1-6), (A1-18)+(B2-1), (A1-18)+(B2-2), (A1-18)+(B2-3), (A1-18)+(B2-4), (A1-18)+(B2-5), (A1-18)+(B2-6), (A1-18)+(B2-7), (A1-18)+(B2-8), (A1-18)+(B2-9), (A1-18)+(B2-10), (A1-18)+(B2-11), (A1-18)+(B2-12), (A1-18)+(B2-13), (A1-18)+(B2-14), (A1-18)+(B2-15), (A1-18)+(B2-16), (A1-18)+(B2-17), (A1-18)+(B2-18), (A1-18)+(B2-19), (A1-18)+(B2-20), (A1-18)+(B2-21), (A1-18)+(B2-22), (A1-18)+(B2-23), (A1-18)+(B2-24), (A1-18)+(B2-25), (A1-18)+(B2-26), (A1-18)+(B2-27), (A1-18)+(B2-28), (A1-18)+(B2-29), (A1-18)+(B3-1), (A1-18)+(B3-2), (A1-18)+(B4-1), (A1-18)+(B4-2), (A1-18)+(B4-3), (A1-18)+(B4-4), (A1-18)+(B4-5), (A1-18)+(B4-6), (A1-18)+(B4-7), (A1-18)+(B4-8), (A1-18)+(B4-9), (A1-18)+(B4-10), (A1-18)+(B4-11), (A1-18)+(B5-1), (A1-18)+(B5-2), (A1-18)+(B5-3), (A1-18)+(B5-4), (A1-18)+(B5-5), (A1-18)+(B6-1), (A1-18)+(B6-2), (A1-18)+(B6-3), (A1-18)+(B6-4), (A1-18)+(B6-5), (A1-18)+(B6-6), (A1-18)+(B7-1), (A1-18)+(B7-2), (A1-18)+(B7-3), (A1-18)+(B7-4), (A1-18)+(B7-5), (A1-18)+(B7-6), (A1-18)+(B7-7)), (A1-18)+(B7-7), (A1-18)+(B7-8), (A1-18)+(B8-1), (A1-18)+(B8-2), (A1-18)+(B8-3), (A1-18)+(B8-4), (A1-18)+(B8-5), (A1-18)+(B8-6), (A1-18)+(B8-7), (A1-18)+(B9-1), (A1-18)+(B9-2), (A1-18)+(B10-1), (A1-18)+(B10-2), (A1-18)+(B10-3), (A1-18)+(B10-4), (A1-18)+(B10-5), (A1-18)+(B11-1), (A1-18)+(B11-2), (A1-18)+(B11-2),


(A1-19)+(B1-1), (A1-19)+(B1-2), (A1-19)+(B1-3), (A1-19)+(B1-4), (A1-19)+(B1-5), (A1-19)+(B1-6), (A1-19)+(B2-1), (A1-19)+(B2-2), (A1-19)+(B2-3), (A1-19)+(B2-4), (A1-19)+(B2-5), (A1-19)+(B2-6), (A1-19)+(B2-7), (A1-19)+(B2-8), (A1-19)+(B2-9), (A1-19)+(B2-10), (A1-19)+(B2-11), (A1-19)+(B2-12), (A1-19)+(B2-13), (A1-19)+(B2-14), (A1-19)+(B2-15), (A1-19)+(B2-16), (A1-19)+(B2-17), (A1-19)+(B2-18), (A1-19)+(B2-19), (A1-19)+(B2-20), (A1-19)+(B2-21), (A1-19)+(B2-22), (A1-19)+(B2-23), (A1-19)+(B2-24), (A1-19)+(B2-25), (A1-19)+(B2-26), (A1-19)+(B2-27), (A1-19)+(B2-28), (A1-19)+(B2-29), (A1-19)+(B3-1), (A1-19)+(B3-2), (A1-19)+(B4-1), (A1-19)+(B4-2), (A1-19)+(B4-3), (A1-19)+(B4-4), (A1-19)+(B4-5), (A1-19)+(B4-6), (A1-19)+(B4-7), (A1-19)+(B4-8), (A1-19)+(B4-9), (A1-19)+(B4-10), (A1-19)+(B4-11), (A1-19)+(B5-1), (A1-19)+(B5-2), (A1-19)+(B5-3), (A1-19)+(B5-4), (A1-19)+(B5-5), (A1-19)+(B6-1), (A1-19)+(B6-2), (A1-19)+(B6-3), (A1-19)+(B6-4), (A1-19)+(B6-5), (A1-19)+(B6-6), (A1-19)+(B7-1), (A1-19)+(B7-2), (A1-19)+(B7-3), (A1-19)+(B7-4), (A1-19)+(B7-5), (A1-19)+(B7-6), (A1-19)+(B7-7)), (A1-19)+(B7-7), (A1-19)+(B7-8), (A1-19)+(B8-1), (A1-19)+(B8-2), (A1-19)+(B8-3), (A1-19)+(B8-4), (A1-19)+(B8-5), (A1-19)+(B8-6), (A1-19)+(B8-7), (A1-19)+(B9-1), (A1-19)+(B9-2), (A1-19)+(B10-1), (A1-19)+(B10-2), (A1-19)+(B10-3), (A1-19)+(B10-4), (A1-19)+(B10-5), (A1-19)+(B11-1), (A1-19)+(B11-2), (A1-19)+(B11-2),


(A1-20)+(B1-1), (A1-20)+(B1-2), (A1-20)+(B1-3), (A1-20)+(B1-4), (A1-20)+(B1-5), (A1-20)+(B1-6), (A1-20)+(B2-1), (A1-20)+(B2-2), (A1-20)+(B2-3), (A1-20)+(B2-4), (A1-20)+(B2-5), (A1-20)+(B2-6), (A1-20)+(B2-7), (A1-20)+(B2-8), (A1-20)+(B2-9), (A1-20)+(B2-10), (A1-20)+(B2-11), (A1-20)+(B2-12), (A1-20)+(B2-13), (A1-20)+(B2-14), (A1-20)+(B2-15), (A1-20)+(B2-16), (A1-20)+(B2-17), (A1-20)+(B2-18), (A1-20)+(B2-19), (A1-20)+(B2-20), (A1-20)+(B2-21), (A1-20)+(B2-22), (A1-20)+(B2-23), (A1-20)+(B2-24), (A1-20)+(B2-25), (A1-20)+(B2-26), (A1-20)+(B2-27), (A1-20)+(B2-28), (A1-20)+(B2-29), (A1-20)+(B3-1), (A1-20)+(B3-2), (A1-20)+(B4-1), (A1-20)+(B4-2), (A1-20)+(B4-3), (A1-20)+(B4-4), (A1-20)+(B4-5), (A1-20)+(B4-6), (A1-20)+(B4-7), (A1-20)+(B4-8), (A1-20)+(B4-9), (A1-20)+(B4-10), (A1-20)+(B4-11), (A1-20)+(B5-1), (A1-20)+(B5-2), (A1-20)+(B5-3), (A1-20)+(B5-4), (A1-20)+(B5-5), (A1-20)+(B6-1), (A1-20)+(B6-2), (A1-20)+(B6-3), (A1-20)+(B6-4), (A1-20)+(B6-5), (A1-20)+(B6-6), (A1-20)+(B7-1), (A1-20)+(B7-2), (A1-20)+(B7-3), (A1-20)+(B7-4), (A1-20)+(B7-5), (A1-20)+(B7-6), (A1-20)+(B7-7)), (A1-20)+(B7-7), (A1-20)+(B7-8), (A1-20)+(B8-1), (A1-20)+(B8-2), (A1-20)+(B8-3), (A1-20)+(B8-4), (A1-20)+(B8-5), (A1-20)+(B8-6), (A1-20)+(B8-7), (A1-20)+(B9-1), (A1-20)+(B9-2), (A1-20)+(B10-1), (A1-20)+(B10-2), (A1-20)+(B10-3), (A1-20)+(B10-4), (A1-20)+(B10-5), (A1-20)+(B11-1), (A1-20)+(B11-2), (A1-20)+(B11-2),


(A1-21)+(B1-1), (A1-21)+(B1-2), (A1-21)+(B1-3), (A1-21)+(B1-4), (A1-21)+(B1-5), (A1-21)+(B1-6), (A1-21)+(B2-1), (A1-21)+(B2-2), (A1-21)+(B2-3), (A1-21)+(B2-4), (A1-21)+(B2-5), (A1-21)+(B2-6), (A1-21)+(B2-7), (A1-21)+(B2-8), (A1-21)+(B2-9), (A1-21)+(B2-10), (A1-21)+(B2-11), (A1-21)+(B2-12), (A1-21)+(B2-13), (A1-21)+(B2-14), (A1-21)+(B2-15), (A1-21)+(B2-16), (A1-21)+(B2-17), (A1-21)+(B2-18), (A1-21)+(B2-19), (A1-21)+(B2-20), (A1-21)+(B2-21), (A1-21)+(B2-22), (A1-21)+(B2-23), (A1-21)+(B2-24), (A1-21)+(B2-25), (A1-21)+(B2-26), (A1-21)+(B2-27), (A1-21)+(B2-28), (A1-21)+(B2-29), (A1-21)+(B3-1), (A1-21)+(B3-2), (A1-21)+(B4-1), (A1-21)+(B4-2), (A1-21)+(B4-3), (A1-21)+(B4-4), (A1-21)+(B4-5), (A1-21)+(B4-6), (A1-21)+(B4-7), (A1-21)+(B4-8), (A1-21)+(B4-9), (A1-21)+(B4-10), (A1-21)+(B4-11), (A1-21)+(B5-1), (A1-21)+(B5-2), (A1-21)+(B5-3), (A1-21)+(B5-4), (A1-21)+(B5-5), (A1-21)+(B6-1), (A1-21)+(B6-2), (A1-21)+(B6-3), (A1-21)+(B6-4), (A1-21)+(B6-5), (A1-21)+(B6-6), (A1-21)+(B7-1), (A1-21)+(B7-2), (A1-21)+(B7-3), (A1-21)+(B7-4), (A1-21)+(B7-5), (A1-21)+(B7-6), (A1-21)+(B7-7)), (A1-21)+(B7-7), (A1-21)+(B7-8), (A1-21)+(B8-1), (A1-21)+(B8-2), (A1-21)+(B8-3), (A1-21)+(B8-4), (A1-21)+(B8-5), (A1-21)+(B8-6), (A1-21)+(B8-7), (A1-21)+(B9-1), (A1-21)+(B9-2), (A1-21)+(B10-1), (A1-21)+(B10-2), (A1-21)+(B10-3), (A1-21)+(B10-4), (A1-21)+(B10-5), (A1-21)+(B11-1), (A1-21)+(B11-2), (A1-21)+(B11-2),


(A1-22)+(B1-1), (A1-22)+(B1-2), (A1-22)+(B1-3), (A1-22)+(B1-4), (A1-22)+(B1-5), (A1-22)+(B1-6), (A1-22)+(B2-1), (A1-22)+(B2-2), (A1-22)+(B2-3), (A1-22)+(B2-4), (A1-22)+(B2-5), (A1-22)+(B2-6), (A1-22)+(B2-7), (A1-22)+(B2-8), (A1-22)+(B2-9), (A1-22)+(B2-10), (A1-22)+(B2-11), (A1-22)+(B2-12), (A1-22)+(B2-13), (A1-22)+(B2-14), (A1-22)+(B2-15), (A1-22)+(B2-16), (A1-22)+(B2-17), (A1-22)+(B2-18), (A1-22)+(B2-19), (A1-22)+(B2-20), (A1-22)+(B2-21), (A1-22)+(B2-22), (A1-22)+(B2-23), (A1-22)+(B2-24), (A1-22)+(B2-25), (A1-22)+(B2-26), (A1-22)+(B2-27), (A1-22)+(B2-28), (A1-22)+(B2-29), (A1-22)+(B3-1), (A1-22)+(B3-2), (A1-22)+(B4-1), (A1-22)+(B4-2), (A1-22)+(B4-3), (A1-22)+(B4-4), (A1-22)+(B4-5), (A1-22)+(B4-6), (A1-22)+(B4-7), (A1-22)+(B4-8), (A1-22)+(B4-9), (A1-22)+(B4-10), (A1-22)+(B4-11), (A1-22)+(B5-1), (A1-22)+(B5-2), (A1-22)+(B5-3), (A1-22)+(B5-4), (A1-22)+(B5-5), (A1-22)+(B6-1), (A1-22)+(B6-2), (A1-22)+(B6-3), (A1-22)+(B6-4), (A1-22)+(B6-5), (A1-22)+(B6-6), (A1-22)+(B7-1), (A1-22)+(B7-2), (A1-22)+(B7-3), (A1-22)+(B7-4), (A1-22)+(B7-5), (A1-22)+(B7-6), (A1-22)+(B7-7)), (A1-22)+(B7-7), (A1-22)+(B7-8), (A1-22)+(B8-1), (A1-22)+(B8-2), (A1-22)+(B8-3), (A1-22)+(B8-4), (A1-22)+(B8-5), (A1-22)+(B8-6), (A1-22)+(B8-7), (A1-22)+(B9-1), (A1-22)+(B9-2), (A1-22)+(B10-1), (A1-22)+(B10-2), (A1-22)+(B10-3), (A1-22)+(B10-4), (A1-22)+(B10-5), (A1-22)+(B11-1), (A1-22)+(B11-2), (A1-22)+(B11-2),


(A1-23)+(B1-1), (A1-23)+(B1-2), (A1-23)+(B1-3), (A1-23)+(B1-4), (A1-23)+(B1-5), (A1-23)+(B1-6), (A1-23)+(B2-1), (A1-23)+(B2-2), (A1-23)+(B2-3), (A1-23)+(B2-4), (A1-23)+(B2-5), (A1-23)+(B2-6), (A1-23)+(B2-7), (A1-23)+(B2-8), (A1-23)+(B2-9), (A1-23)+(B2-10), (A1-23)+(B2-11), (A1-23)+(B2-12), (A1-23)+(B2-13), (A1-23)+(B2-14), (A1-23)+(B2-15), (A1-23)+(B2-16), (A1-23)+(B2-17), (A1-23)+(B2-18), (A1-23)+(B2-19), (A1-23)+(B2-20), (A1-23)+(B2-21), (A1-23)+(B2-22), (A1-23)+(B2-23), (A1-23)+(B2-24), (A1-23)+(B2-25), (A1-23)+(B2-26), (A1-23)+(B2-27), (A1-23)+(B2-28), (A1-23)+(B2-29), (A1-23)+(B3-1), (A1-23)+(B3-2), (A1-23)+(B4-1), (A1-23)+(B4-2), (A1-23)+(B4-3), (A1-23)+(B4-4), (A1-23)+(B4-5), (A1-23)+(B4-6), (A1-23)+(B4-7), (A1-23)+(B4-8), (A1-23)+(B4-9), (A1-23)+(B4-10), (A1-23)+(B4-11), (A1-23)+(B5-1), (A1-23)+(B5-2), (A1-23)+(B5-3), (A1-23)+(B5-4), (A1-23)+(B5-5), (A1-23)+(B6-1), (A1-23)+(B6-2), (A1-23)+(B6-3), (A1-23)+(B6-4), (A1-23)+(B6-5), (A1-23)+(B6-6), (A1-23)+(B7-1), (A1-23)+(B7-2), (A1-23)+(B7-3), (A1-23)+(B7-4), (A1-23)+(B7-5), (A1-23)+(B7-6), (A1-23)+(B7-7)), (A1-23)+(B7-7), (A1-23)+(B7-8), (A1-23)+(B8-1), (A1-23)+(B8-2), (A1-23)+(B8-3), (A1-23)+(B8-4), (A1-23)+(B8-5), (A1-23)+(B8-6), (A1-23)+(B8-7), (A1-23)+(B9-1), (A1-23)+(B9-2), (A1-23)+(B10-1), (A1-23)+(B10-2), (A1-23)+(B10-3), (A1-23)+(B10-4), (A1-23)+(B10-5), (A1-23)+(B11-1), (A1-23)+(B11-2), (A1-23)+(B11-2),


(A1-24)+(B1-1), (A1-24)+(B1-2), (A1-24)+(B1-3), (A1-24)+(B1-4), (A1-24)+(B1-5), (A1-24)+(B1-6), (A1-24)+(B2-1), (A1-24)+(B2-2), (A1-24)+(B2-3), (A1-24)+(B2-4), (A1-24)+(B2-5), (A1-24)+(B2-6), (A1-24)+(B2-7), (A1-24)+(B2-8), (A1-24)+(B2-9), (A1-24)+(B2-10), (A1-24)+(B2-11), (A1-24)+(B2-12), (A1-24)+(B2-13), (A1-24)+(B2-14), (A1-24)+(B2-15), (A1-24)+(B2-16), (A1-24)+(B2-17), (A1-24)+(B2-18), (A1-24)+(B2-19), (A1-24)+(B2-20), (A1-24)+(B2-21), (A1-24)+(B2-22), (A1-24)+(B2-23), (A1-24)+(B2-24), (A1-24)+(B2-25), (A1-24)+(B2-26), (A1-24)+(B2-27), (A1-24)+(B2-28), (A1-24)+(B2-29), (A1-24)+(B3-1), (A1-24)+(B3-2), (A1-24)+(B4-1), (A1-24)+(B4-2), (A1-24)+(B4-3), (A1-24)+(B4-4), (A1-24)+(B4-5), (A1-24)+(B4-6), (A1-24)+(B4-7), (A1-24)+(B4-8), (A1-24)+(B4-9), (A1-24)+(B4-10), (A1-24)+(B4-11), (A1-24)+(B5-1), (A1-24)+(B5-2), (A1-24)+(B5-3), (A1-24)+(B5-4), (A1-24)+(B5-5), (A1-24)+(B6-1), (A1-24)+(B6-2), (A1-24)+(B6-3), (A1-24)+(B6-4), (A1-24)+(B6-5), (A1-24)+(B6-6), (A1-24)+(B7-1), (A1-24)+(B7-2), (A1-24)+(B7-3), (A1-24)+(B7-4), (A1-24)+(B7-5), (A1-24)+(B7-6), (A1-24)+(B7-7)), (A1-24)+(B7-7), (A1-24)+(B7-8), (A1-24)+(B8-1), (A1-24)+(B8-2), (A1-24)+(B8-3), (A1-24)+(B8-4), (A1-24)+(B8-5), (A1-24)+(B8-6), (A1-24)+(B8-7), (A1-24)+(B9-1), (A1-24)+(B9-2), (A1-24)+(B10-1), (A1-24)+(B10-2), (A1-24)+(B10-3), (A1-24)+(B10-4), (A1-24)+(B10-5), (A1-24)+(B11-1), (A1-24)+(B11-2), (A1-24)+(B11-2),


(A1-25)+(B1-1), (A1-25)+(B1-2), (A1-25)+(B1-3), (A1-25)+(B1-4), (A1-25)+(B1-5), (A1-25)+(B1-6), (A1-25)+(B2-1), (A1-25)+(B2-2), (A1-25)+(B2-3), (A1-25)+(B2-4), (A1-25)+(B2-5), (A1-25)+(B2-6), (A1-25)+(B2-7), (A1-25)+(B2-8), (A1-25)+(B2-9), (A1-25)+(B2-10), (A1-25)+(B2-11), (A1-25)+(B2-12), (A1-25)+(B2-13), (A1-25)+(B2-14), (A1-25)+(B2-15), (A1-25)+(B2-16), (A1-25)+(B2-17), (A1-25)+(B2-18), (A1-25)+(B2-19), (A1-25)+(B2-20), (A1-25)+(B2-21), (A1-25)+(B2-22), (A1-25)+(B2-23), (A1-25)+(B2-24), (A1-25)+(B2-25), (A1-25)+(B2-26), (A1-25)+(B2-27), (A1-25)+(B2-28), (A1-25)+(B2-29), (A1-25)+(B3-1), (A1-25)+(B3-2), (A1-25)+(B4-1), (A1-25)+(B4-2), (A1-25)+(B4-3), (A1-25)+(B4-4), (A1-25)+(B4-5), (A1-25)+(B4-6), (A1-25)+(B4-7), (A1-25)+(B4-8), (A1-25)+(B4-9), (A1-25)+(B4-10), (A1-25)+(B4-11), (A1-25)+(B5-1), (A1-25)+(B5-2), (A1-25)+(B5-3), (A1-25)+(B5-4), (A1-25)+(B5-5), (A1-25)+(B6-1), (A1-25)+(B6-2), (A1-25)+(B6-3), (A1-25)+(B6-4), (A1-25)+(B6-5), (A1-25)+(B6-6), (A1-25)+(B7-1), (A1-25)+(B7-2), (A1-25)+(B7-3), (A1-25)+(B7-4), (A1-25)+(B7-5), (A1-25)+(B7-6), (A1-25)+(B7-7)), (A1-25)+(B7-7), (A1-25)+(B7-8), (A1-25)+(B8-1), (A1-25)+(B8-2), (A1-25)+(B8-3), (A1-25)+(B8-4), (A1-25)+(B8-5), (A1-25)+(B8-6), (A1-25)+(B8-7), (A1-25)+(B9-1), (A1-25)+(B9-2), (A1-25)+(B10-1), (A1-25)+(B10-2), (A1-25)+(B10-3), (A1-25)+(B10-4), (A1-25)+(B10-5), (A1-25)+(B11-1), (A1-25)+(B11-2), (A1-25)+(B11-2),


(A1-26)+(B1-1), (A1-26)+(B1-2), (A1-26)+(B1-3), (A1-26)+(B1-4), (A1-26)+(B1-5), (A1-26)+(B1-6), (A1-26)+(B2-1), (A1-26)+(B2-2), (A1-26)+(B2-3), (A1-26)+(B2-4), (A1-26)+(B2-5), (A1-26)+(B2-6), (A1-26)+(B2-7), (A1-26)+(B2-8), (A1-26)+(B2-9), (A1-26)+(B2-10), (A1-26)+(B2-11), (A1-26)+(B2-12), (A1-26)+(B2-13), (A1-26)+(B2-14), (A1-26)+(B2-15), (A1-26)+(B2-16), (A1-26)+(B2-17), (A1-26)+(B2-18), (A1-26)+(B2-19), (A1-26)+(B2-20), (A1-26)+(B2-21), (A1-26)+(B2-22), (A1-26)+(B2-23), (A1-26)+(B2-24), (A1-26)+(B2-25), (A1-26)+(B2-26), (A1-26)+(B2-27), (A1-26)+(B2-28), (A1-26)+(B2-29), (A1-26)+(B3-1), (A1-26)+(B3-2), (A1-26)+(B4-1), (A1-26)+(B4-2), (A1-26)+(B4-3), (A1-26)+(B4-4), (A1-26)+(B4-5), (A1-26)+(B4-6), (A1-26)+(B4-7), (A1-26)+(B4-8), (A1-26)+(B4-9), (A1-26)+(B4-10), (A1-26)+(B4-11), (A1-26)+(B5-1), (A1-26)+(B5-2), (A1-26)+(B5-3), (A1-26)+(B5-4), (A1-26)+(B5-5), (A1-26)+(B6-1), (A1-26)+(B6-2), (A1-26)+(B6-3), (A1-26)+(B6-4), (A1-26)+(B6-5), (A1-26)+(B6-6), (A1-26)+(B7-1), (A1-26)+(B7-2), (A1-26)+(B7-3), (A1-26)+(B7-4), (A1-26)+(B7-5), (A1-26)+(B7-6), (A1-26)+(B7-7)), (A1-26)+(B7-7), (A1-26)+(B7-8), (A1-26)+(B8-1), (A1-26)+(B8-2), (A1-26)+(B8-3), (A1-26)+(B8-4), (A1-26)+(B8-5), (A1-26)+(B8-6), (A1-26)+(B8-7), (A1-26)+(B9-1), (A1-26)+(B9-2), (A1-26)+(B10-1), (A1-26)+(B10-2), (A1-26)+(B10-3), (A1-26)+(B10-4), (A1-26)+(B10-5), (A1-26)+(B11-1), (A1-26)+(B11-2), (A1-26)+(B11-2),


(A1-27)+(B1-1), (A1-27)+(B1-2), (A1-27)+(B1-3), (A1-27)+(B1-4), (A1-27)+(B1-5), (A1-27)+(B1-6), (A1-27)+(B2-1), (A1-27)+(B2-2), (A1-27)+(B2-3), (A1-27)+(B2-4), (A1-27)+(B2-5), (A1-27)+(B2-6), (A1-27)+(B2-7), (A1-27)+(B2-8), (A1-27)+(B2-9), (A1-27)+(B2-10), (A1-27)+(B2-11), (A1-27)+(B2-12), (A1-27)+(B2-13), (A1-27)+(B2-14), (A1-27)+(B2-15), (A1-27)+(B2-16), (A1-27)+(B2-17), (A1-27)+(B2-18), (A1-27)+(B2-19), (A1-27)+(B2-20), (A1-27)+(B2-21), (A1-27)+(B2-22), (A1-27)+(B2-23), (A1-27)+(B2-24), (A1-27)+(B2-25), (A1-27)+(B2-26), (A1-27)+(B2-27), (A1-27)+(B2-28), (A1-27)+(B2-29), (A1-27)+(B3-1), (A1-27)+(B3-2), (A1-27)+(B4-1), (A1-27)+(B4-2), (A1-27)+(B4-3), (A1-27)+(B4-4), (A1-27)+(B4-5), (A1-27)+(B4-6), (A1-27)+(B4-7), (A1-27)+(B4-8), (A1-27)+(B4-9), (A1-27)+(B4-10), (A1-27)+(B4-11), (A1-27)+(B5-1), (A1-27)+(B5-2), (A1-27)+(B5-3), (A1-27)+(B5-4), (A1-27)+(B5-5), (A1-27)+(B6-1), (A1-27)+(B6-2), (A1-27)+(B6-3), (A1-27)+(B6-4), (A1-27)+(B6-5), (A1-27)+(B6-6), (A1-27)+(B7-1), (A1-27)+(B7-2), (A1-27)+(B7-3), (A1-27)+(B7-4), (A1-27)+(B7-5), (A1-27)+(B7-6), (A1-27)+(B7-7)), (A1-27)+(B7-7), (A1-27)+(B7-8), (A1-27)+(B8-1), (A1-27)+(B8-2), (A1-27)+(B8-3), (A1-27)+(B8-4), (A1-27)+(B8-5), (A1-27)+(B8-6), (A1-27)+(B8-7), (A1-27)+(B9-1), (A1-27)+(B9-2), (A1-27)+(B10-1), (A1-27)+(B10-2), (A1-27)+(B10-3), (A1-27)+(B10-4), (A1-27)+(B10-5), (A1-27)+(B11-1), (A1-27)+(B11-2), (A1-27)+(B11-2),


(A1-28)+(B1-1), (A1-28)+(B1-2), (A1-28)+(B1-3), (A1-28)+(B1-4), (A1-28)+(B1-5), (A1-28)+(B1-6), (A1-28)+(B2-1), (A1-28)+(B2-2), (A1-28)+(B2-3), (A1-28)+(B2-4), (A1-28)+(B2-5), (A1-28)+(B2-6), (A1-28)+(B2-7), (A1-28)+(B2-8), (A1-28)+(B2-9), (A1-28)+(B2-10), (A1-28)+(B2-11), (A1-28)+(B2-12), (A1-28)+(B2-13), (A1-28)+(B2-14), (A1-28)+(B2-15), (A1-28)+(B2-16), (A1-28)+(B2-17), (A1-28)+(B2-18), (A1-28)+(B2-19), (A1-28)+(B2-20), (A1-28)+(B2-21), (A1-28)+(B2-22), (A1-28)+(B2-23), (A1-28)+(B2-24), (A1-28)+(B2-25), (A1-28)+(B2-26), (A1-28)+(B2-27), (A1-28)+(B2-28), (A1-28)+(B2-29), (A1-28)+(B3-1), (A1-28)+(B3-2), (A1-28)+(B4-1), (A1-28)+(B4-2), (A1-28)+(B4-3), (A1-28)+(B4-4), (A1-28)+(B4-5), (A1-28)+(B4-6), (A1-28)+(B4-7), (A1-28)+(B4-8), (A1-28)+(B4-9), (A1-28)+(B4-10), (A1-28)+(B4-11), (A1-28)+(B5-1), (A1-28)+(B5-2), (A1-28)+(B5-3), (A1-28)+(B5-4), (A1-28)+(B5-5), (A1-28)+(B6-1), (A1-28)+(B6-2), (A1-28)+(B6-3), (A1-28)+(B6-4), (A1-28)+(B6-5), (A1-28)+(B6-6), (A1-28)+(B7-1), (A1-28)+(B7-2), (A1-28)+(B7-3), (A1-28)+(B7-4), (A1-28)+(B7-5), (A1-28)+(B7-6), (A1-28)+(B7-7)), (A1-28)+(B7-7), (A1-28)+(B7-8), (A1-28)+(B8-1), (A1-28)+(B8-2), (A1-28)+(B8-3), (A1-28)+(B8-4), (A1-28)+(B8-5), (A1-28)+(B8-6), (A1-28)+(B8-7), (A1-28)+(B9-1), (A1-28)+(B9-2), (A1-28)+(B10-1), (A1-28)+(B10-2), (A1-28)+(B10-3), (A1-28)+(B10-4), (A1-28)+(B10-5), (A1-28)+(B11-1), (A1-28)+(B11-2), (A1-28)+(B11-2),


(A1-29)+(B1-1), (A1-29)+(B1-2), (A1-29)+(B1-3), (A1-29)+(B1-4), (A1-29)+(B1-5), (A1-29)+(B1-6), (A1-29)+(B2-1), (A1-29)+(B2-2), (A1-29)+(B2-3), (A1-29)+(B2-4), (A1-29)+(B2-5), (A1-29)+(B2-6), (A1-29)+(B2-7), (A1-29)+(B2-8), (A1-29)+(B2-9), (A1-29)+(B2-10), (A1-29)+(B2-11), (A1-29)+(B2-12), (A1-29)+(B2-13), (A1-29)+(B2-14), (A1-29)+(B2-15), (A1-29)+(B2-16), (A1-29)+(B2-17), (A1-29)+(B2-18), (A1-29)+(B2-19), (A1-29)+(B2-20), (A1-29)+(B2-21), (A1-29)+(B2-22), (A1-29)+(B2-23), (A1-29)+(B2-24), (A1-29)+(B2-25), (A1-29)+(B2-26), (A1-29)+(B2-27), (A1-29)+(B2-28), (A1-29)+(B2-29), (A1-29)+(B3-1), (A1-29)+(B3-2), (A1-29)+(B4-1), (A1-29)+(B4-2), (A1-29)+(B4-3), (A1-29)+(B4-4), (A1-29)+(B4-5), (A1-29)+(B4-6), (A1-29)+(B4-7), (A1-29)+(B4-8), (A1-29)+(B4-9), (A1-29)+(B4-10), (A1-29)+(B4-11), (A1-29)+(B5-1), (A1-29)+(B5-2), (A1-29)+(B5-3), (A1-29)+(B5-4), (A1-29)+(B5-5), (A1-29)+(B6-1), (A1-29)+(B6-2), (A1-29)+(B6-3), (A1-29)+(B6-4), (A1-29)+(B6-5), (A1-29)+(B6-6), (A1-29)+(B7-1), (A1-29)+(B7-2), (A1-29)+(B7-3), (A1-29)+(B7-4), (A1-29)+(B7-5), (A1-29)+(B7-6), (A1-29)+(B7-7)), (A1-29)+(B7-7), (A1-29)+(B7-8), (A1-29)+(B8-1), (A1-29)+(B8-2), (A1-29)+(B8-3), (A1-29)+(B8-4), (A1-29)+(B8-5), (A1-29)+(B8-6), (A1-29)+(B8-7), (A1-29)+(B9-1), (A1-29)+(B9-2), (A1-29)+(B10-1), (A1-29)+(B10-2), (A1-29)+(B10-3), (A1-29)+(B10-4), (A1-29)+(B10-5), (A1-29)+(B11-1), (A1-29)+(B11-2), (A1-29)+(B11-2),


(A1-30)+(B1-1), (A1-30)+(B1-2), (A1-30)+(B1-3), (A1-30)+(B1-4), (A1-30)+(B1-5), (A1-30)+(B1-6), (A1-30)+(B2-1), (A1-30)+(B2-2), (A1-30)+(B2-3), (A1-30)+(B2-4), (A1-30)+(B2-5), (A1-30)+(B2-6), (A1-30)+(B2-7), (A1-30)+(B2-8), (A1-30)+(B2-9), (A1-30)+(B2-10), (A1-30)+(B2-11), (A1-30)+(B2-12), (A1-30)+(B2-13), (A1-30)+(B2-14), (A1-30)+(B2-15), (A1-30)+(B2-16), (A1-30)+(B2-17), (A1-30)+(B2-18), (A1-30)+(B2-19), (A1-30)+(B2-20), (A1-30)+(B2-21), (A1-30)+(B2-22), (A1-30)+(B2-23), (A1-30)+(B2-24), (A1-30)+(B2-25), (A1-30)+(B2-26), (A1-30)+(B2-27), (A1-30)+(B2-28), (A1-30)+(B2-29), (A1-30)+(B3-1), (A1-30)+(B3-2), (A1-30)+(B4-1), (A1-30)+(B4-2), (A1-30)+(B4-3), (A1-30)+(B4-4), (A1-30)+(B4-5), (A1-30)+(B4-6), (A1-30)+(B4-7), (A1-30)+(B4-8), (A1-30)+(B4-9), (A1-30)+(B4-10), (A1-30)+(B4-11), (A1-30)+(B5-1), (A1-30)+(B5-2), (A1-30)+(B5-3), (A1-30)+(B5-4), (A1-30)+(B5-5), (A1-30)+(B6-1), (A1-30)+(B6-2), (A1-30)+(B6-3), (A1-30)+(B6-4), (A1-30)+(B6-5), (A1-30)+(B6-6), (A1-30)+(B7-1), (A1-30)+(B7-2), (A1-30)+(B7-3), (A1-30)+(B7-4), (A1-30)+(B7-5), (A1-30)+(B7-6), (A1-30)+(B7-7)), (A1-30)+(B7-7), (A1-30)+(B7-8), (A1-30)+(B8-1), (A1-30)+(B8-2), (A1-30)+(B8-3), (A1-30)+(B8-4), (A1-30)+(B8-5), (A1-30)+(B8-6), (A1-30)+(B8-7), (A1-30)+(B9-1), (A1-30)+(B9-2), (A1-30)+(B10-1), (A1-30)+(B10-2), (A1-30)+(B10-3), (A1-30)+(B10-4), (A1-30)+(B10-5), (A1-30)+(B11-1), (A1-30)+(B11-2), (A1-30)+(B11-2),


(A1-31)+(B1-1), (A1-31)+(B1-2), (A1-31)+(B1-3), (A1-31)+(B1-4), (A1-31)+(B1-5), (A1-31)+(B1-6), (A1-31)+(B2-1), (A1-31)+(B2-2), (A1-31)+(B2-3), (A1-31)+(B2-4), (A1-31)+(B2-5), (A1-31)+(B2-6), (A1-31)+(B2-7), (A1-31)+(B2-8), (A1-31)+(B2-9), (A1-31)+(B2-10), (A1-31)+(B2-11), (A1-31)+(B2-12), (A1-31)+(B2-13), (A1-31)+(B2-14), (A1-31)+(B2-15), (A1-31)+(B2-16), (A1-31)+(B2-17), (A1-31)+(B2-18), (A1-31)+(B2-19), (A1-31)+(B2-20), (A1-31)+(B2-21), (A1-31)+(B2-22), (A1-31)+(B2-23), (A1-31)+(B2-24), (A1-31)+(B2-25), (A1-31)+(B2-26), (A1-31)+(B2-27), (A1-31)+(B2-28), (A1-31)+(B2-29), (A1-31)+(B3-1), (A1-31)+(B3-2), (A1-31)+(B4-1), (A1-31)+(B4-2), (A1-31)+(B4-3), (A1-31)+(B4-4), (A1-31)+(B4-5), (A1-31)+(B4-6), (A1-31)+(B4-7), (A1-31)+(B4-8), (A1-31)+(B4-9), (A1-31)+(B4-10), (A1-31)+(B4-11), (A1-31)+(B5-1), (A1-31)+(B5-2), (A1-31)+(B5-3), (A1-31)+(B5-4), (A1-31)+(B5-5), (A1-31)+(B6-1), (A1-31)+(B6-2), (A1-31)+(B6-3), (A1-31)+(B6-4), (A1-31)+(B6-5), (A1-31)+(B6-6), (A1-31)+(B7-1), (A1-31)+(B7-2), (A1-31)+(B7-3), (A1-31)+(B7-4), (A1-31)+(B7-5), (A1-31)+(B7-6), (A1-31)+(B7-7)), (A1-31)+(B7-7), (A1-31)+(B7-8), (A1-31)+(B8-1), (A1-31)+(B8-2), (A1-31)+(B8-3), (A1-31)+(B8-4), (A1-31)+(B8-5), (A1-31)+(B8-6), (A1-31)+(B8-7), (A1-31)+(B9-1), (A1-31)+(B9-2), (A1-31)+(B10-1), (A1-31)+(B10-2), (A1-31)+(B10-3), (A1-31)+(B10-4), (A1-31)+(B10-5), (A1-31)+(B11-1), (A1-31)+(B11-2), (A1-31)+(B11-2),


(A1-32)+(B1-1), (A1-32)+(B1-2), (A1-32)+(B1-3), (A1-32)+(B1-4), (A1-32)+(B1-5), (A1-32)+(B1-6), (A1-32)+(B2-1), (A1-32)+(B2-2), (A1-32)+(B2-3), (A1-32)+(B2-4), (A1-32)+(B2-5), (A1-32)+(B2-6), (A1-32)+(B2-7), (A1-32)+(B2-8), (A1-32)+(B2-9), (A1-32)+(B2-10), (A1-32)+(B2-11), (A1-32)+(B2-12), (A1-32)+(B2-13), (A1-32)+(B2-14), (A1-32)+(B2-15), (A1-32)+(B2-16), (A1-32)+(B2-17), (A1-32)+(B2-18), (A1-32)+(B2-19), (A1-32)+(B2-20), (A1-32)+(B2-21), (A1-32)+(B2-22), (A1-32)+(B2-23), (A1-32)+(B2-24), (A1-32)+(B2-25), (A1-32)+(B2-26), (A1-32)+(B2-27), (A1-32)+(B2-28), (A1-32)+(B2-29), (A1-32)+(B3-1), (A1-32)+(B3-2), (A1-32)+(B4-1), (A1-32)+(B4-2), (A1-32)+(B4-3), (A1-32)+(B4-4), (A1-32)+(B4-5), (A1-32)+(B4-6), (A1-32)+(B4-7), (A1-32)+(B4-8), (A1-32)+(B4-9), (A1-32)+(B4-10), (A1-32)+(B4-11), (A1-32)+(B5-1), (A1-32)+(B5-2), (A1-32)+(B5-3), (A1-32)+(B5-4), (A1-32)+(B5-5), (A1-32)+(B6-1), (A1-32)+(B6-2), (A1-32)+(B6-3), (A1-32)+(B6-4), (A1-32)+(B6-5), (A1-32)+(B6-6), (A1-32)+(B7-1), (A1-32)+(B7-2), (A1-32)+(B7-3), (A1-32)+(B7-4), (A1-32)+(B7-5), (A1-32)+(B7-6), (A1-32)+(B7-7)), (A1-32)+(B7-7), (A1-32)+(B7-8), (A1-32)+(B8-1), (A1-32)+(B8-2), (A1-32)+(B8-3), (A1-32)+(B8-4), (A1-32)+(B8-5), (A1-32)+(B8-6), (A1-32)+(B8-7), (A1-32)+(B9-1), (A1-32)+(B9-2), (A1-32)+(B10-1), (A1-32)+(B10-2), (A1-32)+(B10-3), (A1-32)+(B10-4), (A1-32)+(B10-5), (A1-32)+(B11-1), (A1-32)+(B11-2), (A1-32)+(B11-2),


(A1-33)+(B1-1), (A1-33)+(B1-2), (A1-33)+(B1-3), (A1-33)+(B1-4), (A1-33)+(B1-5), (A1-33)+(B1-6), (A1-33)+(B2-1), (A1-33)+(B2-2), (A1-33)+(B2-3), (A1-33)+(B2-4), (A1-33)+(B2-5), (A1-33)+(B2-6), (A1-33)+(B2-7), (A1-33)+(B2-8), (A1-33)+(B2-9), (A1-33)+(B2-10), (A1-33)+(B2-11), (A1-33)+(B2-12), (A1-33)+(B2-13), (A1-33)+(B2-14), (A1-33)+(B2-15), (A1-33)+(B2-16), (A1-33)+(B2-17), (A1-33)+(B2-18), (A1-33)+(B2-19), (A1-33)+(B2-20), (A1-33)+(B2-21), (A1-33)+(B2-22), (A1-33)+(B2-23), (A1-33)+(B2-24), (A1-33)+(B2-25), (A1-33)+(B2-26), (A1-33)+(B2-27), (A1-33)+(B2-28), (A1-33)+(B2-29), (A1-33)+(B3-1), (A1-33)+(B3-2), (A1-33)+(B4-1), (A1-33)+(B4-2), (A1-33)+(B4-3), (A1-33)+(B4-4), (A1-33)+(B4-5), (A1-33)+(B4-6), (A1-33)+(B4-7), (A1-33)+(B4-8), (A1-33)+(B4-9), (A1-33)+(B4-10), (A1-33)+(B4-11), (A1-33)+(B5-1), (A1-33)+(B5-2), (A1-33)+(B5-3), (A1-33)+(B5-4), (A1-33)+(B5-5), (A1-33)+(B6-1), (A1-33)+(B6-2), (A1-33)+(B6-3), (A1-33)+(B6-4), (A1-33)+(B6-5), (A1-33)+(B6-6), (A1-33)+(B7-1), (A1-33)+(B7-2), (A1-33)+(B7-3), (A1-33)+(B7-4), (A1-33)+(B7-5), (A1-33)+(B7-6), (A1-33)+(B7-7)), (A1-33)+(B7-7), (A1-33)+(B7-8), (A1-33)+(B8-1), (A1-33)+(B8-2), (A1-33)+(B8-3), (A1-33)+(B8-4), (A1-33)+(B8-5), (A1-33)+(B8-6), (A1-33)+(B8-7), (A1-33)+(B9-1), (A1-33)+(B9-2), (A1-33)+(B10-1), (A1-33)+(B10-2), (A1-33)+(B10-3), (A1-33)+(B10-4), (A1-33)+(B10-5), (A1-33)+(B11-1), (A1-33)+(B11-2), (A1-33)+(B11-2),


(A1-34)+(B1-1), (A1-34)+(B1-2), (A1-34)+(B1-3), (A1-34)+(B1-4), (A1-34)+(B1-5), (A1-34)+(B1-6), (A1-34)+(B2-1), (A1-34)+(B2-2), (A1-34)+(B2-3), (A1-34)+(B2-4), (A1-34)+(B2-5), (A1-34)+(B2-6), (A1-34)+(B2-7), (A1-34)+(B2-8), (A1-34)+(B2-9), (A1-34)+(B2-10), (A1-34)+(B2-11), (A1-34)+(B2-12), (A1-34)+(B2-13), (A1-34)+(B2-14), (A1-34)+(B2-15), (A1-34)+(B2-16), (A1-34)+(B2-17), (A1-34)+(B2-18), (A1-34)+(B2-19), (A1-34)+(B2-20), (A1-34)+(B2-21), (A1-34)+(B2-22), (A1-34)+(B2-23), (A1-34)+(B2-24), (A1-34)+(B2-25), (A1-34)+(B2-26), (A1-34)+(B2-27), (A1-34)+(B2-28), (A1-34)+(B2-29), (A1-34)+(B3-1), (A1-34)+(B3-2), (A1-34)+(B4-1), (A1-34)+(B4-2), (A1-34)+(B4-3), (A1-34)+(B4-4), (A1-34)+(B4-5), (A1-34)+(B4-6), (A1-34)+(B4-7), (A1-34)+(B4-8), (A1-34)+(B4-9), (A1-34)+(B4-10), (A1-34)+(B4-11), (A1-34)+(B5-1), (A1-34)+(B5-2), (A1-34)+(B5-3), (A1-34)+(B5-4), (A1-34)+(B5-5), (A1-34)+(B6-1), (A1-34)+(B6-2), (A1-34)+(B6-3), (A1-34)+(B6-4), (A1-34)+(B6-5), (A1-34)+(B6-6), (A1-34)+(B7-1), (A1-34)+(B7-2), (A1-34)+(B7-3), (A1-34)+(B7-4), (A1-34)+(B7-5), (A1-34)+(B7-6), (A1-34)+(B7-7)), (A1-34)+(B7-7), (A1-34)+(B7-8), (A1-34)+(B8-1), (A1-34)+(B8-2), (A1-34)+(B8-3), (A1-34)+(B8-4), (A1-34)+(B8-5), (A1-34)+(B8-6), (A1-34)+(B8-7), (A1-34)+(B9-1), (A1-34)+(B9-2), (A1-34)+(B10-1), (A1-34)+(B10-2), (A1-34)+(B10-3), (A1-34)+(B10-4), (A1-34)+(B10-5), (A1-34)+(B11-1), (A1-34)+(B11-2), (A1-34)+(B11-2),


(A1-35)+(B1-1), (A1-35)+(B1-2), (A1-35)+(B1-3), (A1-35)+(B1-4), (A1-35)+(B1-5), (A1-35)+(B1-6), (A1-35)+(B2-1), (A1-35)+(B2-2), (A1-35)+(B2-3), (A1-35)+(B2-4), (A1-35)+(B2-5), (A1-35)+(B2-6), (A1-35)+(B2-7), (A1-35)+(B2-8), (A1-35)+(B2-9), (A1-35)+(B2-10), (A1-35)+(B2-11), (A1-35)+(B2-12), (A1-35)+(B2-13), (A1-35)+(B2-14), (A1-35)+(B2-15), (A1-35)+(B2-16), (A1-35)+(B2-17), (A1-35)+(B2-18), (A1-35)+(B2-19), (A1-35)+(B2-20), (A1-35)+(B2-21), (A1-35)+(B2-22), (A1-35)+(B2-23), (A1-35)+(B2-24), (A1-35)+(B2-25), (A1-35)+(B2-26), (A1-35)+(B2-27), (A1-35)+(B2-28), (A1-35)+(B2-29), (A1-35)+(B3-1), (A1-35)+(B3-2), (A1-35)+(B4-1), (A1-35)+(B4-2), (A1-35)+(B4-3), (A1-35)+(B4-4), (A1-35)+(B4-5), (A1-35)+(B4-6), (A1-35)+(B4-7), (A1-35)+(B4-8), (A1-35)+(B4-9), (A1-35)+(B4-10), (A1-35)+(B4-11), (A1-35)+(B5-1), (A1-35)+(B5-2), (A1-35)+(B5-3), (A1-35)+(B5-4), (A1-35)+(B5-5), (A1-35)+(B6-1), (A1-35)+(B6-2), (A1-35)+(B6-3), (A1-35)+(B6-4), (A1-35)+(B6-5), (A1-35)+(B6-6), (A1-35)+(B7-1), (A1-35)+(B7-2), (A1-35)+(B7-3), (A1-35)+(B7-4), (A1-35)+(B7-5), (A1-35)+(B7-6), (A1-35)+(B7-7)), (A1-35)+(B7-7), (A1-35)+(B7-8), (A1-35)+(B8-1), (A1-35)+(B8-2), (A1-35)+(B8-3), (A1-35)+(B8-4), (A1-35)+(B8-5), (A1-35)+(B8-6), (A1-35)+(B8-7), (A1-35)+(B9-1), (A1-35)+(B9-2), (A1-35)+(B10-1), (A1-35)+(B10-2), (A1-35)+(B10-3), (A1-35)+(B10-4), (A1-35)+(B10-5), (A1-35)+(B11-1), (A1-35)+(B11-2), (A1-35)+(B11-2),


(A1-36)+(B1-1), (A1-36)+(B1-2), (A1-36)+(B1-3), (A1-36)+(B1-4), (A1-36)+(B1-5), (A1-36)+(B1-6), (A1-36)+(B2-1), (A1-36)+(B2-2), (A1-36)+(B2-3), (A1-36)+(B2-4), (A1-36)+(B2-5), (A1-36)+(B2-6), (A1-36)+(B2-7), (A1-36)+(B2-8), (A1-36)+(B2-9), (A1-36)+(B2-10), (A1-36)+(B2-11), (A1-36)+(B2-12), (A1-36)+(B2-13), (A1-36)+(B2-14), (A1-36)+(B2-15), (A1-36)+(B2-16), (A1-36)+(B2-17), (A1-36)+(B2-18), (A1-36)+(B2-19), (A1-36)+(B2-20), (A1-36)+(B2-21), (A1-36)+(B2-22), (A1-36)+(B2-23), (A1-36)+(B2-24), (A1-36)+(B2-25), (A1-36)+(B2-26), (A1-36)+(B2-27), (A1-36)+(B2-28), (A1-36)+(B2-29), (A1-36)+(B3-1), (A1-36)+(B3-2), (A1-36)+(B4-1), (A1-36)+(B4-2), (A1-36)+(B4-3), (A1-36)+(B4-4), (A1-36)+(B4-5), (A1-36)+(B4-6), (A1-36)+(B4-7), (A1-36)+(B4-8), (A1-36)+(B4-9), (A1-36)+(B4-10), (A1-36)+(B4-11), (A1-36)+(B5-1), (A1-36)+(B5-2), (A1-36)+(B5-3), (A1-36)+(B5-4), (A1-36)+(B5-5), (A1-36)+(B6-1), (A1-36)+(B6-2), (A1-36)+(B6-3), (A1-36)+(B6-4), (A1-36)+(B6-5), (A1-36)+(B6-6), (A1-36)+(B7-1), (A1-36)+(B7-2), (A1-36)+(B7-3), (A1-36)+(B7-4), (A1-36)+(B7-5), (A1-36)+(B7-6), (A1-36)+(B7-7)), (A1-36)+(B7-7), (A1-36)+(B7-8), (A1-36)+(B8-1), (A1-36)+(B8-2), (A1-36)+(B8-3), (A1-36)+(B8-4), (A1-36)+(B8-5), (A1-36)+(B8-6), (A1-36)+(B8-7), (A1-36)+(B9-1), (A1-36)+(B9-2), (A1-36)+(B10-1), (A1-36)+(B10-2), (A1-36)+(B10-3), (A1-36)+(B10-4), (A1-36)+(B10-5), (A1-36)+(B11-1), (A1-36)+(B11-2), (A1-36)+(B11-2),


(A1-37)+(B1-1), (A1-37)+(B1-2), (A1-37)+(B1-3), (A1-37)+(B1-4), (A1-37)+(B1-5), (A1-37)+(B1-6), (A1-37)+(B2-1), (A1-37)+(B2-2), (A1-37)+(B2-3), (A1-37)+(B2-4), (A1-37)+(B2-5), (A1-37)+(B2-6), (A1-37)+(B2-7), (A1-37)+(B2-8), (A1-37)+(B2-9), (A1-37)+(B2-10), (A1-37)+(B2-11), (A1-37)+(B2-12), (A1-37)+(B2-13), (A1-37)+(B2-14), (A1-37)+(B2-15), (A1-37)+(B2-16), (A1-37)+(B2-17), (A1-37)+(B2-18), (A1-37)+(B2-19), (A1-37)+(B2-20), (A1-37)+(B2-21), (A1-37)+(B2-22), (A1-37)+(B2-23), (A1-37)+(B2-24), (A1-37)+(B2-25), (A1-37)+(B2-26), (A1-37)+(B2-27), (A1-37)+(B2-28), (A1-37)+(B2-29), (A1-37)+(B3-1), (A1-37)+(B3-2), (A1-37)+(B4-1), (A1-37)+(B4-2), (A1-37)+(B4-3), (A1-37)+(B4-4), (A1-37)+(B4-5), (A1-37)+(B4-6), (A1-37)+(B4-7), (A1-37)+(B4-8), (A1-37)+(B4-9), (A1-37)+(B4-10), (A1-37)+(B4-11), (A1-37)+(B5-1), (A1-37)+(B5-2), (A1-37)+(B5-3), (A1-37)+(B5-4), (A1-37)+(B5-5), (A1-37)+(B6-1), (A1-37)+(B6-2), (A1-37)+(B6-3), (A1-37)+(B6-4), (A1-37)+(B6-5), (A1-37)+(B6-6), (A1-37)+(B7-1), (A1-37)+(B7-2), (A1-37)+(B7-3), (A1-37)+(B7-4), (A1-37)+(B7-5), (A1-37)+(B7-6), (A1-37)+(B7-7)), (A1-37)+(B7-7), (A1-37)+(B7-8), (A1-37)+(B8-1), (A1-37)+(B8-2), (A1-37)+(B8-3), (A1-37)+(B8-4), (A1-37)+(B8-5), (A1-37)+(B8-6), (A1-37)+(B8-7), (A1-37)+(B9-1), (A1-37)+(B9-2), (A1-37)+(B10-1), (A1-37)+(B10-2), (A1-37)+(B10-3), (A1-37)+(B10-4), (A1-37)+(B10-5), (A1-37)+(B11-1), (A1-37)+(B11-2), (A1-37)+(B11-2),


(A1-38)+(B1-1), (A1-38)+(B1-2), (A1-38)+(B1-3), (A1-38)+(B1-4), (A1-38)+(B1-5), (A1-38)+(B1-6), (A1-38)+(B2-1), (A1-38)+(B2-2), (A1-38)+(B2-3), (A1-38)+(B2-4), (A1-38)+(B2-5), (A1-38)+(B2-6), (A1-38)+(B2-7), (A1-38)+(B2-8), (A1-38)+(B2-9), (A1-38)+(B2-10), (A1-38)+(B2-11), (A1-38)+(B2-12), (A1-38)+(B2-13), (A1-38)+(B2-14), (A1-38)+(B2-15), (A1-38)+(B2-16), (A1-38)+(B2-17), (A1-38)+(B2-18), (A1-38)+(B2-19), (A1-38)+(B2-20), (A1-38)+(B2-21), (A1-38)+(B2-22), (A1-38)+(B2-23), (A1-38)+(B2-24), (A1-38)+(B2-25), (A1-38)+(B2-26), (A1-38)+(B2-27), (A1-38)+(B2-28), (A1-38)+(B2-29), (A1-38)+(B3-1), (A1-38)+(B3-2), (A1-38)+(B4-1), (A1-38)+(B4-2), (A1-38)+(B4-3), (A1-38)+(B4-4), (A1-38)+(B4-5), (A1-38)+(B4-6), (A1-38)+(B4-7), (A1-38)+(B4-8), (A1-38)+(B4-9), (A1-38)+(B4-10), (A1-38)+(B4-11), (A1-38)+(B5-1), (A1-38)+(B5-2), (A1-38)+(B5-3), (A1-38)+(B5-4), (A1-38)+(B5-5), (A1-38)+(B6-1), (A1-38)+(B6-2), (A1-38)+(B6-3), (A1-38)+(B6-4), (A1-38)+(B6-5), (A1-38)+(B6-6), (A1-38)+(B7-1), (A1-38)+(B7-2), (A1-38)+(B7-3), (A1-38)+(B7-4), (A1-38)+(B7-5), (A1-38)+(B7-6), (A1-38)+(B7-7)), (A1-38)+(B7-7), (A1-38)+(B7-8), (A1-38)+(B8-1), (A1-38)+(B8-2), (A1-38)+(B8-3), (A1-38)+(B8-4), (A1-38)+(B8-5), (A1-38)+(B8-6), (A1-38)+(B8-7), (A1-38)+(B9-1), (A1-38)+(B9-2), (A1-38)+(B10-1), (A1-38)+(B10-2), (A1-38)+(B10-3), (A1-38)+(B10-4), (A1-38)+(B10-5), (A1-38)+(B11-1), (A1-38)+(B11-2), (A1-38)+(B11-2),


(A1-39)+(B1-1), (A1-39)+(B1-2), (A1-39)+(B1-3), (A1-39)+(B1-4), (A1-39)+(B1-5), (A1-39)+(B1-6), (A1-39)+(B2-1), (A1-39)+(B2-2), (A1-39)+(B2-3), (A1-39)+(B2-4), (A1-39)+(B2-5), (A1-39)+(B2-6), (A1-39)+(B2-7), (A1-39)+(B2-8), (A1-39)+(B2-9), (A1-39)+(B2-10), (A1-39)+(B2-11), (A1-39)+(B2-12), (A1-39)+(B2-13), (A1-39)+(B2-14), (A1-39)+(B2-15), (A1-39)+(B2-16), (A1-39)+(B2-17), (A1-39)+(B2-18), (A1-39)+(B2-19), (A1-39)+(B2-20), (A1-39)+(B2-21), (A1-39)+(B2-22), (A1-39)+(B2-23), (A1-39)+(B2-24), (A1-39)+(B2-25), (A1-39)+(B2-26), (A1-39)+(B2-27), (A1-39)+(B2-28), (A1-39)+(B2-29), (A1-39)+(B3-1), (A1-39)+(B3-2), (A1-39)+(B4-1), (A1-39)+(B4-2), (A1-39)+(B4-3), (A1-39)+(B4-4), (A1-39)+(B4-5), (A1-39)+(B4-6), (A1-39)+(B4-7), (A1-39)+(B4-8), (A1-39)+(B4-9), (A1-39)+(B4-10), (A1-39)+(B4-11), (A1-39)+(B5-1), (A1-39)+(B5-2), (A1-39)+(B5-3), (A1-39)+(B5-4), (A1-39)+(B5-5), (A1-39)+(B6-1), (A1-39)+(B6-2), (A1-39)+(B6-3), (A1-39)+(B6-4), (A1-39)+(B6-5), (A1-39)+(B6-6), (A1-39)+(B7-1), (A1-39)+(B7-2), (A1-39)+(B7-3), (A1-39)+(B7-4), (A1-39)+(B7-5), (A1-39)+(B7-6), (A1-39)+(B7-7)), (A1-39)+(B7-7), (A1-39)+(B7-8), (A1-39)+(B8-1), (A1-39)+(B8-2), (A1-39)+(B8-3), (A1-39)+(B8-4), (A1-39)+(B8-5), (A1-39)+(B8-6), (A1-39)+(B8-7), (A1-39)+(B9-1), (A1-39)+(B9-2), (A1-39)+(B10-1), (A1-39)+(B10-2), (A1-39)+(B10-3), (A1-39)+(B10-4), (A1-39)+(B10-5), (A1-39)+(B11-1), (A1-39)+(B11-2), (A1-39)+(B11-2),


(A1-40)+(B1-1), (A1-40)+(B1-2), (A1-40)+(B1-3), (A1-40)+(B1-4), (A1-40)+(B1-5), (A1-40)+(B1-6), (A1-40)+(B2-1), (A1-40)+(B2-2), (A1-40)+(B2-3), (A1-40)+(B2-4), (A1-40)+(B2-5), (A1-40)+(B2-6), (A1-40)+(B2-7), (A1-40)+(B2-8), (A1-40)+(B2-9), (A1-40)+(B2-10), (A1-40)+(B2-11), (A1-40)+(B2-12), (A1-40)+(B2-13), (A1-40)+(B2-14), (A1-40)+(B2-15), (A1-40)+(B2-16), (A1-40)+(B2-17), (A1-40)+(B2-18), (A1-40)+(B2-19), (A1-40)+(B2-20), (A1-40)+(B2-21), (A1-40)+(B2-22), (A1-40)+(B2-23), (A1-40)+(B2-24), (A1-40)+(B2-25), (A1-40)+(B2-26), (A1-40)+(B2-27), (A1-40)+(B2-28), (A1-40)+(B2-29), (A1-40)+(B3-1), (A1-40)+(B3-2), (A1-40)+(B4-1), (A1-40)+(B4-2), (A1-40)+(B4-3), (A1-40)+(B4-4), (A1-40)+(B4-5), (A1-40)+(B4-6), (A1-40)+(B4-7), (A1-40)+(B4-8), (A1-40)+(B4-9), (A1-40)+(B4-10), (A1-40)+(B4-11), (A1-40)+(B5-1), (A1-40)+(B5-2), (A1-40)+(B5-3), (A1-40)+(B5-4), (A1-40)+(B5-5), (A1-40)+(B6-1), (A1-40)+(B6-2), (A1-40)+(B6-3), (A1-40)+(B6-4), (A1-40)+(B6-5), (A1-40)+(B6-6), (A1-40)+(B7-1), (A1-40)+(B7-2), (A1-40)+(B7-3), (A1-40)+(B7-4), (A1-40)+(B7-5), (A1-40)+(B7-6), (A1-40)+(B7-7)), (A1-40)+(B7-7), (A1-40)+(B7-8), (A1-40)+(B8-1), (A1-40)+(B8-2), (A1-40)+(B8-3), (A1-40)+(B8-4), (A1-40)+(B8-5), (A1-40)+(B8-6), (A1-40)+(B8-7), (A1-40)+(B9-1), (A1-40)+(B9-2), (A1-40)+(B10-1), (A1-40)+(B10-2), (A1-40)+(B10-3), (A1-40)+(B10-4), (A1-40)+(B10-5), (A1-40)+(B11-1), (A1-40)+(B11-2), (A1-40)+(B11-2),


(A1-41)+(B1-1), (A1-41)+(B1-2), (A1-41)+(B1-3), (A1-41)+(B1-4), (A1-41)+(B1-5), (A1-41)+(B1-6), (A1-41)+(B2-1), (A1-41)+(B2-2), (A1-41)+(B2-3), (A1-41)+(B2-4), (A1-41)+(B2-5), (A1-41)+(B2-6), (A1-41)+(B2-7), (A1-41)+(B2-8), (A1-41)+(B2-9), (A1-41)+(B2-10), (A1-41)+(B2-11), (A1-41)+(B2-12), (A1-41)+(B2-13), (A1-41)+(B2-14), (A1-41)+(B2-15), (A1-41)+(B2-16), (A1-41)+(B2-17), (A1-41)+(B2-18), (A1-41)+(B2-19), (A1-41)+(B2-20), (A1-41)+(B2-21), (A1-41)+(B2-22), (A1-41)+(B2-23), (A1-41)+(B2-24), (A1-41)+(B2-25), (A1-41)+(B2-26), (A1-41)+(B2-27), (A1-41)+(B2-28), (A1-41)+(B2-29), (A1-41)+(B3-1), (A1-41)+(B3-2), (A1-41)+(B4-1), (A1-41)+(B4-2), (A1-41)+(B4-3), (A1-41)+(B4-4), (A1-41)+(B4-5), (A1-41)+(B4-6), (A1-41)+(B4-7), (A1-41)+(B4-8), (A1-41)+(B4-9), (A1-41)+(B4-10), (A1-41)+(B4-11), (A1-41)+(B5-1), (A1-41)+(B5-2), (A1-41)+(B5-3), (A1-41)+(B5-4), (A1-41)+(B5-5), (A1-41)+(B6-1), (A1-41)+(B6-2), (A1-41)+(B6-3), (A1-41)+(B6-4), (A1-41)+(B6-5), (A1-41)+(B6-6), (A1-41)+(B7-1), (A1-41)+(B7-2), (A1-41)+(B7-3), (A1-41)+(B7-4), (A1-41)+(B7-5), (A1-41)+(B7-6), (A1-41)+(B7-7)), (A1-41)+(B7-7), (A1-41)+(B7-8), (A1-41)+(B8-1), (A1-41)+(B8-2), (A1-41)+(B8-3), (A1-41)+(B8-4), (A1-41)+(B8-5), (A1-41)+(B8-6), (A1-41)+(B8-7), (A1-41)+(B9-1), (A1-41)+(B9-2), (A1-41)+(B10-1), (A1-41)+(B10-2), (A1-41)+(B10-3), (A1-41)+(B10-4), (A1-41)+(B10-5), (A1-41)+(B11-1), (A1-41)+(B11-2), (A1-41)+(B11-2),


(A1-42)+(B1-1), (A1-42)+(B1-2), (A1-42)+(B1-3), (A1-42)+(B1-4), (A1-42)+(B1-5), (A1-42)+(B1-6), (A1-42)+(B2-1), (A1-42)+(B2-2), (A1-42)+(B2-3), (A1-42)+(B2-4), (A1-42)+(B2-5), (A1-42)+(B2-6), (A1-42)+(B2-7), (A1-42)+(B2-8), (A1-42)+(B2-9), (A1-42)+(B2-10), (A1-42)+(B2-11), (A1-42)+(B2-12), (A1-42)+(B2-13), (A1-42)+(B2-14), (A1-42)+(B2-15), (A1-42)+(B2-16), (A1-42)+(B2-17), (A1-42)+(B2-18), (A1-42)+(B2-19), (A1-42)+(B2-20), (A1-42)+(B2-21), (A1-42)+(B2-22), (A1-42)+(B2-23), (A1-42)+(B2-24), (A1-42)+(B2-25), (A1-42)+(B2-26), (A1-42)+(B2-27), (A1-42)+(B2-28), (A1-42)+(B2-29), (A1-42)+(B3-1), (A1-42)+(B3-2), (A1-42)+(B4-1), (A1-42)+(B4-2), (A1-42)+(B4-3), (A1-42)+(B4-4), (A1-42)+(B4-5), (A1-42)+(B4-6), (A1-42)+(B4-7), (A1-42)+(B4-8), (A1-42)+(B4-9), (A1-42)+(B4-10), (A1-42)+(B4-11), (A1-42)+(B5-1), (A1-42)+(B5-2), (A1-42)+(B5-3), (A1-42)+(B5-4), (A1-42)+(B5-5), (A1-42)+(B6-1), (A1-42)+(B6-2), (A1-42)+(B6-3), (A1-42)+(B6-4), (A1-42)+(B6-5), (A1-42)+(B6-6), (A1-42)+(B7-1), (A1-42)+(B7-2), (A1-42)+(B7-3), (A1-42)+(B7-4), (A1-42)+(B7-5), (A1-42)+(B7-6), (A1-42)+(B7-7)), (A1-42)+(B7-7), (A1-42)+(B7-8), (A1-42)+(B8-1), (A1-42)+(B8-2), (A1-42)+(B8-3), (A1-42)+(B8-4), (A1-42)+(B8-5), (A1-42)+(B8-6), (A1-42)+(B8-7), (A1-42)+(B9-1), (A1-42)+(B9-2), (A1-42)+(B10-1), (A1-42)+(B10-2), (A1-42)+(B10-3), (A1-42)+(B10-4), (A1-42)+(B10-5), (A1-42)+(B11-1), (A1-42)+(B11-2), (A1-42)+(B11-2),


(A1-43)+(B1-1), (A1-43)+(B1-2), (A1-43)+(B1-3), (A1-43)+(B1-4), (A1-43)+(B1-5), (A1-43)+(B1-6), (A1-43)+(B2-1), (A1-43)+(B2-2), (A1-43)+(B2-3), (A1-43)+(B2-4), (A1-43)+(B2-5), (A1-43)+(B2-6), (A1-43)+(B2-7), (A1-43)+(B2-8), (A1-43)+(B2-9), (A1-43)+(B2-10), (A1-43)+(B2-11), (A1-43)+(B2-12), (A1-43)+(B2-13), (A1-43)+(B2-14), (A1-43)+(B2-15), (A1-43)+(B2-16), (A1-43)+(B2-17), (A1-43)+(B2-18), (A1-43)+(B2-19), (A1-43)+(B2-20), (A1-43)+(B2-21), (A1-43)+(B2-22), (A1-43)+(B2-23), (A1-43)+(B2-24), (A1-43)+(B2-25), (A1-43)+(B2-26), (A1-43)+(B2-27), (A1-43)+(B2-28), (A1-43)+(B2-29), (A1-43)+(B3-1), (A1-43)+(B3-2), (A1-43)+(B4-1), (A1-43)+(B4-2), (A1-43)+(B4-3), (A1-43)+(B4-4), (A1-43)+(B4-5), (A1-43)+(B4-6), (A1-43)+(B4-7), (A1-43)+(B4-8), (A1-43)+(B4-9), (A1-43)+(B4-10), (A1-43)+(B4-11), (A1-43)+(B5-1), (A1-43)+(B5-2), (A1-43)+(B5-3), (A1-43)+(B5-4), (A1-43)+(B5-5), (A1-43)+(B6-1), (A1-43)+(B6-2), (A1-43)+(B6-3), (A1-43)+(B6-4), (A1-43)+(B6-5), (A1-43)+(B6-6), (A1-43)+(B7-1), (A1-43)+(B7-2), (A1-43)+(B7-3), (A1-43)+(B7-4), (A1-43)+(B7-5), (A1-43)+(B7-6), (A1-43)+(B7-7)), (A1-43)+(B7-7), (A1-43)+(B7-8), (A1-43)+(B8-1), (A1-43)+(B8-2), (A1-43)+(B8-3), (A1-43)+(B8-4), (A1-43)+(B8-5), (A1-43)+(B8-6), (A1-43)+(B8-7), (A1-43)+(B9-1), (A1-43)+(B9-2), (A1-43)+(B10-1), (A1-43)+(B10-2), (A1-43)+(B10-3), (A1-43)+(B10-4), (A1-43)+(B10-5), (A1-43)+(B11-1), (A1-43)+(B11-2), (A1-43)+(B11-2),


(A1-44)+(B1-1), (A1-44)+(B1-2), (A1-44)+(B1-3), (A1-44)+(B1-4), (A1-44)+(B1-5), (A1-44)+(B1-6), (A1-44)+(B2-1), (A1-44)+(B2-2), (A1-44)+(B2-3), (A1-44)+(B2-4), (A1-44)+(B2-5), (A1-44)+(B2-6), (A1-44)+(B2-7), (A1-44)+(B2-8), (A1-44)+(B2-9), (A1-44)+(B2-10), (A1-44)+(B2-11), (A1-44)+(B2-12), (A1-44)+(B2-13), (A1-44)+(B2-14), (A1-44)+(B2-15), (A1-44)+(B2-16), (A1-44)+(B2-17), (A1-44)+(B2-18), (A1-44)+(B2-19), (A1-44)+(B2-20), (A1-44)+(B2-21), (A1-44)+(B2-22), (A1-44)+(B2-23), (A1-44)+(B2-24), (A1-44)+(B2-25), (A1-44)+(B2-26), (A1-44)+(B2-27), (A1-44)+(B2-28), (A1-44)+(B2-29), (A1-44)+(B3-1), (A1-44)+(B3-2), (A1-44)+(B4-1), (A1-44)+(B4-2), (A1-44)+(B4-3), (A1-44)+(B4-4), (A1-44)+(B4-5), (A1-44)+(B4-6), (A1-44)+(B4-7), (A1-44)+(B4-8), (A1-44)+(B4-9), (A1-44)+(B4-10), (A1-44)+(B4-11), (A1-44)+(B5-1), (A1-44)+(B5-2), (A1-44)+(B5-3), (A1-44)+(B5-4), (A1-44)+(B5-5), (A1-44)+(B6-1), (A1-44)+(B6-2), (A1-44)+(B6-3), (A1-44)+(B6-4), (A1-44)+(B6-5), (A1-44)+(B6-6), (A1-44)+(B7-1), (A1-44)+(B7-2), (A1-44)+(B7-3), (A1-44)+(B7-4), (A1-44)+(B7-5), (A1-44)+(B7-6), (A1-44)+(B7-7)), (A1-44)+(B7-7), (A1-44)+(B7-8), (A1-44)+(B8-1), (A1-44)+(B8-2), (A1-44)+(B8-3), (A1-44)+(B8-4), (A1-44)+(B8-5), (A1-44)+(B8-6), (A1-44)+(B8-7), (A1-44)+(B9-1), (A1-44)+(B9-2), (A1-44)+(B10-1), (A1-44)+(B10-2), (A1-44)+(B10-3), (A1-44)+(B10-4), (A1-44)+(B10-5), (A1-44)+(B11-1), (A1-44)+(B11-2), (A1-44)+(B11-2),


(A1-45)+(B1-1), (A1-45)+(B1-2), (A1-45)+(B1-3), (A1-45)+(B1-4), (A1-45)+(B1-5), (A1-45)+(B1-6), (A1-45)+(B2-1), (A1-45)+(B2-2), (A1-45)+(B2-3), (A1-45)+(B2-4), (A1-45)+(B2-5), (A1-45)+(B2-6), (A1-45)+(B2-7), (A1-45)+(B2-8), (A1-45)+(B2-9), (A1-45)+(B2-10), (A1-45)+(B2-11), (A1-45)+(B2-12), (A1-45)+(B2-13), (A1-45)+(B2-14), (A1-45)+(B2-15), (A1-45)+(B2-16), (A1-45)+(B2-17), (A1-45)+(B2-18), (A1-45)+(B2-19), (A1-45)+(B2-20), (A1-45)+(B2-21), (A1-45)+(B2-22), (A1-45)+(B2-23), (A1-45)+(B2-24), (A1-45)+(B2-25), (A1-45)+(B2-26), (A1-45)+(B2-27), (A1-45)+(B2-28), (A1-45)+(B2-29), (A1-45)+(B3-1), (A1-45)+(B3-2), (A1-45)+(B4-1), (A1-45)+(B4-2), (A1-45)+(B4-3), (A1-45)+(B4-4), (A1-45)+(B4-5), (A1-45)+(B4-6), (A1-45)+(B4-7), (A1-45)+(B4-8), (A1-45)+(B4-9), (A1-45)+(B4-10), (A1-45)+(B4-11), (A1-45)+(B5-1), (A1-45)+(B5-2), (A1-45)+(B5-3), (A1-45)+(B5-4), (A1-45)+(B5-5), (A1-45)+(B6-1), (A1-45)+(B6-2), (A1-45)+(B6-3), (A1-45)+(B6-4), (A1-45)+(B6-5), (A1-45)+(B6-6), (A1-45)+(B7-1), (A1-45)+(B7-2), (A1-45)+(B7-3), (A1-45)+(B7-4), (A1-45)+(B7-5), (A1-45)+(B7-6), (A1-45)+(B7-7)), (A1-45)+(B7-7), (A1-45)+(B7-8), (A1-45)+(B8-1), (A1-45)+(B8-2), (A1-45)+(B8-3), (A1-45)+(B8-4), (A1-45)+(B8-5), (A1-45)+(B8-6), (A1-45)+(B8-7), (A1-45)+(B9-1), (A1-45)+(B9-2), (A1-45)+(B10-1), (A1-45)+(B10-2), (A1-45)+(B10-3), (A1-45)+(B10-4), (A1-45)+(B10-5), (A1-45)+(B11-1), (A1-45)+(B11-2), (A1-45)+(B11-2),


(A1-46)+(B1-1), (A1-46)+(B1-2), (A1-46)+(B1-3), (A1-46)+(B1-4), (A1-46)+(B1-5), (A1-46)+(B1-6), (A1-46)+(B2-1), (A1-46)+(B2-2), (A1-46)+(B2-3), (A1-46)+(B2-4), (A1-46)+(B2-5), (A1-46)+(B2-6), (A1-46)+(B2-7), (A1-46)+(B2-8), (A1-46)+(B2-9), (A1-46)+(B2-10), (A1-46)+(B2-11), (A1-46)+(B2-12), (A1-46)+(B2-13), (A1-46)+(B2-14), (A1-46)+(B2-15), (A1-46)+(B2-16), (A1-46)+(B2-17), (A1-46)+(B2-18), (A1-46)+(B2-19), (A1-46)+(B2-20), (A1-46)+(B2-21), (A1-46)+(B2-22), (A1-46)+(B2-23), (A1-46)+(B2-24), (A1-46)+(B2-25), (A1-46)+(B2-26), (A1-46)+(B2-27), (A1-46)+(B2-28), (A1-46)+(B2-29), (A1-46)+(B3-1), (A1-46)+(B3-2), (A1-46)+(B4-1), (A1-46)+(B4-2), (A1-46)+(B4-3), (A1-46)+(B4-4), (A1-46)+(B4-5), (A1-46)+(B4-6), (A1-46)+(B4-7), (A1-46)+(B4-8), (A1-46)+(B4-9), (A1-46)+(B4-10), (A1-46)+(B4-11), (A1-46)+(B5-1), (A1-46)+(B5-2), (A1-46)+(B5-3), (A1-46)+(B5-4), (A1-46)+(B5-5), (A1-46)+(B6-1), (A1-46)+(B6-2), (A1-46)+(B6-3), (A1-46)+(B6-4), (A1-46)+(B6-5), (A1-46)+(B6-6), (A1-46)+(B7-1), (A1-46)+(B7-2), (A1-46)+(B7-3), (A1-46)+(B7-4), (A1-46)+(B7-5), (A1-46)+(B7-6), (A1-46)+(B7-7)), (A1-46)+(B7-7), (A1-46)+(B7-8), (A1-46)+(B8-1), (A1-46)+(B8-2), (A1-46)+(B8-3), (A1-46)+(B8-4), (A1-46)+(B8-5), (A1-46)+(B8-6), (A1-46)+(B8-7), (A1-46)+(B9-1), (A1-46)+(B9-2), (A1-46)+(B10-1), (A1-46)+(B10-2), (A1-46)+(B10-3), (A1-46)+(B10-4), (A1-46)+(B10-5), (A1-46)+(B11-1), (A1-46)+(B11-2), (A1-46)+(B11-2),


(A1-47)+(B1-1), (A1-47)+(B1-2), (A1-47)+(B1-3), (A1-47)+(B1-4), (A1-47)+(B1-5), (A1-47)+(B1-6), (A1-47)+(B2-1), (A1-47)+(B2-2), (A1-47)+(B2-3), (A1-47)+(B2-4), (A1-47)+(B2-5), (A1-47)+(B2-6), (A1-47)+(B2-7), (A1-47)+(B2-8), (A1-47)+(B2-9), (A1-47)+(B2-10), (A1-47)+(B2-11), (A1-47)+(B2-12), (A1-47)+(B2-13), (A1-47)+(B2-14), (A1-47)+(B2-15), (A1-47)+(B2-16), (A1-47)+(B2-17), (A1-47)+(B2-18), (A1-47)+(B2-19), (A1-47)+(B2-20), (A1-47)+(B2-21), (A1-47)+(B2-22), (A1-47)+(B2-23), (A1-47)+(B2-24), (A1-47)+(B2-25), (A1-47)+(B2-26), (A1-47)+(B2-27), (A1-47)+(B2-28), (A1-47)+(B2-29), (A1-47)+(B3-1), (A1-47)+(B3-2), (A1-47)+(B4-1), (A1-47)+(B4-2), (A1-47)+(B4-3), (A1-47)+(B4-4), (A1-47)+(B4-5), (A1-47)+(B4-6), (A1-47)+(B4-7), (A1-47)+(B4-8), (A1-47)+(B4-9), (A1-47)+(B4-10), (A1-47)+(B4-11), (A1-47)+(B5-1), (A1-47)+(B5-2), (A1-47)+(B5-3), (A1-47)+(B5-4), (A1-47)+(B5-5), (A1-47)+(B6-1), (A1-47)+(B6-2), (A1-47)+(B6-3), (A1-47)+(B6-4), (A1-47)+(B6-5), (A1-47)+(B6-6), (A1-47)+(B7-1), (A1-47)+(B7-2), (A1-47)+(B7-3), (A1-47)+(B7-4), (A1-47)+(B7-5), (A1-47)+(B7-6), (A1-47)+(B7-7)), (A1-47)+(B7-7), (A1-47)+(B7-8), (A1-47)+(B8-1), (A1-47)+(B8-2), (A1-47)+(B8-3), (A1-47)+(B8-4), (A1-47)+(B8-5), (A1-47)+(B8-6), (A1-47)+(B8-7), (A1-47)+(B9-1), (A1-47)+(B9-2), (A1-47)+(B10-1), (A1-47)+(B10-2), (A1-47)+(B10-3), (A1-47)+(B10-4), (A1-47)+(B10-5), (A1-47)+(B11-1), (A1-47)+(B11-2), (A1-47)+(B11-2),


(A1-48)+(B1-1), (A1-48)+(B1-2), (A1-48)+(B1-3), (A1-48)+(B1-4), (A1-48)+(B1-5), (A1-48)+(B1-6), (A1-48)+(B2-1), (A1-48)+(B2-2), (A1-48)+(B2-3), (A1-48)+(B2-4), (A1-48)+(B2-5), (A1-48)+(B2-6), (A1-48)+(B2-7), (A1-48)+(B2-8), (A1-48)+(B2-9), (A1-48)+(B2-10), (A1-48)+(B2-11), (A1-48)+(B2-12), (A1-48)+(B2-13), (A1-48)+(B2-14), (A1-48)+(B2-15), (A1-48)+(B2-16), (A1-48)+(B2-17), (A1-48)+(B2-18), (A1-48)+(B2-19), (A1-48)+(B2-20), (A1-48)+(B2-21), (A1-48)+(B2-22), (A1-48)+(B2-23), (A1-48)+(B2-24), (A1-48)+(B2-25), (A1-48)+(B2-26), (A1-48)+(B2-27), (A1-48)+(B2-28), (A1-48)+(B2-29), (A1-48)+(B3-1), (A1-48)+(B3-2), (A1-48)+(B4-1), (A1-48)+(B4-2), (A1-48)+(B4-3), (A1-48)+(B4-4), (A1-48)+(B4-5), (A1-48)+(B4-6), (A1-48)+(B4-7), (A1-48)+(B4-8), (A1-48)+(B4-9), (A1-48)+(B4-10), (A1-48)+(B4-11), (A1-48)+(B5-1), (A1-48)+(B5-2), (A1-48)+(B5-3), (A1-48)+(B5-4), (A1-48)+(B5-5), (A1-48)+(B6-1), (A1-48)+(B6-2), (A1-48)+(B6-3), (A1-48)+(B6-4), (A1-48)+(B6-5), (A1-48)+(B6-6), (A1-48)+(B7-1), (A1-48)+(B7-2), (A1-48)+(B7-3), (A1-48)+(B7-4), (A1-48)+(B7-5), (A1-48)+(B7-6), (A1-48)+(B7-7)), (A1-48)+(B7-7), (A1-48)+(B7-8), (A1-48)+(B8-1), (A1-48)+(B8-2), (A1-48)+(B8-3), (A1-48)+(B8-4), (A1-48)+(B8-5), (A1-48)+(B8-6), (A1-48)+(B8-7), (A1-48)+(B9-1), (A1-48)+(B9-2), (A1-48)+(B10-1), (A1-48)+(B10-2), (A1-48)+(B10-3), (A1-48)+(B10-4), (A1-48)+(B10-5), (A1-48)+(B11-1), (A1-48)+(B11-2), (A1-48)+(B11-2),


(A1-49)+(B1-1), (A1-49)+(B1-2), (A1-49)+(B1-3), (A1-49)+(B1-4), (A1-49)+(B1-5), (A1-49)+(B1-6), (A1-49)+(B2-1), (A1-49)+(B2-2), (A1-49)+(B2-3), (A1-49)+(B2-4), (A1-49)+(B2-5), (A1-49)+(B2-6), (A1-49)+(B2-7), (A1-49)+(B2-8), (A1-49)+(B2-9), (A1-49)+(B2-10), (A1-49)+(B2-11), (A1-49)+(B2-12), (A1-49)+(B2-13), (A1-49)+(B2-14), (A1-49)+(B2-15), (A1-49)+(B2-16), (A1-49)+(B2-17), (A1-49)+(B2-18), (A1-49)+(B2-19), (A1-49)+(B2-20), (A1-49)+(B2-21), (A1-49)+(B2-22), (A1-49)+(B2-23), (A1-49)+(B2-24), (A1-49)+(B2-25), (A1-49)+(B2-26), (A1-49)+(B2-27), (A1-49)+(B2-28), (A1-49)+(B2-29), (A1-49)+(B3-1), (A1-49)+(B3-2), (A1-49)+(B4-1), (A1-49)+(B4-2), (A1-49)+(B4-3), (A1-49)+(B4-4), (A1-49)+(B4-5), (A1-49)+(B4-6), (A1-49)+(B4-7), (A1-49)+(B4-8), (A1-49)+(B4-9), (A1-49)+(B4-10), (A1-49)+(B4-11), (A1-49)+(B5-1), (A1-49)+(B5-2), (A1-49)+(B5-3), (A1-49)+(B5-4), (A1-49)+(B5-5), (A1-49)+(B6-1), (A1-49)+(B6-2), (A1-49)+(B6-3), (A1-49)+(B6-4), (A1-49)+(B6-5), (A1-49)+(B6-6), (A1-49)+(B7-1), (A1-49)+(B7-2), (A1-49)+(B7-3), (A1-49)+(B7-4), (A1-49)+(B7-5), (A1-49)+(B7-6), (A1-49)+(B7-7)), (A1-49)+(B7-7), (A1-49)+(B7-8), (A1-49)+(B8-1), (A1-49)+(B8-2), (A1-49)+(B8-3), (A1-49)+(B8-4), (A1-49)+(B8-5), (A1-49)+(B8-6), (A1-49)+(B8-7), (A1-49)+(B9-1), (A1-49)+(B9-2), (A1-49)+(B10-1), (A1-49)+(B10-2), (A1-49)+(B10-3), (A1-49)+(B10-4), (A1-49)+(B10-5), (A1-49)+(B11-1), (A1-49)+(B11-2), (A1-49)+(B11-2),


(A1-50)+(B1-1), (A1-50)+(B1-2), (A1-50)+(B1-3), (A1-50)+(B1-4), (A1-50)+(B1-5), (A1-50)+(B1-6), (A1-50)+(B2-1), (A1-50)+(B2-2), (A1-50)+(B2-3), (A1-50)+(B2-4), (A1-50)+(B2-5), (A1-50)+(B2-6), (A1-50)+(B2-7), (A1-50)+(B2-8), (A1-50)+(B2-9), (A1-50)+(B2-10), (A1-50)+(B2-11), (A1-50)+(B2-12), (A1-50)+(B2-13), (A1-50)+(B2-14), (A1-50)+(B2-15), (A1-50)+(B2-16), (A1-50)+(B2-17), (A1-50)+(B2-18), (A1-50)+(B2-19), (A1-50)+(B2-20), (A1-50)+(B2-21), (A1-50)+(B2-22), (A1-50)+(B2-23), (A1-50)+(B2-24), (A1-50)+(B2-25), (A1-50)+(B2-26), (A1-50)+(B2-27), (A1-50)+(B2-28), (A1-50)+(B2-29), (A1-50)+(B3-1), (A1-50)+(B3-2), (A1-50)+(B4-1), (A1-50)+(B4-2), (A1-50)+(B4-3), (A1-50)+(B4-4), (A1-50)+(B4-5), (A1-50)+(B4-6), (A1-50)+(B4-7), (A1-50)+(B4-8), (A1-50)+(B4-9), (A1-50)+(B4-10), (A1-50)+(B4-11), (A1-50)+(B5-1), (A1-50)+(B5-2), (A1-50)+(B5-3), (A1-50)+(B5-4), (A1-50)+(B5-5), (A1-50)+(B6-1), (A1-50)+(B6-2), (A1-50)+(B6-3), (A1-50)+(B6-4), (A1-50)+(B6-5), (A1-50)+(B6-6), (A1-50)+(B7-1), (A1-50)+(B7-2), (A1-50)+(B7-3), (A1-50)+(B7-4), (A1-50)+(B7-5), (A1-50)+(B7-6), (A1-50)+(B7-7)), (A1-50)+(B7-7), (A1-50)+(B7-8), (A1-50)+(B8-1), (A1-50)+(B8-2), (A1-50)+(B8-3), (A1-50)+(B8-4), (A1-50)+(B8-5), (A1-50)+(B8-6), (A1-50)+(B8-7), (A1-50)+(B9-1), (A1-50)+(B9-2), (A1-50)+(B10-1), (A1-50)+(B10-2), (A1-50)+(B10-3), (A1-50)+(B10-4), (A1-50)+(B10-5), (A1-50)+(B11-1), (A1-50)+(B11-2), (A1-50)+(B11-2),


(A1-51)+(B1-1), (A1-51)+(B1-2), (A1-51)+(B1-3), (A1-51)+(B1-4), (A1-51)+(B1-5), (A1-51)+(B1-6), (A1-51)+(B2-1), (A1-51)+(B2-2), (A1-51)+(B2-3), (A1-51)+(B2-4), (A1-51)+(B2-5), (A1-51)+(B2-6), (A1-51)+(B2-7), (A1-51)+(B2-8), (A1-51)+(B2-9), (A1-51)+(B2-10), (A1-51)+(B2-11), (A1-51)+(B2-12), (A1-51)+(B2-13), (A1-51)+(B2-14), (A1-51)+(B2-15), (A1-51)+(B2-16), (A1-51)+(B2-17), (A1-51)+(B2-18), (A1-51)+(B2-19), (A1-51)+(B2-20), (A1-51)+(B2-21), (A1-51)+(B2-22), (A1-51)+(B2-23), (A1-51)+(B2-24), (A1-51)+(B2-25), (A1-51)+(B2-26), (A1-51)+(B2-27), (A1-51)+(B2-28), (A1-51)+(B2-29), (A1-51)+(B3-1), (A1-51)+(B3-2), (A1-51)+(B4-1), (A1-51)+(B4-2), (A1-51)+(B4-3), (A1-51)+(B4-4), (A1-51)+(B4-5), (A1-51)+(B4-6), (A1-51)+(B4-7), (A1-51)+(B4-8), (A1-51)+(B4-9), (A1-51)+(B4-10), (A1-51)+(B4-11), (A1-51)+(B5-1), (A1-51)+(B5-2), (A1-51)+(B5-3), (A1-51)+(B5-4), (A1-51)+(B5-5), (A1-51)+(B6-1), (A1-51)+(B6-2), (A1-51)+(B6-3), (A1-51)+(B6-4), (A1-51)+(B6-5), (A1-51)+(B6-6), (A1-51)+(B7-1), (A1-51)+(B7-2), (A1-51)+(B7-3), (A1-51)+(B7-4), (A1-51)+(B7-5), (A1-51)+(B7-6), (A1-51)+(B7-7)), (A1-51)+(B7-7), (A1-51)+(B7-8), (A1-51)+(B8-1), (A1-51)+(B8-2), (A1-51)+(B8-3), (A1-51)+(B8-4), (A1-51)+(B8-5), (A1-51)+(B8-6), (A1-51)+(B8-7), (A1-51)+(B9-1), (A1-51)+(B9-2), (A1-51)+(B10-1), (A1-51)+(B10-2), (A1-51)+(B10-3), (A1-51)+(B10-4), (A1-51)+(B10-5), (A1-51)+(B11-1), (A1-51)+(B11-2), (A1-51)+(B11-2),


(A1-52)+(B1-1), (A1-52)+(B1-2), (A1-52)+(B1-3), (A1-52)+(B1-4), (A1-52)+(B1-5), (A1-52)+(B1-6), (A1-52)+(B2-1), (A1-52)+(B2-2), (A1-52)+(B2-3), (A1-52)+(B2-4), (A1-52)+(B2-5), (A1-52)+(B2-6), (A1-52)+(B2-7), (A1-52)+(B2-8), (A1-52)+(B2-9), (A1-52)+(B2-10), (A1-52)+(B2-11), (A1-52)+(B2-12), (A1-52)+(B2-13), (A1-52)+(B2-14), (A1-52)+(B2-15), (A1-52)+(B2-16), (A1-52)+(B2-17), (A1-52)+(B2-18), (A1-52)+(B2-19), (A1-52)+(B2-20), (A1-52)+(B2-21), (A1-52)+(B2-22), (A1-52)+(B2-23), (A1-52)+(B2-24), (A1-52)+(B2-25), (A1-52)+(B2-26), (A1-52)+(B2-27), (A1-52)+(B2-28), (A1-52)+(B2-29), (A1-52)+(B3-1), (A1-52)+(B3-2), (A1-52)+(B4-1), (A1-52)+(B4-2), (A1-52)+(B4-3), (A1-52)+(B4-4), (A1-52)+(B4-5), (A1-52)+(B4-6), (A1-52)+(B4-7), (A1-52)+(B4-8), (A1-52)+(B4-9), (A1-52)+(B4-10), (A1-52)+(B4-11), (A1-52)+(B5-1), (A1-52)+(B5-2), (A1-52)+(B5-3), (A1-52)+(B5-4), (A1-52)+(B5-5), (A1-52)+(B6-1), (A1-52)+(B6-2), (A1-52)+(B6-3), (A1-52)+(B6-4), (A1-52)+(B6-5), (A1-52)+(B6-6), (A1-52)+(B7-1), (A1-52)+(B7-2), (A1-52)+(B7-3), (A1-52)+(B7-4), (A1-52)+(B7-5), (A1-52)+(B7-6), (A1-52)+(B7-7)), (A1-52)+(B7-7), (A1-52)+(B7-8), (A1-52)+(B8-1), (A1-52)+(B8-2), (A1-52)+(B8-3), (A1-52)+(B8-4), (A1-52)+(B8-5), (A1-52)+(B8-6), (A1-52)+(B8-7), (A1-52)+(B9-1), (A1-52)+(B9-2), (A1-52)+(B10-1), (A1-52)+(B10-2), (A1-52)+(B10-3), (A1-52)+(B10-4), (A1-52)+(B10-5), (A1-52)+(B11-1), (A1-52)+(B11-2), (A1-52)+(B11-2),


(A1-53)+(B1-1), (A1-53)+(B1-2), (A1-53)+(B1-3), (A1-53)+(B1-4), (A1-53)+(B1-5), (A1-53)+(B1-6), (A1-53)+(B2-1), (A1-53)+(B2-2), (A1-53)+(B2-3), (A1-53)+(B2-4), (A1-53)+(B2-5), (A1-53)+(B2-6), (A1-53)+(B2-7), (A1-53)+(B2-8), (A1-53)+(B2-9), (A1-53)+(B2-10), (A1-53)+(B2-11), (A1-53)+(B2-12), (A1-53)+(B2-13), (A1-53)+(B2-14), (A1-53)+(B2-15), (A1-53)+(B2-16), (A1-53)+(B2-17), (A1-53)+(B2-18), (A1-53)+(B2-19), (A1-53)+(B2-20), (A1-53)+(B2-21), (A1-53)+(B2-22), (A1-53)+(B2-23), (A1-53)+(B2-24), (A1-53)+(B2-25), (A1-53)+(B2-26), (A1-53)+(B2-27), (A1-53)+(B2-28), (A1-53)+(B2-29), (A1-53)+(B3-1), (A1-53)+(B3-2), (A1-53)+(B4-1), (A1-53)+(B4-2), (A1-53)+(B4-3), (A1-53)+(B4-4), (A1-53)+(B4-5), (A1-53)+(B4-6), (A1-53)+(B4-7), (A1-53)+(B4-8), (A1-53)+(B4-9), (A1-53)+(B4-10), (A1-53)+(B4-11), (A1-53)+(B5-1), (A1-53)+(B5-2), (A1-53)+(B5-3), (A1-53)+(B5-4), (A1-53)+(B5-5), (A1-53)+(B6-1), (A1-53)+(B6-2), (A1-53)+(B6-3), (A1-53)+(B6-4), (A1-53)+(B6-5), (A1-53)+(B6-6), (A1-53)+(B7-1), (A1-53)+(B7-2), (A1-53)+(B7-3), (A1-53)+(B7-4), (A1-53)+(B7-5), (A1-53)+(B7-6), (A1-53)+(B7-7)), (A1-53)+(B7-7), (A1-53)+(B7-8), (A1-53)+(B8-1), (A1-53)+(B8-2), (A1-53)+(B8-3), (A1-53)+(B8-4), (A1-53)+(B8-5), (A1-53)+(B8-6), (A1-53)+(B8-7), (A1-53)+(B9-1), (A1-53)+(B9-2), (A1-53)+(B10-1), (A1-53)+(B10-2), (A1-53)+(B10-3), (A1-53)+(B10-4), (A1-53)+(B10-5), (A1-53)+(B11-1), (A1-53)+(B11-2), (A1-53)+(B11-2),


(A1-54)+(B1-1), (A1-54)+(B1-2), (A1-54)+(B1-3), (A1-54)+(B1-4), (A1-54)+(B1-5), (A1-54)+(B1-6), (A1-54)+(B2-1), (A1-54)+(B2-2), (A1-54)+(B2-3), (A1-54)+(B2-4), (A1-54)+(B2-5), (A1-54)+(B2-6), (A1-54)+(B2-7), (A1-54)+(B2-8), (A1-54)+(B2-9), (A1-54)+(B2-10), (A1-54)+(B2-11), (A1-54)+(B2-12), (A1-54)+(B2-13), (A1-54)+(B2-14), (A1-54)+(B2-15), (A1-54)+(B2-16), (A1-54)+(B2-17), (A1-54)+(B2-18), (A1-54)+(B2-19), (A1-54)+(B2-20), (A1-54)+(B2-21), (A1-54)+(B2-22), (A1-54)+(B2-23), (A1-54)+(B2-24), (A1-54)+(B2-25), (A1-54)+(B2-26), (A1-54)+(B2-27), (A1-54)+(B2-28), (A1-54)+(B2-29), (A1-54)+(B3-1), (A1-54)+(B3-2), (A1-54)+(B4-1), (A1-54)+(B4-2), (A1-54)+(B4-3), (A1-54)+(B4-4), (A1-54)+(B4-5), (A1-54)+(B4-6), (A1-54)+(B4-7), (A1-54)+(B4-8), (A1-54)+(B4-9), (A1-54)+(B4-10), (A1-54)+(B4-11), (A1-54)+(B5-1), (A1-54)+(B5-2), (A1-54)+(B5-3), (A1-54)+(B5-4), (A1-54)+(B5-5), (A1-54)+(B6-1), (A1-54)+(B6-2), (A1-54)+(B6-3), (A1-54)+(B6-4), (A1-54)+(B6-5), (A1-54)+(B6-6), (A1-54)+(B7-1), (A1-54)+(B7-2), (A1-54)+(B7-3), (A1-54)+(B7-4), (A1-54)+(B7-5), (A1-54)+(B7-6), (A1-54)+(B7-7)), (A1-54)+(B7-7), (A1-54)+(B7-8), (A1-54)+(B8-1), (A1-54)+(B8-2), (A1-54)+(B8-3), (A1-54)+(B8-4), (A1-54)+(B8-5), (A1-54)+(B8-6), (A1-54)+(B8-7), (A1-54)+(B9-1), (A1-54)+(B9-2), (A1-54)+(B10-1), (A1-54)+(B10-2), (A1-54)+(B10-3), (A1-54)+(B10-4), (A1-54)+(B10-5), (A1-54)+(B11-1), (A1-54)+(B11-2), (A1-54)+(B11-2),


(A1-55)+(B1-1), (A1-55)+(B1-2), (A1-55)+(B1-3), (A1-55)+(B1-4), (A1-55)+(B1-5), (A1-55)+(B1-6), (A1-55)+(B2-1), (A1-55)+(B2-2), (A1-55)+(B2-3), (A1-55)+(B2-4), (A1-55)+(B2-5), (A1-55)+(B2-6), (A1-55)+(B2-7), (A1-55)+(B2-8), (A1-55)+(B2-9), (A1-55)+(B2-10), (A1-55)+(B2-11), (A1-55)+(B2-12), (A1-55)+(B2-13), (A1-55)+(B2-14), (A1-55)+(B2-15), (A1-55)+(B2-16), (A1-55)+(B2-17), (A1-55)+(B2-18), (A1-55)+(B2-19), (A1-55)+(B2-20), (A1-55)+(B2-21), (A1-55)+(B2-22), (A1-55)+(B2-23), (A1-55)+(B2-24), (A1-55)+(B2-25), (A1-55)+(B2-26), (A1-55)+(B2-27), (A1-55)+(B2-28), (A1-55)+(B2-29), (A1-55)+(B3-1), (A1-55)+(B3-2), (A1-55)+(B4-1), (A1-55)+(B4-2), (A1-55)+(B4-3), (A1-55)+(B4-4), (A1-55)+(B4-5), (A1-55)+(B4-6), (A1-55)+(B4-7), (A1-55)+(B4-8), (A1-55)+(B4-9), (A1-55)+(B4-10), (A1-55)+(B4-11), (A1-55)+(B5-1), (A1-55)+(B5-2), (A1-55)+(B5-3), (A1-55)+(B5-4), (A1-55)+(B5-5), (A1-55)+(B6-1), (A1-55)+(B6-2), (A1-55)+(B6-3), (A1-55)+(B6-4), (A1-55)+(B6-5), (A1-55)+(B6-6), (A1-55)+(B7-1), (A1-55)+(B7-2), (A1-55)+(B7-3), (A1-55)+(B7-4), (A1-55)+(B7-5), (A1-55)+(B7-6), (A1-55)+(B7-7)), (A1-55)+(B7-7), (A1-55)+(B7-8), (A1-55)+(B8-1), (A1-55)+(B8-2), (A1-55)+(B8-3), (A1-55)+(B8-4), (A1-55)+(B8-5), (A1-55)+(B8-6), (A1-55)+(B8-7), (A1-55)+(B9-1), (A1-55)+(B9-2), (A1-55)+(B10-1), (A1-55)+(B10-2), (A1-55)+(B10-3), (A1-55)+(B10-4), (A1-55)+(B10-5), (A1-55)+(B11-1), (A1-55)+(B11-2), (A1-55)+(B11-2),


(A1-56)+(B1-1), (A1-56)+(B1-2), (A1-56)+(B1-3), (A1-56)+(B1-4), (A1-56)+(B1-5), (A1-56)+(B1-6), (A1-56)+(B2-1), (A1-56)+(B2-2), (A1-56)+(B2-3), (A1-56)+(B2-4), (A1-56)+(B2-5), (A1-56)+(B2-6), (A1-56)+(B2-7), (A1-56)+(B2-8), (A1-56)+(B2-9), (A1-56)+(B2-10), (A1-56)+(B2-11), (A1-56)+(B2-12), (A1-56)+(B2-13), (A1-56)+(B2-14), (A1-56)+(B2-15), (A1-56)+(B2-16), (A1-56)+(B2-17), (A1-56)+(B2-18), (A1-56)+(B2-19), (A1-56)+(B2-20), (A1-56)+(B2-21), (A1-56)+(B2-22), (A1-56)+(B2-23), (A1-56)+(B2-24), (A1-56)+(B2-25), (A1-56)+(B2-26), (A1-56)+(B2-27), (A1-56)+(B2-28), (A1-56)+(B2-29), (A1-56)+(B3-1), (A1-56)+(B3-2), (A1-56)+(B4-1), (A1-56)+(B4-2), (A1-56)+(B4-3), (A1-56)+(B4-4), (A1-56)+(B4-5), (A1-56)+(B4-6), (A1-56)+(B4-7), (A1-56)+(B4-8), (A1-56)+(B4-9), (A1-56)+(B4-10), (A1-56)+(B4-11), (A1-56)+(B5-1), (A1-56)+(B5-2), (A1-56)+(B5-3), (A1-56)+(B5-4), (A1-56)+(B5-5), (A1-56)+(B6-1), (A1-56)+(B6-2), (A1-56)+(B6-3), (A1-56)+(B6-4), (A1-56)+(B6-5), (A1-56)+(B6-6), (A1-56)+(B7-1), (A1-56)+(B7-2), (A1-56)+(B7-3), (A1-56)+(B7-4), (A1-56)+(B7-5), (A1-56)+(B7-6), (A1-56)+(B7-7)), (A1-56)+(B7-7), (A1-56)+(B7-8), (A1-56)+(B8-1), (A1-56)+(B8-2), (A1-56)+(B8-3), (A1-56)+(B8-4), (A1-56)+(B8-5), (A1-56)+(B8-6), (A1-56)+(B8-7), (A1-56)+(B9-1), (A1-56)+(B9-2), (A1-56)+(B10-1), (A1-56)+(B10-2), (A1-56)+(B10-3), (A1-56)+(B10-4), (A1-56)+(B10-5), (A1-56)+(B11-1), (A1-56)+(B11-2), (A1-56)+(B11-2),


(A1-57)+(B1-1), (A1-57)+(B1-2), (A1-57)+(B1-3), (A1-57)+(B1-4), (A1-57)+(B1-5), (A1-57)+(B1-6), (A1-57)+(B2-1), (A1-57)+(B2-2), (A1-57)+(B2-3), (A1-57)+(B2-4), (A1-57)+(B2-5), (A1-57)+(B2-6), (A1-57)+(B2-7), (A1-57)+(B2-8), (A1-57)+(B2-9), (A1-57)+(B2-10), (A1-57)+(B2-11), (A1-57)+(B2-12), (A1-57)+(B2-13), (A1-57)+(B2-14), (A1-57)+(B2-15), (A1-57)+(B2-16), (A1-57)+(B2-17), (A1-57)+(B2-18), (A1-57)+(B2-19), (A1-57)+(B2-20), (A1-57)+(B2-21), (A1-57)+(B2-22), (A1-57)+(B2-23), (A1-57)+(B2-24), (A1-57)+(B2-25), (A1-57)+(B2-26), (A1-57)+(B2-27), (A1-57)+(B2-28), (A1-57)+(B2-29), (A1-57)+(B3-1), (A1-57)+(B3-2), (A1-57)+(B4-1), (A1-57)+(B4-2), (A1-57)+(B4-3), (A1-57)+(B4-4), (A1-57)+(B4-5), (A1-57)+(B4-6), (A1-57)+(B4-7), (A1-57)+(B4-8), (A1-57)+(B4-9), (A1-57)+(B4-10), (A1-57)+(B4-11), (A1-57)+(B5-1), (A1-57)+(B5-2), (A1-57)+(B5-3), (A1-57)+(B5-4), (A1-57)+(B5-5), (A1-57)+(B6-1), (A1-57)+(B6-2), (A1-57)+(B6-3), (A1-57)+(B6-4), (A1-57)+(B6-5), (A1-57)+(B6-6), (A1-57)+(B7-1), (A1-57)+(B7-2), (A1-57)+(B7-3), (A1-57)+(B7-4), (A1-57)+(B7-5), (A1-57)+(B7-6), (A1-57)+(B7-7)), (A1-57)+(B7-7), (A1-57)+(B7-8), (A1-57)+(B8-1), (A1-57)+(B8-2), (A1-57)+(B8-3), (A1-57)+(B8-4), (A1-57)+(B8-5), (A1-57)+(B8-6), (A1-57)+(B8-7), (A1-57)+(B9-1), (A1-57)+(B9-2), (A1-57)+(B10-1), (A1-57)+(B10-2), (A1-57)+(B10-3), (A1-57)+(B10-4), (A1-57)+(B10-5), (A1-57)+(B11-1), (A1-57)+(B11-2), (A1-57)+(B11-2),


(A1-58)+(B1-1), (A1-58)+(B1-2), (A1-58)+(B1-3), (A1-58)+(B1-4), (A1-58)+(B1-5), (A1-58)+(B1-6), (A1-58)+(B2-1), (A1-58)+(B2-2), (A1-58)+(B2-3), (A1-58)+(B2-4), (A1-58)+(B2-5), (A1-58)+(B2-6), (A1-58)+(B2-7), (A1-58)+(B2-8), (A1-58)+(B2-9), (A1-58)+(B2-10), (A1-58)+(B2-11), (A1-58)+(B2-12), (A1-58)+(B2-13), (A1-58)+(B2-14), (A1-58)+(B2-15), (A1-58)+(B2-16), (A1-58)+(B2-17), (A1-58)+(B2-18), (A1-58)+(B2-19), (A1-58)+(B2-20), (A1-58)+(B2-21), (A1-58)+(B2-22), (A1-58)+(B2-23), (A1-58)+(B2-24), (A1-58)+(B2-25), (A1-58)+(B2-26), (A1-58)+(B2-27), (A1-58)+(B2-28), (A1-58)+(B2-29), (A1-58)+(B3-1), (A1-58)+(B3-2), (A1-58)+(B4-1), (A1-58)+(B4-2), (A1-58)+(B4-3), (A1-58)+(B4-4), (A1-58)+(B4-5), (A1-58)+(B4-6), (A1-58)+(B4-7), (A1-58)+(B4-8), (A1-58)+(B4-9), (A1-58)+(B4-10), (A1-58)+(B4-11), (A1-58)+(B5-1), (A1-58)+(B5-2), (A1-58)+(B5-3), (A1-58)+(B5-4), (A1-58)+(B5-5), (A1-58)+(B6-1), (A1-58)+(B6-2), (A1-58)+(B6-3), (A1-58)+(B6-4), (A1-58)+(B6-5), (A1-58)+(B6-6), (A1-58)+(B7-1), (A1-58)+(B7-2), (A1-58)+(B7-3), (A1-58)+(B7-4), (A1-58)+(B7-5), (A1-58)+(B7-6), (A1-58)+(B7-7)), (A1-58)+(B7-7), (A1-58)+(B7-8), (A1-58)+(B8-1), (A1-58)+(B8-2), (A1-58)+(B8-3), (A1-58)+(B8-4), (A1-58)+(B8-5), (A1-58)+(B8-6), (A1-58)+(B8-7), (A1-58)+(B9-1), (A1-58)+(B9-2), (A1-58)+(B10-1), (A1-58)+(B10-2), (A1-58)+(B10-3), (A1-58)+(B10-4), (A1-58)+(B10-5), (A1-58)+(B11-1), (A1-58)+(B11-2), (A1-58)+(B11-2),


(A1-59)+(B1-1), (A1-59)+(B1-2), (A1-59)+(B1-3), (A1-59)+(B1-4), (A1-59)+(B1-5), (A1-59)+(B1-6), (A1-59)+(B2-1), (A1-59)+(B2-2), (A1-59)+(B2-3), (A1-59)+(B2-4), (A1-59)+(B2-5), (A1-59)+(B2-6), (A1-59)+(B2-7), (A1-59)+(B2-8), (A1-59)+(B2-9), (A1-59)+(B2-10), (A1-59)+(B2-11), (A1-59)+(B2-12), (A1-59)+(B2-13), (A1-59)+(B2-14), (A1-59)+(B2-15), (A1-59)+(B2-16), (A1-59)+(B2-17), (A1-59)+(B2-18), (A1-59)+(B2-19), (A1-59)+(B2-20), (A1-59)+(B2-21), (A1-59)+(B2-22), (A1-59)+(B2-23), (A1-59)+(B2-24), (A1-59)+(B2-25), (A1-59)+(B2-26), (A1-59)+(B2-27), (A1-59)+(B2-28), (A1-59)+(B2-29), (A1-59)+(B3-1), (A1-59)+(B3-2), (A1-59)+(B4-1), (A1-59)+(B4-2), (A1-59)+(B4-3), (A1-59)+(B4-4), (A1-59)+(B4-5), (A1-59)+(B4-6), (A1-59)+(B4-7), (A1-59)+(B4-8), (A1-59)+(B4-9), (A1-59)+(B4-10), (A1-59)+(B4-11), (A1-59)+(B5-1), (A1-59)+(B5-2), (A1-59)+(B5-3), (A1-59)+(B5-4), (A1-59)+(B5-5), (A1-59)+(B6-1), (A1-59)+(B6-2), (A1-59)+(B6-3), (A1-59)+(B6-4), (A1-59)+(B6-5), (A1-59)+(B6-6), (A1-59)+(B7-1), (A1-59)+(B7-2), (A1-59)+(B7-3), (A1-59)+(B7-4), (A1-59)+(B7-5), (A1-59)+(B7-6), (A1-59)+(B7-7)), (A1-59)+(B7-7), (A1-59)+(B7-8), (A1-59)+(B8-1), (A1-59)+(B8-2), (A1-59)+(B8-3), (A1-59)+(B8-4), (A1-59)+(B8-5), (A1-59)+(B8-6), (A1-59)+(B8-7), (A1-59)+(B9-1), (A1-59)+(B9-2), (A1-59)+(B10-1), (A1-59)+(B10-2), (A1-59)+(B10-3), (A1-59)+(B10-4), (A1-59)+(B10-5), (A1-59)+(B11-1), (A1-59)+(B11-2), (A1-59)+(B11-2),


(A1-60)+(B1-1), (A1-60)+(B1-2), (A1-60)+(B1-3), (A1-60)+(B1-4), (A1-60)+(B1-5), (A1-60)+(B1-6), (A1-60)+(B2-1), (A1-60)+(B2-2), (A1-60)+(B2-3), (A1-60)+(B2-4), (A1-60)+(B2-5), (A1-60)+(B2-6), (A1-60)+(B2-7), (A1-60)+(B2-8), (A1-60)+(B2-9), (A1-60)+(B2-10), (A1-60)+(B2-11), (A1-60)+(B2-12), (A1-60)+(B2-13), (A1-60)+(B2-14), (A1-60)+(B2-15), (A1-60)+(B2-16), (A1-60)+(B2-17), (A1-60)+(B2-18), (A1-60)+(B2-19), (A1-60)+(B2-20), (A1-60)+(B2-21), (A1-60)+(B2-22), (A1-60)+(B2-23), (A1-60)+(B2-24), (A1-60)+(B2-25), (A1-60)+(B2-26), (A1-60)+(B2-27), (A1-60)+(B2-28), (A1-60)+(B2-29), (A1-60)+(B3-1), (A1-60)+(B3-2), (A1-60)+(B4-1), (A1-60)+(B4-2), (A1-60)+(B4-3), (A1-60)+(B4-4), (A1-60)+(B4-5), (A1-60)+(B4-6), (A1-60)+(B4-7), (A1-60)+(B4-8), (A1-60)+(B4-9), (A1-60)+(B4-10), (A1-60)+(B4-11), (A1-60)+(B5-1), (A1-60)+(B5-2), (A1-60)+(B5-3), (A1-60)+(B5-4), (A1-60)+(B5-5), (A1-60)+(B6-1), (A1-60)+(B6-2), (A1-60)+(B6-3), (A1-60)+(B6-4), (A1-60)+(B6-5), (A1-60)+(B6-6), (A1-60)+(B7-1), (A1-60)+(B7-2), (A1-60)+(B7-3), (A1-60)+(B7-4), (A1-60)+(B7-5), (A1-60)+(B7-6), (A1-60)+(B7-7)), (A1-60)+(B7-7), (A1-60)+(B7-8), (A1-60)+(B8-1), (A1-60)+(B8-2), (A1-60)+(B8-3), (A1-60)+(B8-4), (A1-60)+(B8-5), (A1-60)+(B8-6), (A1-60)+(B8-7), (A1-60)+(B9-1), (A1-60)+(B9-2), (A1-60)+(B10-1), (A1-60)+(B10-2), (A1-60)+(B10-3), (A1-60)+(B10-4), (A1-60)+(B10-5), (A1-60)+(B11-1), (A1-60)+(B11-2), (A1-60)+(B11-2),


(A1-61)+(B1-1), (A1-61)+(B1-2), (A1-61)+(B1-3), (A1-61)+(B1-4), (A1-61)+(B1-5), (A1-61)+(B1-6), (A1-61)+(B2-1), (A1-61)+(B2-2), (A1-61)+(B2-3), (A1-61)+(B2-4), (A1-61)+(B2-5), (A1-61)+(B2-6), (A1-61)+(B2-7), (A1-61)+(B2-8), (A1-61)+(B2-9), (A1-61)+(B2-10), (A1-61)+(B2-11), (A1-61)+(B2-12), (A1-61)+(B2-13), (A1-61)+(B2-14), (A1-61)+(B2-15), (A1-61)+(B2-16), (A1-61)+(B2-17), (A1-61)+(B2-18), (A1-61)+(B2-19), (A1-61)+(B2-20), (A1-61)+(B2-21), (A1-61)+(B2-22), (A1-61)+(B2-23), (A1-61)+(B2-24), (A1-61)+(B2-25), (A1-61)+(B2-26), (A1-61)+(B2-27), (A1-61)+(B2-28), (A1-61)+(B2-29), (A1-61)+(B3-1), (A1-61)+(B3-2), (A1-61)+(B4-1), (A1-61)+(B4-2), (A1-61)+(B4-3), (A1-61)+(B4-4), (A1-61)+(B4-5), (A1-61)+(B4-6), (A1-61)+(B4-7), (A1-61)+(B4-8), (A1-61)+(B4-9), (A1-61)+(B4-10), (A1-61)+(B4-11), (A1-61)+(B5-1), (A1-61)+(B5-2), (A1-61)+(B5-3), (A1-61)+(B5-4), (A1-61)+(B5-5), (A1-61)+(B6-1), (A1-61)+(B6-2), (A1-61)+(B6-3), (A1-61)+(B6-4), (A1-61)+(B6-5), (A1-61)+(B6-6), (A1-61)+(B7-1), (A1-61)+(B7-2), (A1-61)+(B7-3), (A1-61)+(B7-4), (A1-61)+(B7-5), (A1-61)+(B7-6), (A1-61)+(B7-7)), (A1-61)+(B7-7), (A1-61)+(B7-8), (A1-61)+(B8-1), (A1-61)+(B8-2), (A1-61)+(B8-3), (A1-61)+(B8-4), (A1-61)+(B8-5), (A1-61)+(B8-6), (A1-61)+(B8-7), (A1-61)+(B9-1), (A1-61)+(B9-2), (A1-61)+(B10-1), (A1-61)+(B10-2), (A1-61)+(B10-3), (A1-61)+(B10-4), (A1-61)+(B10-5), (A1-61)+(B11-1), (A1-61)+(B11-2), (A1-61)+(B11-2),


(A2-1)+(B1-1), (A2-1)+(B1-2), (A2-1)+(B1-3), (A2-1)+(B1-4), (A2-1)+(B1-5), (A2-1)+(B1-6), (A2-1)+(B2-1), (A2-1)+(B2-2), (A2-1)+(B2-3), (A2-1)+(B2-4), (A2-1)+(B2-5), (A2-1)+(B2-6), (A2-1)+(B2-7), (A2-1)+(B2-8), (A2-1)+(B2-9), (A2-1)+(B2-10), (A2-1)+(B2-11), (A2-1)+(B2-12), (A2-1)+(B2-13), (A2-1)+(B2-14), (A2-1)+(B2-15), (A2-1)+(B2-16), (A2-1)+(B2-17), (A2-1)+(B2-18), (A2-1)+(B2-19), (A2-1)+(B2-20), (A2-1)+(B2-21), (A2-1)+(B2-22), (A2-1)+(B2-23), (A2-1)+(B2-24), (A2-1)+(B2-25), (A2-1)+(B2-26), (A2-1)+(B2-27), (A2-1)+(B2-28), (A2-1)+(B2-29), (A2-1)+(B3-1), (A2-1)+(B3-2), (A2-1)+(B4-1), (A2-1)+(B4-2), (A2-1)+(B4-3), (A2-1)+(B4-4), (A2-1)+(B4-5), (A2-1)+(B4-6), (A2-1)+(B4-7), (A2-1)+(B4-8), (A2-1)+(B4-9), (A2-1)+(B4-10), (A2-1)+(B4-11), (A2-1)+(B5-1), (A2-1)+(B5-2), (A2-1)+(B5-3), (A2-1)+(B5-4), (A2-1)+(B5-5), (A2-1)+(B6-1), (A2-1)+(B6-2), (A2-1)+(B6-3), (A2-1)+(B6-4), (A2-1)+(B6-5), (A2-1)+(B6-6), (A2-1)+(B7-1), (A2-1)+(B7-2), (A2-1)+(B7-3), (A2-1)+(B7-4), (A2-1)+(B7-5), (A2-1)+(B7-6), (A2-1)+(B7-7)), (A2-1)+(B7-7), (A2-1)+(B7-8), (A2-1)+(B8-1), (A2-1)+(B8-2), (A2-1)+(B8-3), (A2-1)+(B8-4), (A2-1)+(B8-5), (A2-1)+(B8-6), (A2-1)+(B8-7), (A2-1)+(B9-1), (A2-1)+(B9-2), (A2-1)+(B10-1), (A2-1)+(B10-2), (A2-1)+(B10-3), (A2-1)+(B10-4), (A2-1)+(B10-5), (A2-1)+(B11-1), (A2-1)+(B11-2), (A2-1)+(B11-2),


(A2-2)+(B1-1), (A2-2)+(B1-2), (A2-2)+(B1-3), (A2-2)+(B1-4), (A2-2)+(B1-5), (A2-2)+(B1-6), (A2-2)+(B2-1), (A2-2)+(B2-2), (A2-2)+(B2-3), (A2-2)+(B2-4), (A2-2)+(B2-5), (A2-2)+(B2-6), (A2-2)+(B2-7), (A2-2)+(B2-8), (A2-2)+(B2-9), (A2-2)+(B2-10), (A2-2)+(B2-11), (A2-2)+(B2-12), (A2-2)+(B2-13), (A2-2)+(B2-14), (A2-2)+(B2-15), (A2-2)+(B2-16), (A2-2)+(B2-17), (A2-2)+(B2-18), (A2-2)+(B2-19), (A2-2)+(B2-20), (A2-2)+(B2-21), (A2-2)+(B2-22), (A2-2)+(B2-23), (A2-2)+(B2-24), (A2-2)+(B2-25), (A2-2)+(B2-26), (A2-2)+(B2-27), (A2-2)+(B2-28), (A2-2)+(B2-29), (A2-2)+(B3-1), (A2-2)+(B3-2), (A2-2)+(B4-1), (A2-2)+(B4-2), (A2-2)+(B4-3), (A2-2)+(B4-4), (A2-2)+(B4-5), (A2-2)+(B4-6), (A2-2)+(B4-7), (A2-2)+(B4-8), (A2-2)+(B4-9), (A2-2)+(B4-10), (A2-2)+(B4-11), (A2-2)+(B5-1), (A2-2)+(B5-2), (A2-2)+(B5-3), (A2-2)+(B5-4), (A2-2)+(B5-5), (A2-2)+(B6-1), (A2-2)+(B6-2), (A2-2)+(B6-3), (A2-2)+(B6-4), (A2-2)+(B6-5), (A2-2)+(B6-6), (A2-2)+(B7-1), (A2-2)+(B7-2), (A2-2)+(B7-3), (A2-2)+(B7-4), (A2-2)+(B7-5), (A2-2)+(B7-6), (A2-2)+(B7-7)), (A2-2)+(B7-7), (A2-2)+(B7-8), (A2-2)+(B8-1), (A2-2)+(B8-2), (A2-2)+(B8-3), (A2-2)+(B8-4), (A2-2)+(B8-5), (A2-2)+(B8-6), (A2-2)+(B8-7), (A2-2)+(B9-1), (A2-2)+(B9-2), (A2-2)+(B10-1), (A2-2)+(B10-2), (A2-2)+(B10-3), (A2-2)+(B10-4), (A2-2)+(B10-5), (A2-2)+(B11-1), (A2-2)+(B11-2), (A2-2)+(B11-2),


(A2-3)+(B1-1), (A2-3)+(B1-2), (A2-3)+(B1-3), (A2-3)+(B1-4), (A2-3)+(B1-5), (A2-3)+(B1-6), (A2-3)+(B2-1), (A2-3)+(B2-2), (A2-3)+(B2-3), (A2-3)+(B2-4), (A2-3)+(B2-5), (A2-3)+(B2-6), (A2-3)+(B2-7), (A2-3)+(B2-8), (A2-3)+(B2-9), (A2-3)+(B2-10), (A2-3)+(B2-11), (A2-3)+(B2-12), (A2-3)+(B2-13), (A2-3)+(B2-14), (A2-3)+(B2-15), (A2-3)+(B2-16), (A2-3)+(B2-17), (A2-3)+(B2-18), (A2-3)+(B2-19), (A2-3)+(B2-20), (A2-3)+(B2-21), (A2-3)+(B2-22), (A2-3)+(B2-23), (A2-3)+(B2-24), (A2-3)+(B2-25), (A2-3)+(B2-26), (A2-3)+(B2-27), (A2-3)+(B2-28), (A2-3)+(B2-29), (A2-3)+(B3-1), (A2-3)+(B3-2), (A2-3)+(B4-1), (A2-3)+(B4-2), (A2-3)+(B4-3), (A2-3)+(B4-4), (A2-3)+(B4-5), (A2-3)+(B4-6), (A2-3)+(B4-7), (A2-3)+(B4-8), (A2-3)+(B4-9), (A2-3)+(B4-10), (A2-3)+(B4-11), (A2-3)+(B5-1), (A2-3)+(B5-2), (A2-3)+(B5-3), (A2-3)+(B5-4), (A2-3)+(B5-5), (A2-3)+(B6-1), (A2-3)+(B6-2), (A2-3)+(B6-3), (A2-3)+(B6-4), (A2-3)+(B6-5), (A2-3)+(B6-6), (A2-3)+(B7-1), (A2-3)+(B7-2), (A2-3)+(B7-3), (A2-3)+(B7-4), (A2-3)+(B7-5), (A2-3)+(B7-6), (A2-3)+(B7-7)), (A2-3)+(B7-7), (A2-3)+(B7-8), (A2-3)+(B8-1), (A2-3)+(B8-2), (A2-3)+(B8-3), (A2-3)+(B8-4), (A2-3)+(B8-5), (A2-3)+(B8-6), (A2-3)+(B8-7), (A2-3)+(B9-1), (A2-3)+(B9-2), (A2-3)+(B10-1), (A2-3)+(B10-2), (A2-3)+(B10-3), (A2-3)+(B10-4), (A2-3)+(B10-5), (A2-3)+(B11-1), (A2-3)+(B11-2), (A2-3)+(B11-2),


(A2-4)+(B1-1), (A2-4)+(B1-2), (A2-4)+(B1-3), (A2-4)+(B1-4), (A2-4)+(B1-5), (A2-4)+(B1-6), (A2-4)+(B2-1), (A2-4)+(B2-2), (A2-4)+(B2-3), (A2-4)+(B2-4), (A2-4)+(B2-5), (A2-4)+(B2-6), (A2-4)+(B2-7), (A2-4)+(B2-8), (A2-4)+(B2-9), (A2-4)+(B2-10), (A2-4)+(B2-11), (A2-4)+(B2-12), (A2-4)+(B2-13), (A2-4)+(B2-14), (A2-4)+(B2-15), (A2-4)+(B2-16), (A2-4)+(B2-17), (A2-4)+(B2-18), (A2-4)+(B2-19), (A2-4)+(B2-20), (A2-4)+(B2-21), (A2-4)+(B2-22), (A2-4)+(B2-23), (A2-4)+(B2-24), (A2-4)+(B2-25), (A2-4)+(B2-26), (A2-4)+(B2-27), (A2-4)+(B2-28), (A2-4)+(B2-29), (A2-4)+(B3-1), (A2-4)+(B3-2), (A2-4)+(B4-1), (A2-4)+(B4-2), (A2-4)+(B4-3), (A2-4)+(B4-4), (A2-4)+(B4-5), (A2-4)+(B4-6), (A2-4)+(B4-7), (A2-4)+(B4-8), (A2-4)+(B4-9), (A2-4)+(B4-10), (A2-4)+(B4-11), (A2-4)+(B5-1), (A2-4)+(B5-2), (A2-4)+(B5-3), (A2-4)+(B5-4), (A2-4)+(B5-5), (A2-4)+(B6-1), (A2-4)+(B6-2), (A2-4)+(B6-3), (A2-4)+(B6-4), (A2-4)+(B6-5), (A2-4)+(B6-6), (A2-4)+(B7-1), (A2-4)+(B7-2), (A2-4)+(B7-3), (A2-4)+(B7-4), (A2-4)+(B7-5), (A2-4)+(B7-6), (A2-4)+(B7-7)), (A2-4)+(B7-7), (A2-4)+(B7-8), (A2-4)+(B8-1), (A2-4)+(B8-2), (A2-4)+(B8-3), (A2-4)+(B8-4), (A2-4)+(B8-5), (A2-4)+(B8-6), (A2-4)+(B8-7), (A2-4)+(B9-1), (A2-4)+(B9-2), (A2-4)+(B10-1), (A2-4)+(B10-2), (A2-4)+(B10-3), (A2-4)+(B10-4), (A2-4)+(B10-5), (A2-4)+(B11-1), (A2-4)+(B11-2), (A2-4)+(B11-2).


In the inventive herbicidal compositions, the application rate of the herbicides of the general formula (I) (component A) is typically 1 to 500 g of active ingredient (a.i.) per hectare, preferably 2 to 300 g of a.i./ha, more preferably 3 to 200 g of a.i./ha. The application rate of the herbicides of component B is typically 1 to 5000 g of active ingredient per hectare, preferably 2 to 3000 g of a.i./ha, more preferably 3 to 2000 g of a.i./ha. The application rate of the safeners of component C is typically 1 to 500 g of active ingredient per hectare, preferably 2 to 400 g of a.i./ha, more preferably 3 to 300 g of a.i./ha.


On application of the inventive herbicidal compositions, a very broad spectrum of harmful plants is controlled pre-emergence and post-emergence, for example annual and perennial mono- or dicotyledonous weeds and unwanted crop plants. The inventive herbicidal compositions are particularly suitable for use in crops such as cereals, corn, rice, soya, oilseed rape, sugar beet, cotton, sugar cane, and also for use in perennial crops, plantations and on non-crop land. They are likewise highly suitable for use in transgenic crops of corn, cereals, sugar beet, rice, cotton and Glycine max. (e.g. RR soya or LL soya) and crossbreeds thereof), Phaseolus, Pisum, Vicia and Arachis, or vegetable crops from various botanical groups such as potato, leek, cabbage, carrot, tomato, onion, and also perennial and plantation crops such as pome fruit and stone fruit, soft fruit, wine, Hevea, bananas, sugar cane, coffee, tea, citrus, nut plantations, lawn, palm crops and forest crops. For the use of the inventive herbicide-safener combinations (A)+(B), these crops are likewise preferred, particular preference being given to use in cereals (e.g. wheat, barley, rye, oats), rice, corn, millet/sorghum, sugar beet, sugar cane, sunflower, oilseed rape and cotton. The herbicide-safener combinations (A)+(B) can also be used in tolerant and non-tolerant mutant crops and tolerant and non-tolerant transgenic crops, preferably of corn, rice, cereals, oilseed rape, cotton, sugar beet and soya, for example those resistant to imidazolinone herbicides, atrazine, glufosinate, glyphosate, 2,4 D, dicamba and herbicides from the group of the inhibitors of hydroxyphenylpyruvate dioxygenase, such as sulcotrione, mesotrione, tembotrione, tefuryltrione, benzobicyclon, bicyclopyrone and ketospiradox.


A herbicidally effective amount in the context of the invention means an amount of one or more herbicides capable of adversely affecting plant growth. An antidotically effective amount in the context of the invention means an amount of one or more safeners capable of reducing the phytotoxic effect of crop protection active ingredients (for example of herbicides) on crop plants.


According to their properties, the safeners (C) present in the inventive herbicidal compositions can also be used for pretreatment of the seed of the crop plant (for example for dressing of the seed) or introduced into the seed furrows prior to sowing or employed together with the herbicide prior to or after emergence of the plants. Pre-emergence treatment includes both the treatment of the area under cultivation (including any water present in the area under cultivation, for example in the case of applications to rice) prior to sowing and the treatment of the areas under cultivation in which seeds have been sown but which are not yet covered by growing plants. Preference is given to application together with the herbicide. For this purpose, it is possible to use tank-mixes or ready-made formulations.


In a preferred embodiment, the seed (for example grains, seeds or vegetative propagation organs such as tubers or budded parts of shoots) or seedlings are pretreated with the safeners (C), optionally in combination with other active agrochemical ingredients. For pretreatment of the seed, the active ingredients can be applied to the seed, for example by dressing, or the active ingredients and the seed can be added to water or other solvents, and the active ingredients can be taken up, for example, by adsorption or diffusion in a dipping process or by swelling or pre-germination. For pretreatment of seedlings, the young plants can be contacted with the safeners, optionally in combination with other active agrochemical ingredients, for example by spraying, dipping or watering, and then transplanted and optionally aftertreated with the herbicides (A) and (B).


The seed or seedlings can be treated with the safeners (C) alone or together with other active agrochemical ingredients—such as fungicides, insecticides or plant fortifiers, fertilizers or swelling and germination accelerators. After the pretreatment application, the safeners may subsequently be applied once again before, after or together with one or more herbicides of the formula (I) (A) and herbicides (B), possibly also in combination with other known herbicides. The pretreatment of the seed or seedlings can achieve improved long-term efficacy of the safeners.


The present invention thus further provides a method of controlling unwanted plants in plant crops, which is characterized in that components (A), (B) and optionally (C) of the inventive herbicidal compositions are deployed, for example separately or together, on the plants (for example harmful plants such as mono- or dicotyledonous weeds or unwanted crop plants), the seed (for example grains, seeds or vegetative propagation organs such as tubers or budded parts of shoots) or the area on which the plants grow (for example the area under cultivation). One or more safeners (C) may be applied before, after or simultaneously with the herbicide(s) of the general formula (I) (A) and the herbicides (B) to the plants, the seed or the area on which the plants grow (for example the area under cultivation). In a preferred embodiment, the safeners (C) are used for seed treatment.


Unwanted plants are understood to mean all plants which grow at sites where they are unwanted. These may, for example, be harmful plants (for example monocotyledonous or dicotyledonous weeds or unwanted crop plants), including, for example, those which are resistant to certain active herbicidal compounds, such as glyphosate, atrazine, glufosinate or imidazolinone herbicides. Monocotyledonous weeds are classified, for example, in the genera Echinochloa, Setaria, Panicum, Digitaria, Phleum, Poa, Festuca, Eleusine, Brachiaria, Lolium, Bromus, Avena, Cyperus, Sorghum, Agropyron, Cynodon, Monochoria, Fimbristylis, Sagittaria, Eleocharis, Scirpus, Paspalum, Ischaemum, Sphenoclea, Dactyloctenium, Agrostis, Alopecurus, Apera, Phalaris. Dicotyledonous weeds are classified, for example, in the genera Sinapis, Lepidium, Galium, Stellaria, Matricaria, Anthemis, Galinsoga, Chenopodium, Urtica, Senecio, Amaranthus, Portulaca, Xanthium, Convolvulus, Ipomoea, Polygonum, Sesbania, Ambrosia, Cirsium, Carduus, Sonchus, Solanum, Rorippa, Rotala, Lindernia, Lamium, Veronica, Abutilon, Emex, Datura, Viola, Galeopsis, Papaver, Centaurea, Trifolium, Ranunculus, Taraxacum, Euphorbia, Kochia, Biden, Stellaria.


The invention also provides for the use of the inventive herbicidal compositions for controlling unwanted vegetation, preferably in plant crops.


The inventive herbicidal compositions can be prepared by known methods, for example as mixed formulations of the individual components, optionally with further active ingredients, additives and/or customary formulation auxiliaries, and these are then applied in a customary manner after dilution with water, or as tank mixes by joint dilution of the separately formulated or partly separately formulated individual components with water. Likewise possible is the application at different times (split application) of the separately formulated or partly separately formulated individual components. It is also possible to apply the individual components or the herbicidal compositions in a plurality of portions (sequential application), for example by pre-emergence applications followed by post-emergence applications or by early post-emergence applications followed by medium or late post-emergence applications. Preference is given to the joint or immediately successive application of the active ingredients in the respective combination.


The inventive herbicidal compositions can also be used for control of harmful plants in crops of genetically modified plants which are known or are yet to be developed.


In general, transgenic plants are characterized by particular advantageous properties, for example by resistances to certain pesticides, in particular certain herbicides, resistances to plant diseases or pathogens of plant diseases, such as certain insects or microorganisms such as fungi, bacteria or viruses. Other particular properties relate, for example, to the harvested material with regard to quantity, quality, storability, composition and specific constituents. For instance, there are known transgenic plants with an elevated starch content or altered starch quality, or those with a different fatty acid composition in the harvested material. Other particular properties may be tolerance or resistance to abiotic stressors, for example heat, low temperatures, drought, salinity and ultraviolet radiation.


Preference is given to the use of the inventive herbicidal compositions in economically important transgenic crops of useful plants and ornamentals, for example of cereals such as wheat, barley, rye, oats, millet/sorghum, rice, cassava and corn, or else crops of sugar beet, cotton, soybean, oilseed rape, potato, tomato, peas and other vegetables.


Conventional ways of producing novel plants which have modified properties in comparison to existing plants consist, for example, in traditional breeding methods and the generation of mutants. Alternatively, novel plants with modified properties can be generated with the aid of recombinant methods (see, for example, EP-A-0221044, EP-A-0131624). For example, there have been descriptions in several cases of:

    • genetic modifications of crop plants for the purpose of modifying the starch synthesized in the plants (for example WO 92/11376, WO 92/14827, WO 91/19806),
    • transgenic crop plants which are resistant to particular herbicides of the glufosinate type (cf., for example, EP-A-0242236, EP-A-242246) or glyphosate type (WO 92/00377) or of the sulfonylurea type (EP-A-0257993, U.S. Pat. No. 5,013,659),
    • transgenic crop plants, for example cotton, with the ability to produce Bacillus thuringiensis toxins (Bt toxins), which make the plants resistant to particular pests (EP-A-0142924, EP-A-0193259),
    • transgenic crop plants with a modified fatty acid composition (WO 91/13972),
    • genetically modified crop plants with novel constituents or secondary metabolites, for example novel phytoalexins, which bring about an increased disease resistance (EPA 309862, EPA0464461),
    • genetically modified plants having reduced photorespiration, which have higher yields and higher stress tolerance (EPA 0305398),
    • transgenic crop plants which produce pharmaceutically or diagnostically important proteins (“molecular pharming”),
    • transgenic crop plants which feature higher yields or better quality,
    • transgenic crop plants which feature a combination, for example, of the abovementioned novel properties (“gene stacking”).


Numerous molecular biology techniques which can be used to produce novel transgenic plants with modified properties are known in principle; see, for example, I. Potrykus and G. Spangenberg (eds.) Gene Transfer to Plants, Springer Lab Manual (1995), Springer Verlag Berlin, Heidelberg, or Christou, “Trends in Plant Science” 1 (1996) 423-431).


For such recombinant manipulations, nucleic acid molecules which allow mutagenesis or sequence alteration by recombination of DNA sequences can be introduced into plasmids. With the aid of standard methods, it is possible, for example, to undertake base exchanges, remove parts of sequences or add natural or synthetic sequences. For the connection of the DNA fragments to one another, it is possible to add adapters or linkers to the fragments; see, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.; or Winnacker “Gene und Klone”, VCH Weinheim, 2nd edition, 1996.


For example, the generation of plant cells with a reduced activity of a gene product can be achieved by expressing at least one corresponding antisense RNA, a sense RNA for achieving a cosuppression effect, or by expressing at least one suitably constructed ribozyme which specifically cleaves transcripts of the abovementioned gene product.


To this end, it is firstly possible to use DNA molecules which encompass the entire coding sequence of a gene product inclusive of any flanking sequences which may be present, and also DNA molecules which only encompass portions of the coding sequence, in which case it is necessary for these portions to be long enough to have an antisense effect in the cells. It is also possible to use DNA sequences which have a high degree of homology to the coding sequences of a gene product, but are not completely identical to them.


When expressing nucleic acid molecules in plants, the protein synthesized may be localized in any desired compartment of the plant cell. However, to achieve localization in a particular compartment, it is possible, for example, to join the coding region to DNA sequences which ensure localization in a particular compartment. Such sequences are known to those skilled in the art (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227; Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 846-850; Sonnewald et al., Plant J. 1 (1991), 95-106). The nucleic acid molecules can also be expressed in the organelles of the plant cells.


The transgenic plant cells can be regenerated by known techniques to give rise to entire plants. In principle, the transgenic plants may be plants of any desired plant species, i.e. not only monocotyledonous but also dicotyledonous plants.


Thus, transgenic plants can be obtained whose properties are altered by overexpression, suppression or inhibition of homologous (=natural) genes or gene sequences or expression of heterologous (=foreign) genes or gene sequences.


Preferably the inventive compositions can be used in transgenic crops which are resistant to growth regulators such as, for example, dicamba, or to herbicides which inhibit essential plant enzymes, for example acetolactate synthases (ALS), EPSP synthases, glutamine synthases (GS) or hydroxyphenylpyruvate dioxygenases (HPPD), or to herbicides from the group of the sulfonylureas, the glyphosates, glufosinates or benzoylisoxazoles and analogous active ingredients.


On employment of the inventive compositions in transgenic crops, not only do the effects toward harmful plants observed in other crops occur, but often also effects which are specific to application in the particular transgenic crop, for example an altered or specifically widened spectrum of weeds which can be controlled, altered application rates which can be used for the application, preferably good combinability with the herbicides to which the transgenic crop is resistant, and influencing of growth and yield of the transgenic crop plants.


The invention therefore also provides for the use of the inventive compositions for control of harmful plants in transgenic crop plants.


Preference is given to the use of the inventive compositions in economically important transgenic crops of useful plants and ornamentals, for example of cereals (e.g. wheat, barley, rye, oats), millet/sorghum, rice, cassava and corn, or else crops of sugar beet, cotton, soybean, oilseed rape, potato, tomato, peas and other vegetable crops.


The invention therefore also provides for the use of the inventive compositions for control of harmful plants in transgenic crop plants or crop plants having tolerance through selective breeding.


The herbicides (A), (B) and the safeners (C) can be converted together or separately to customary formulations, for example for application by spraying, watering, sprinkling and seed dressing, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols, active ingredient-impregnated natural and synthetic substances, microencapsulations in polymeric substances. The formulations may comprise the customary auxiliaries and additives.


These formulations are produced in a known manner, for example by mixing the active ingredients with extenders, i.e. liquid solvents, pressurized liquefied gases and/or solid carriers, optionally with use of surfactants, i.e. emulsifiers and/or dispersants and/or foam formers.


If the extender used is water, it is also possible to use, for example, organic solvents as auxiliary solvents. Useful liquid solvents essentially include: aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, for example mineral oil fractions, mineral and vegetable oils, alcohols such as butanol or glycol and the ethers and esters thereof, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide or dimethyl sulfoxide, and water.


Useful solid carriers include: for example ammonium salts and ground natural minerals, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals, such as finely divided silica, alumina and silicates; useful solid carriers for granules include: for example crushed and fractionated natural rocks, such as calcite, marble, pumice, sepiolite, dolomite and synthetic granules of inorganic and organic flours, and granules of organic material, such as sawdust, coconut shells, corn cobs and tobacco stalks; useful emulsifiers and/or foam formers include: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, e.g. alkylaryl polyglycol ethers, alkylsulfonates, alkylsulfates, arylsulfonates and protein hydrolyzates; useful dispersants include: for example lignosulfite waste liquors and methylcellulose.


In the formulations, it is possible to use tackifiers such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or else natural phospholipids such as cephalins and lecithins and synthetic phospholipids. Further additives may be mineral and vegetable oils.


It is possible to use colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian blue, and organic colorants such as alizarin colorants, azo colorants and metal phthalocyanine colorants, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.


The formulations contain generally between 0.1 and 95 percent by weight of active ingredient, preferably between 0.5 and 90% by weight.


As such or in their formulations, the herbicides (A), (B) and the safeners (C) can also be used as a mixture with other active agrochemical ingredients for controlling unwanted vegetation, for example for controlling weeds or for controlling unwanted crop plants, finished formulations or tank mixes, for example, being possible.


Also possible are mixtures with other known active ingredients such as fungicides, insecticides, acaricides, nematicides, bird antifeedants, plant nutrients and soil structure improvers, and likewise with additives and formulation auxiliaries customary in crop protection.


The herbicides (A), (B) and the safeners (C) can be used as such, in the form of their formulations or the use forms prepared therefrom by further dilution, such as ready-to-use solutions, suspensions, emulsions, powders, pastes and granules. Application is typically accomplished, for example, by watering, sprinkling, spraying, broadcasting.


The active ingredients can be deployed on the plants, plant parts, seed or area under cultivation (farmland), preferably on the seed or the green plants and plant parts, and optionally additionally on the farmland. One means of application is the co-deployment of the active ingredients in the form of tank-mixes, by mixing the optimally formulated concentrated formulations of the individual active ingredients together in the tank with water and deploying the spray liquor obtained.


A co-formulation of the inventive combination of active ingredients (A), (B) and (C) has the advantage of easier applicability, because the amounts of the components can already be set in the optimal ratio with respect to one another. Moreover, the auxiliaries in the formulation can be optimized to one another.


For application, the formulations in commercial form are, if appropriate, diluted in a customary manner, for example in the case of wettable powders, emulsifiable concentrates, dispersions and water-dispersible granules with water. Dust-type formulations, granules for soil application or granules for scattering and sprayable solutions are not normally diluted further with other inert substances prior to application.


BIOLOGICAL EXAMPLES


All trials whose results are shown were conducted in a greenhouse by the methodology specified below. The effect of the inventive herbicidal compositions was examined on the following harmful plants 14 and 21 days after application:



Echinochloa crus-galli (ECHCG), Eleusine indica (ELEIN), Setaria viridis (SETVI), Amaranthus retroflexus (AMARE), Chenopodium album (CHEAL), Kochia scoparia (KCHSC), Solanum nigrum (SOLNI), Avena fatua (AVEFA), Bromus sterilis (BROST), Lolium multiflorum (LOLMU), Phalaris minor (PHAMI), Poa annua (POAAN), Galium aparine (GALAP), Matricaria inodora (MATIN) and Polygonum convolvulus (POLCO).


The harmful plant seeds were sown in pots (diameter 8 cm) with sandy loam soil and germinated under optimal conditions. The inventive herbicidal compositions or the active ingredients alone were applied post-emergence to the planted pots with a spray volume of 300 L/ha. The trial was conducted in a greenhouse under optimum growth conditions. The herbicidal effects were assessed visually by comparison of untreated and treated plants. The percentages mean: 0%=no effects, 100%=the plants die off completely). The percentages are used to calculate interactions between individual treatments and combination treatments according to S. R. Colby, Weeds 15, pages 20 to 22 (1967).


The abbreviations mean:

  • a.i.=active ingredient
  • EC=expected value according to Colby (EC=A+B−A×B/100)
  • Diff: =difference (%) of measured value from expected value (%) (measured value minus expected value)


Assessment:

    • measured value E is greater than EC:->synergism (+ diff.)
    • measured value E equals EC:->additive effect
    • measured value E is smaller than EC:->antagonism(− diff.)


The results are shown in the tables below.









TABLE 1







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
4
40


tembotrione
0.5
10


A1-3 + tembotrione
4 + 0.5
75 (Ec = 46, Diff. = +29)
















TABLE 2







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
1
 0


tembotrione
0.5
10


A1-3 + tembotrione
1 + 0.5
30 (Ec = 10, Diff. = +20)
















TABLE 3







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
4
50


tembotrione
2
40


A1-3 + tembotrione
4 + 2
75 (Ec = 70, Diff. = +5)
















TABLE 4







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
4
50


tembotrione
0.5
30


A1-3 + tembotrione
4 + 0.5
70 (Ec = 65, Diff. = +5)
















TABLE 5







Efficacy against KCHSC, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
4
40


tembotrione
2
20


A1-3 + tembotrione
4 + 2
70 (Ec = 52, Diff. = +18)
















TABLE 6







Efficacy against DIGSA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
0


foramsulfuron
4
40


A1-13 + foramsulfuron
0.4 + 4
60 (Ec = 40, Diff. = +20)
















TABLE 7







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
0


foramsulfuron
1
60


A1-13 + foramsulfuron
0.4 + 1
75 (Ec = 60, Diff. = +15)
















TABLE 8







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


foramsulfuron
1
60


A1-13 + foramsulfuron
0.1 + 1
75 (Ec = 60, Diff. = +15)
















TABLE 9







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


foramsulfuron
1
40


A1-13 + foramsulfuron
0.4 + 1
60 (Ec = 46, Diff. = +14)
















TABLE 10







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


foramsulfuron
1
40


A1-13 + foramsulfuron
0.1 + 1
50 (Ec + 40, Diff. = +10)
















TABLE 11







Efficacy against CHEAL, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


foramsulfuron
1
50


A1-13 + foramsulfuron
0.4 + 1
65 (Ec = 55, Diff. = +10)
















TABLE 12







Efficacy against KCHSC, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
0


foramsulfuron
4
90


A1-13 + foramsulfuron
0.4 + 4
97 (Ec = 90, Diff. = +7)
















TABLE 13







Efficacy against KCHSC, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


foramsulfuron
1
80


A1-13 + foramsulfuron
0.1 + 1
85 (Ec = 80, Diff. = +5)
















TABLE 14







Efficacy against DIGSA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
0


bromoxynil
400
0


A1-14 + bromoxynil
0.4 + 400
30 (Ec = 0, Diff. = +30)
















TABLE 15







Efficacy against DIGSA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
0


bromoxynil
100
0


A1-14 + bromoxynil
0.4 + 100
30 (Ec = 0, Diff. = +30)
















TABLE 16







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
0


bromoxynil
400
0


A1-14 + bromoxynil
0.4 + 400
50 (Ec = 0, Diff. = +50)
















TABLE 17







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
0


bromoxynil
100
0


A1-14 + bromoxynil
0.4 + 100
30 (Ec = 0, Diff. = +30)
















TABLE 18







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-14
    0.4
20


bromoxynil
400
 0


A1-14 +
0.4 + 400
30 (Ec = 20,


bromoxynil

Diff. = +10)
















TABLE 19







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
20


bromoxynil
100
0


A1-14 +
0.4 + 100
30 (Ec = 20,


bromoxynil

Diff. = +10)
















TABLE 20







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.1
0


bromoxynil
400
0


A1-14 +
0.1 + 400
20 (Ec = 0,


bromoxynil

Diff. = +20)
















TABLE 21







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.1
0


bromoxynil
100
0


A1-14 +
0.1 + 100
20 (Ec = 0,


bromoxynil

Diff. = +20)
















TABLE 22







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.1
0


bromoxynil
400
0


A1-14 +
0.1 + 400
20 (Ec = 0,


bromoxynil

Diff. = +20)
















TABLE 23







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.1
0


bromoxynil
100
0


A1-14 +
0.1 + 100
20 (Ec = 0,


bromoxynil

Diff. = +20)
















TABLE 24







Efficacy against AMARE, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.1
0


bromoxynil
100
40


A1-14 +
0.1 + 100
50 (Ec = 40,


bromoxynil

Diff. = +10)
















TABLE 25







Efficacy against CHEAL, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.1
0


bromoxynil
400
85


A1-14 +
0.1 + 400
100 (Ec = 85,


bromoxynil

Diff. = +15)
















TABLE 26







Efficacy against DIGSA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
0.5
10


isoxaflutole
10
10


A1-36 +
0.5 + 10
30 (Ec = 19,


isoxaflutole

Diff. = +11)
















TABLE 27







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
40


isoxaflutole
10
60


A1-36 +
2 + 10
95 (Ec = 76,


isoxaflutole

Diff. = +19)
















TABLE 28







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
40


isoxaflutole
2.5
10


A1-36 +
2 + 2.5
70 (Ec = 46,


isoxaflutole

Diff. = +24)
















TABLE 29







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
0.5
10


isoxaflutole
10
60


A1-36 +
0.5 + 10
70 (Ec = 64,


isoxaflutole

Diff. = +6)
















TABLE 30







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
50


isoxaflutole
10
60


A1-36 +
2 + 10
93 (Ec = 80,


isoxaflutole

Diff. = +13)
















TABLE 31







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
50


isoxaflutole
2.5
20


A1-36 +
2 + 2.5
85 (Ec = 60,


isoxaflutole

Diff. = +25)
















TABLE 32







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
4
50


halauxifen
2
10


A2-1 +
4 + 2
70 (Ec = 55,


halauxifen

Diff. = +15)
















TABLE 33







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
4
50


halauxifen
0.5
0


A2-1 + halauxifen
4 + 0.5
60 (Ec = 50, Diff. = +10)
















TABLE 34







Efficacy against DIGSA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
0.5
20


dicamba
40
0


A1-55 + dicamba
0.5 + 40
30 (Ec = 20, Diff. = +10)
















TABLE 35







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2
40


dicamba
40
10


A1-55 + dicamba
2 + 40
65 (Ec = 46, Diff. = +19)
















TABLE 36







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2
40


dicamba
10
10


A1-55 + dicamba
2 + 10
65 (Ec = 46, Diff. = +19)
















TABLE 37







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2
40


dicamba
40
0


A1-55 + dicamba
2 + 40
65 (Ec = 40, Diff. = +25)
















TABLE 38







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2
40


dicamba
10
0


A1-55 + dicamba
2 + 10
65 (Ec = 40, Diff. = +25)
















TABLE 39







Efficacy against AMARE, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
0.5
20


dicamba
40
65


A1-55 + dicamba
0.5 + 40
80 (Ec = 72, Diff. = +8)
















TABLE 40







Efficacy against CHEAL, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2
70


dicamba
10
50


A1-55 + dicamba
2 + 10
90 (Ec = 85, Diff. = +5)
















TABLE 41







Efficacy against KCHSC, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
1
40


glyphosate
50
30


A1-57 + glyphosate
1 + 50
65 (Ec = 58, Diff. = +7)
















TABLE 42







Efficacy against DIGSA, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]





A1-7
2
20


fenoxaprop-P-ethyl
5
30


A1-7 + fenoxaprop-P-ethyl
2 + 5
70 (Ec = 44, Diff. = +26)
















TABLE 43







Efficacy against AMARE, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-7
0.5
30


fenoxaprop-P-ethyl
20
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 20
40 (Ec = 30, Diff. = +10)
















TABLE 44







Efficacy against AMARE, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-7
0.5
30


fenoxaprop-P-ethyl
5
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 5
40 (Ec = 30, Diff. = +10)
















TABLE 45







Efficacy against CHEAL, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-7
2
50


fenoxaprop-P-ethyl
20
0


A1-7 + fenoxaprop-P-ethyl
2 + 20
70 (Ec = 50, Diff. = +20)
















TABLE 46







Efficacy against CHEAL, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-7
2
50


fenoxaprop-P-ethyl
5
0


A1-7 + fenoxaprop-P-ethyl
2 + 5
65 (Ec = 50, Diff. = +15)
















TABLE 47







Efficacy against CHEAL, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-7
0.5
0


fenoxaprop-P-ethyl
20
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 20
20 (Ec = 0, Diff. = +20)
















TABLE 48







Efficacy against CHEAL, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
0.5
0


fenoxaprop-P-ethyl
5
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 5
20 (Ec = 0, Diff. = +20)
















TABLE 49







Efficacy against KCHSC, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
[%]












A1-7
0.5
0


fenoxaprop-P-ethyl
20
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 20
30 (Ec = 0, Diff. = +30)
















TABLE 50







Efficacy against KCHSC, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
0.5
0


fenoxaprop-P-ethyl
5
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 5
20 (Ec = 0, Diff. = +20)
















TABLE 51







Efficacy against SOLNI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2
20


fenoxaprop-P-ethyl
20
0


A1-7 + fenoxaprop-P-ethyl
2 + 20
40 (Ec = 20, Diff. = +20)
















TABLE 52







Efficacy against SOLNI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2
20


fenoxaprop-P-ethyl
5
0


A1-7 + fenoxaprop-P-ethyl
2 + 5
40 (Ec = 20, Diff. = +20)
















TABLE 53







Efficacy against SOLNI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
0.5
10


fenoxaprop-P-ethyl
20
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 20
20 (Ec = 10, Diff. = +10)
















TABLE 54







Efficacy against SOLNI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
0.5
10


fenoxaprop-P-ethyl
5
0


A1-7 + fenoxaprop-P-ethyl
0.5 +5
20 (Ec = 10, Diff. = +10)
















TABLE 55







Efficacy against DIGSA, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
4
93



lenacil
1200
0



A1-60 + lenacil
4 + 1200
99 (Ec = 93, Diff. = +6)

















TABLE 56







Efficacy against DIGSA, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
4
93



lenacil
300
0



A1-60 + lenacil
4 + 300
99 (Ec = 93, Diff. = +6)

















TABLE 57







Efficacy against ECHCG, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
4
90



lenacil
1200
0



A1-60 + lenacil
4 + 1200
99 (Ec = 90, Diff. = +9)

















TABLE 58







Efficacy against ECHCG, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
4
90



lenacil
300
0



A1-60 + lenacil
4 + 300
99 (Ec = 90, Diff. = +9)

















TABLE 59







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
1
65


lenacil
1200
0


A1-60 + lenacil
1 + 1200
75 (Ec = 65, Diff. = +10)
















TABLE 60







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
1
65


lenacil
300
0


A1-60 + lenacil
1 + 300
75 (Ec = 65, Diff. = +10)
















TABLE 61







Efficacy against ELEIN, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
4
90



lenacil
1200
0



A1-60 + lenacil
4 + 1200
99 (Ec = 90, Diff. = +9)

















TABLE 62







Efficacy against ELEIN, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
4
90



lenacil
300
0



A1-60 + lenacil
4 + 300
98 (Ec = 90, Diff. = +8)

















TABLE 63







Efficacy against ELEIN, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
1
70



lenacil
1200
0



A1-60 + lenacil
1 + 1200
75 (Ec = 70, Diff. = +5)

















TABLE 64







Efficacy against ELEIN, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
1
70



lenacil
300
0



A1-60 + lenacil
1 + 300
75 (Ec = 70, Diff. = +5)

















TABLE 65







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
4
85


lenacil
1200
0


A1-60 + lenacil
4 + 1200
95 (Ec = 85, Diff. = +10)
















TABLE 66







Efficacy against SETVI, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
4
85



lenacil
300
0



A1-60 + lenacil
4 + 300
90 (Ec = 85, Diff. = +5)

















TABLE 67







Efficacy against SETVI, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-60
1
70



lenacil
1200
0



A1-60 + lenacil
1 + 1200
75 (Ec = 70, Diff. = +5)

















TABLE 68







Efficacy against AMARE, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
  4
70


lenacil
1200
 0


A1-60 + lenacil
4 + 1200
85 (Ec = 70, Diff. = +15)
















TABLE 69







Efficacy against SOLNI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
  4
65


lenacil
1200
 0


A1-60 + lenacil
4 + 1200
100 (Ec = 65, Diff. = +35)
















TABLE 70







Efficacy against SOLNI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
 4
65


lenacil
300
 0


A1-60 + lenacil
4 + 300
95 (Ec = 65, Diff. = +30)
















TABLE 71







Efficacy against SOLNI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
  1
65


lenacil
1200
 0


A1-60 + lenacil
1 + 1200
80 (Ec = 65, Diff. = +15)
















TABLE 72







Efficacy against SOLNI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
 1
65


lenacil
300
 0


A1-60 + lenacil
1 + 300
80 (Ec = 65, Diff. = +15)
















TABLE 73







Efficacy against DIGSA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
 0


metribuzin
 20
20


A1-13 + metribuzin
0.4 + 20
60 (Ec = 20, Diff. = +40)
















TABLE 74







Efficacy against DIGSA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
0


metribuzin
  5
0


A1-13 + metribuzin
0.4 + 5
60 (Ec = 0, Diff. = +60)
















TABLE 75







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
 0


metribuzin
 20
30


A1-13 + metribuzin
0.4 + 20
75 (Ec = 30, Diff. = +45)
















TABLE 76







Efficacy against ECHCG, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
 0


metribuzin
  5
10


A1-13 + metribuzin
0.4 + 5
60 (Ec = 10, Diff. = +50)
















TABLE 77







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
20


metribuzin
 20
20


A1-13 + metribuzin
0.4 + 20
80 (Ec = 36, Diff. = +44)
















TABLE 78







Efficacy against ELEIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
20


metribuzin
  5
10


A1-13 + metribuzin
0.4 + 5
70 (Ec = 28, Diff. = +42)
















TABLE 79







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
10


metribuzin
 20
30


A1-13 + metribuzin
0.4 + 20
60 (Ec = 37, Diff. = +23)
















TABLE 80







Efficacy against SETVI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
10


metribuzin
  5
10


A1-13 + metribuzin
0.4 + 5
60 (Ec = 19, Diff. = +41)
















TABLE 81







Efficacy against AMARE, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
 0


metribuzin
 20
30


A1-13 + metribuzin
0.4 + 20
60 (Ec = 30, Diff. = +30)
















TABLE 82







Efficacy against AMARE, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
0.4
 0


metribuzin
  5
20


A1-13 + metribuzin
0.4 + 5
60 (Ec = 20, Diff. = +40)
















TABLE 83







Efficacy against CHEAL, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
10


metribuzin
20
30


A1-13 +
0.4 + 20
60 (Ec = 37,


metribuzin

Diff. = +23)
















TABLE 84







Efficacy against CHEAL, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
10


metribuzin
5
30


A1-13 +
0.4 + 5
60 (Ec = 37,


metribuzin

Diff. = +23)
















TABLE 85







Efficacy against CHEAL, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.1
0


metribuzin
20
30


A1-13 +
0.1 + 20
50 (Ec = 30,


metribuzin

Diff. = +20)
















TABLE 86







Efficacy against KCHSC, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
0


metribuzin
20
20


A1-13 +
0.4 + 20
70 (Ec = 20,


metribuzin

Diff. = +50)
















TABLE 87







Efficacy against KCHSC, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
0


metribuzin
5
20


A1-13 +
0.4 + 5
70 (Ec = 20,


metribuzin

Diff. = +50)
















TABLE 88







Efficacy against KCHSC, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.1
0


metribuzin
20
20


A1-13 +
0.1 + 20
30 (Ec = 20,


metribuzin

Diff. = +10)
















TABLE 89







Efficacy against SOLNI, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
20


metribuzin
20
0


A1-13 +
0.4 + 20
80 (Ec = 20,


metribuzin

Diff. = +60)
















TABLE 90







Efficacy against SOLNI, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
20


metribuzin
5
0


A1-13 +
0.4 + 5
80 (Ec = 20,


metribuzin

Diff. = +60)
















TABLE 91







Efficacy against SOLNI, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.1
10


metribuzin
20
0


A1-13 +
0.1 + 20
30 (Ec = 10,


metribuzin

Diff. = +20)
















TABLE 92







Efficacy against SOLNI, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.1
10


metribuzin
5
0


A1-13 +
0.1 + 5
30 (Ec = 10,


metribuzin

Diff. = +20)
















TABLE 93







Efficacy against ECHCG, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-3
4
10


tembotrione
2
60


A1-3 +
4 + 2
70 (Ec = 64,


tembotrione

Diff. = +6)
















TABLE 94







Efficacy against ECHCG, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-3
4
10


tembotrione
0.5
10


A1-3 +
4 + 0.5
70 (Ec = 19,


tembotrione

Diff. = +51)
















TABLE 95







Efficacy against ECHCG, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-3
1
0


tembotrione
0.5
10


A1-3 +
1 + 0.5
30 (Ec = 10,


tembotrione

Diff. = +20)
















TABLE 96







Efficacy against ELEIN, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-3
4
20


tembotrione
2
10


A1-3 +
4 + 2
40 (Ec = 28,


tembotrione

Diff. = +12)
















TABLE 97







Efficacy against ELEIN, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-3
4
20


tembotrione
0.5
0


A1-3 +
4 + 0.5
40 (Ec = 20,


tembotrione

Diff. = +20)
















TABLE 98







Efficacy against SETVI, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-3
4
20


tembotrione
0.5
0


A1-3 +
4 + 0.5
30 (Ec = 20,


tembotrione

Diff. = +10)
















TABLE 99







Efficacy against SETVI, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-3
1
10


tembotrione
2
10


A1-3 +
1 + 2
30 (Ec = 19,


tembotrione

Diff. = +11)
















TABLE 100







Efficacy against CHEAL, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-3
1
20


tembotrione
2
30


A1-3 +
1 + 2
93 (Ec = 44,


tembotrione

Diff. = +49)
















TABLE 101







Efficacy against KCHSC, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-3
4
20


tembotrione
2
10


A1-3 +
4 + 2
65 (Ec = 28,


tembotrione

Diff. = +37)
















TABLE 102







Efficacy against KCHSC, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-3
4
20


tembotrione
0.5
0


A1-3 +
4 + 0.5
30 (Ec = 20,


tembotrione

Diff. = +10)
















TABLE 103







Efficacy against ECHCG, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
0


foramsulfuron
1
30


A1-13 +
0.4 + 1
60 (Ec = 30,


foramsulfuron

Diff. = +30)
















TABLE 104







Efficacy against ECHCG, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.1
0


foramsulfuron
1
30


A1-13 +
0.1 + 1
60 (Ec = 30,


foramsulfuron

Diff. = +30)
















TABLE 105







Efficacy against ELEIN, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
10


foramsulfuron
1
60


A1-13 +
0.4 + 1
70 (Ec = 64,


foramsulfuron

Diff. = +6)
















TABLE 106







Efficacy against ELEIN, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.1
0


foramsulfuron
1
60


A1-13 +
0.1 + 1
65 (Ec = 60,


foramsulfuron

Diff. = +5)
















TABLE 107







Efficacy against SETVI, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
10


foramsulfuron
4
50


A1-13 +
0.4 + 4
60 (Ec = 55,


foramsulfuron

Diff. = +5)
















TABLE 108







Efficacy against SETVI, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.1
0


foramsulfuron
1
20


A1-13 +
0.1 + 1
30 (Ec = 20,


foramsulfuron

Diff. = +10)
















TABLE 109







Efficacy against KCHSC, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
0.4
0


foramsulfuron
4
80


A1-13 +
0.4 + 4
90 (Ec = 80,


foramsulfuron

Diff. = +10)
















TABLE 110







Efficacy against AMARE, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-34
100
50


thiencarbazone-methyl
0.25
60


A1-34 +
100 + 0.25
95 (Ec = 80,


thiencarbazone-methyl

Diff. = +15)
















TABLE 111







Efficacy against AMARE, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-34
25
30


thiencarbazone-methyl
0.25
60


A1-34 +
25 + 0.25
90 (Ec = 72,


thiencarbazone-methyl

Diff. = +18)
















TABLE 112







Efficacy against CHEAL, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-34
25
70


thiencarbazone-methyl
1
70


A1-34 +
25 + 1
100 (Ec = 91,


thiencarbazone-methyl

Diff. = +9)
















TABLE 113







Efficacy against CHEAL, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
25
70


thiencarbazone-methyl
0.25
50


A1-34 +
25 + 0.25
90 (Ec = 85, Diff. = +5)


thiencarbazone-methyl
















TABLE 114







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
25
10


thiencarbazone-methyl
1
50


A1-34 +
25 + 1
60 (Ec = 55, Diff. = +5)


thiencarbazone-methyl
















TABLE 115







Efficacy against DIGSA, 21 days after application








Active ingredient
Dosage [g of a.i./ha]Efficacy [%]












A1-14
0.4
0


bromoxynil
400
0


A1-14 + bromoxynil
0.4 + 400
10 (Ec = 0, Diff. = +10)
















TABLE 116







Efficacy against DIGSA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
0


bromoxynil
100
0


A1-14 + bromoxynil
0.4 + 100
10 (Ec = 0, Diff. = +10)
















TABLE 117







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
0


bromoxynil
400
0


A1-14 + bromoxynil
0.4 + 400
30 (Ec = 0, Diff. = +30)
















TABLE 118







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
0


bromoxynil
400
0


A1-14 + bromoxynil
0.4 + 400
30 (Ec = 0, Diff. = +30)
















TABLE 119







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.4
0


bromoxynil
100
0


A1-14 + bromoxynil
0.4 + 100
10 (Ec = 0, Diff. = +10)
















TABLE 120







Efficacy against CHEAL, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
0.1
0


bromoxynil
400
75


A1-14 + bromoxynil
0.1 + 400
100 (Ec = 75, Diff. = +25)
















TABLE 121







Efficacy against DIGSA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
0.5
10


isoxaflutole
10
0


A1-36 + isoxaflutole
0.5 + 10
20 (Ec = 10, Diff. = +10)
















TABLE 122







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
20


isoxaflutole
10
60


A1-36 + isoxaflutole
2 + 10
95 (Ec = 68, Diff. = +27)
















TABLE 123







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
20


isoxaflutole
2.5
10


A1-36 + isoxaflutole
2 + 2.5
70 (Ec = 28, Diff. = + 42)
















TABLE 124







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
0.5
0


isoxaflutole
10
60


A1-36 + isoxaflutole
0.5 + 10
70 (Ec = 60, Diff. = +10)
















TABLE 125







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
0.5
0


isoxaflutole
2.5
10


A1-36 + isoxaflutole
0.5 + 2.5
20 (Ec = 10, Diff. = +10)
















TABLE 126







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
30


isoxaflutole
10
20


A1-36 + isoxaflutole
2 + 10
75 (Ec = 44, Diff. = +31)
















TABLE 127







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
30


isoxaflutole
2.5
0


A1-36 + isoxaflutole
2 + 2.5
65 (Ec = 30, Diff. = +35)
















TABLE 128







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
65


isoxaflutole
10
0


A1-36 + isoxaflutole
2 + 10
70 (Ec = 65, Diff. = +5)
















TABLE 129







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
65


isoxaflutole
2.5
0


A1-36 + isoxaflutole
2 + 2.5
70 (Ec = 65, Diff. = +5)
















TABLE 130







Efficacy against AMARE, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
70


isoxaflutole
2.5
40


A1-36 + isoxaflutole
2 + 2.5
93 (Ec = 82, Diff. = +11)
















TABLE 131







Efficacy against AMARE, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
0.5
20


isoxaflutole
2.5
40


A1-36 + isoxaflutole
0.5 + 2.5
70 (Ec = 52, Diff. = +18)
















TABLE 132







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2
50


isoxaflutole
10
65


A1-36 + isoxaflutole
2 + 10
95 (Ec = 82.5, Diff. = +12.5)
















TABLE 133







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
4
40


halauxifen
2
20


A2-1 + halauxifen
4 + 2
65 (Ec = 52, Diff. = +13)
















TABLE 134







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
4
60


halauxifen
2
0


A2-1 + halauxifen
4 + 2
70 (Ec = 60, Diff. = +10)
















TABLE 135







Efficacy against ELEIN, 21 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A2-1
4
60



halauxifen
0.5
0



A2-1 + halauxifen
4 + 0.5
65 (Ec = 60, Diff. = +5)

















TABLE 136







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
4
20


halauxifen
2
0


A2-1 + halauxifen
4 + 2
30 (Ec = 20, Diff. = +10)
















TABLE 137







Efficacy against KCHSC, 21 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A2-1
4
40



halauxifen
2
30



A2-1 + halauxifen
4 + 2
65 (Ec = 58, Diff. = +7)

















TABLE 138







Efficacy against KCHSC, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
4
40


halauxifen
0.5
20


A2-1 + halauxifen
4 + 0.5
65 (Ec = 52, Diff. = +13)
















TABLE 139







Efficacy against SOLNI, 21 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A2-1
1
10



halauxifen
0.5
50



A2-1 + halauxifen
1 + 0.5
60 (Ec = 55, Diff. = +5)

















TABLE 140







Efficacy against DIGSA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2
30


dicamba
40
0


A1-55 + dicamba
2 + 40
40 (Ec = 30, Diff. = +10)
















TABLE 141







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2
30


dicamba
40
0


A1-55 + dicamba
2 + 40
50 (Ec = 30, Diff. = +20)
















TABLE 142







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2
30


dicamba
10
0


A1-55 + dicamba
2 + 10
50 (Ec = 30, Diff. = +20)
















TABLE 143







Efficacy against SETVI, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-55
2
30


dicamba
40
0


A1-55 +
2 + 40
50 (Ec = 30,


dicamba

Diff. = +20)
















TABLE 144







Efficacy against SETVI, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-55
2
30


dicamba
10
0


A1-55 +
2 + 10
40 (Ec = 30,


dicamba

Diff. = +10)
















TABLE 145







Efficacy against AMARE, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-55
0.5
10


dicamba
40
65


A1-55 +
0.5 + 40
75 (Ec = 68.5,


dicamba

Diff. = +6.5)
















TABLE 146







Efficacy against ELEIN, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-57
1
10


glyphosate
50
0


A1-57 +
1 + 50
20 (Ec = 10,


glyphosate

Diff. = +10)
















TABLE 147







Efficacy against CHEAL, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-57
1
30


glyphosate
50
30


A1-57 +
1 + 50
65 (Ec = 51,


glyphosate

Diff. = +14)
















TABLE 148







Efficacy against KCHSC, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-57
1
20


glyphosate
200
30


A1-57 +
1 + 200
50 (Ec = 44,


glyphosate

Diff. = +6)
















TABLE 149







Efficacy against KCHSC, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-57
1
20


glyphosate
50
10


A1-57 +
1 + 50
40 (Ec = 28,


glyphosate

Diff. = +12)
















TABLE 150







Efficacy against DIGSA, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-7
2
10


fenoxaprop-P-ethyl
5
10


A1-7 +
2 + 5
30 (Ec = 19,


fenoxaprop-P-ethyl

Diff. = +11)
















TABLE 151







Efficacy against SETVI, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-7
2
75


fenoxaprop-P-ethyl
20
80


A1-7 +
2 + 20
100 (Ec = 95,


fenoxaprop-P-ethyl

Diff.= +5)
















TABLE 152







Efficacy against SETVI, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-7
0.5
30


fenoxaprop-P-ethyl
20
80


A1-7 +
0.5 + 20
100 (Ec = 86,


fenoxaprop-P-ethyl

Diff. = +14)
















TABLE 153







Efficacy against CHEAL, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-7
2
20


fenoxaprop-P-ethyl
20
0


A1-7 +
2 + 20
60 (Ec = 20,


fenoxaprop-P-ethyl

Diff. = +40)
















TABLE 154







Efficacy against CHEAL, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-7
2
20


fenoxaprop-P-ethyl
5
0


A1-7 +
2 + 5
50 (Ec = 20,


fenoxaprop-P-ethyl

Diff. = +30)
















TABLE 155







Efficacy against CHEAL, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-7
0.5
10


fenoxaprop-P-ethyl
20
0


A1-7 +
0.5 + 20
30 (Ec = 10,


fenoxaprop-P-ethyl

Diff. = +20)
















TABLE 156







Efficacy against CHEAL, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-7
0.5
10


fenoxaprop-P-ethyl
5
0


A1-7 +
0.5 + 5
20 (Ec = 10,


fenoxaprop-P-ethyl

Diff. = +10)
















TABLE 157







Efficacy against KCHSC, 21 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-7
0.5
10


fenoxaprop-P-ethyl
20
0


A1-7 +
0.5 + 20
20 (Ec = 10,


fenoxaprop-P-ethyl

Diff. = +10)
















TABLE 158







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2
10


fenoxaprop-P-ethyl
20
0


A1-7 + fenoxaprop-P-ethyl
2 + 20
20 (Ec = 10, Diff. = +10)
















TABLE 159







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2
10


fenoxaprop-P-ethyl
5
0


A1-7 + fenoxaprop-P-ethyl
2 + 5
20 (Ec = 10, Diff. = +10)
















TABLE 160







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
0.5
0


fenoxaprop-P-ethyl
20
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 20
10 (Ec = 0, Diff. = +10)
















TABLE 161







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
0.5
0


fenoxaprop-P-ethyl
5
0


A1-7 + fenoxaprop-P-ethyl
0.5 + 5
10 (Ec = 0, Diff. = +10)
















TABLE 162







Efficacy against DIGSA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
4
70


lenacil
1200
0


A1-60 + lenacil
4 + 1200
97 (Ec = 70, Diff. = +27)
















TABLE 163







Efficacy against DIGSA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
4
70


lenacil
300
0


A1-60 + lenacil
4 + 300
95 (Ec = 70, Diff. = +25)
















TABLE 164







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
4
75


lenacil
1200
0


A1-60 + lenacil
4 + 1200
100 (Ec = 75, Diff. = + 25)
















TABLE 165







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
4
75


lenacil
300
0


A1-60 + lenacil
4 + 300
100 (Ec = 75, Diff. = +25)
















TABLE 166







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
1
40


lenacil
1200
0


A1-60 + lenacil
1 + 1200
70 (Ec = 40, Diff. = +30)
















TABLE 167







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
1
40


lenacil
300
0


A1-60 + lenacil
1 + 300
70 (Ec = 40, Diff. = +30)
















TABLE 168







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
4
75


lenacil
1200
0


A1-60 + lenacil
4 + 1200
98 (Ec = 75, Diff. = +23)
















TABLE 169







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
4
75


lenacil
300
0


A1-60 + lenacil
4 + 300
95 (Ec = 75, Diff. = +20)
















TABLE 170







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
1
40


lenacil
1200
0


A1-60 + lenacil
1 + 1200
70 (Ec = 40, Diff. = +30)
















TABLE 171







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
1
40


lenacil
300
0


A1-60 + lenacil
1 + 300
95 (Ec = 40, Diff. = +55)
















TABLE 172







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
4
70


lenacil
1200
0


A1-60 + lenacil
4 + 1200
85 (Ec = 70, Diff. = +15)
















TABLE 173







Efficacy against SETVI, 21 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]







A1-60
 4
70



lenacil
300
 0



A1-60 + lenacil
4 + 300
75 (Ec = 70, Diff. = +5)

















TABLE 174







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
  1
50


lenacil
1200
 0


A1-60 + lenacil
1 + 1200
80 (Ec = 50, Diff. = +30)
















TABLE 175







Efficacy against AMARE, 21 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]







A1-60
  4
60



lenacil
1200
 0



A1-60 + lenacil
4 + 1200
65 (Ec = 60, Diff. = +5)

















TABLE 176







Efficacy against AMARE, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
  1
20


lenacil
1200
 0


A1-60 + lenacil
1 + 1200
30 (Ec = 20, Diff. = +10)
















TABLE 177







Efficacy against AMARE, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
 1
20


lenacil
300
 0


A1-60 + lenacil
1 + 300
30 (Ec = 20, Diff. = +10)
















TABLE 178







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
  4
30


lenacil
1200
 0


A1-60 + lenacil
4 + 1200
100 (Ec = 30, Diff. = +70)
















TABLE 179







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
 4
30


lenacil
300
 0


A1-60 + lenacil
4 + 300
80 (Ec = 30, Diff. = +50)
















TABLE 180







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
  1
20


lenacil
1200
 0


A1-60 + lenacil
1 + 1200
60 (Ec = 20, Diff. = +40)
















TABLE 181







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-60
 1
20


lenacil
300
 0


A1-60 + lenacil
1 + 300
60 (Ec = 20, Diff. = +40)
















TABLE 182







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
0


metribuzin
20
0


A1-13 + metribuzin
0.4 + 20
75 (Ec = 0, Diff. = +75)
















TABLE 183







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
0


metribuzin
5
0


A1-13 + metribuzin
0.4 + 5
60 (Ec = 0, Diff. = +60)
















TABLE 184







Efficacy against ECHCG, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


metribuzin
20
0


A1-13 + metribuzin
0.1 + 20
20 (Ec = 0, Diff. = +20)
















TABLE 185







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


metribuzin
20
 0


A1-13 + metribuzin
0.4 + 20
70 (Ec = 10, Diff. = +60)
















TABLE 186







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


metribuzin
5
 0


A1-13 + metribuzin
0.4 + 5
60 (Ec = 10, Diff. = +50)
















TABLE 187







Efficacy against ELEIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


metribuzin
20
0


A1-13 + metribuzin
0.1 + 20
10 (Ec = 0, Diff. = +10)
















TABLE 188







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


metribuzin
20
0


A1-13 + metribuzin
0.4 + 20
50 (Ec = 10, Diff. = +40)
















TABLE 189







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


metribuzin
5
0


A1-13 + metribuzin
0.4 + 5
40 (Ec = 10, Diff. = +30)
















TABLE 190







Efficacy against SETVI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


metribuzin
20
0


A1-13 + metribuzin
0.1 + 20
10 (Ec = 0, Diff. = +10)
















TABLE 191







Efficacy against AMARE, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


metribuzin
20
10


A1-13 + metribuzin
0.4 + 20
30 (Ec = 19, Diff. = +11)
















TABLE 192







Efficacy against AMARE, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


metribuzin
5
0


A1-13 + metribuzin
0.4 + 5
30 (Ec = 10, Diff. = +20)
















TABLE 193







Efficacy against CHEAL, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


metribuzin
20
20


A1-13 + metribuzin
0.1 + 20
30 (Ec = 20, Diff. = +10)
















TABLE 194







Efficacy against CHEAL, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


metribuzin
5
20


A1-13 + metribuzin
0.1 + 5
30 (Ec = 20, Diff. = +10)
















TABLE 195







Efficacy against KCHSC, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
0


metribuzin
20
10


A1-13 + metribuzin
0.4 + 20
65 (Ec = 10, Diff. = +55)
















TABLE 196







Efficacy against KCHSC, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
0


metribuzin
5
0


A1-13 + metribuzin
0.4 + 5
60 (Ec = 0, Diff. = +60)
















TABLE 197







Efficacy against KCHSC, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


metribuzin
20
10


A1-13 + metribuzin
0.1 + 20
20 (Ec = 10, Diff. = +10)
















TABLE 198







Efficacy against KCHSC, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.1
0


metribuzin
5
0


A1-13 + metribuzin
0.1 + 5
10 (Ec = 0, Diff. = +10)
















TABLE 199







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


metribuzin
20
0


A1-13 + metribuzin
0.4 + 20
50 (Ec = 10, Diff. = +40)
















TABLE 200







Efficacy against SOLNI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
0.4
10


metribuzin
5
0


A1-13 + metribuzin
0.4 + 5
65 (Ec = 10, Diff. = +55)
















TABLE 201







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
0


pinoxaden
20
20


A1-3 + pinoxaden
20 + 20
30 (Ec = 20, Diff. = +10)
















TABLE 202







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
5
0


pinoxaden
5
0


A1-3 + pinoxaden
5 + 5
15 (Ec = 0, Diff. = +15)
















TABLE 203







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
5


pinoxaden
20
10


A1-3 + pinoxaden
20 + 20
30 (Ec = 14.5, Diff. = +15.5)
















TABLE 204







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
5


pinoxaden
5
0


A1-3 + pinoxaden
20 + 5
25 (Ec = 5, Diff. = +20)
















TABLE 205







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
0


pinoxaden
20
10


A1-3 + pinoxaden
5 + 20
30 (Ec = 10, Diff. = +20)
















TABLE 206







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
5
0


pinoxaden
5
0


A1-3 + pinoxaden
5 + 5
15 (Ec = 0, Diff. = +15)
















TABLE 207







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
0


pinoxaden
20
85


A1-3 + pinoxaden
5 + 20
90 (Ec = 85, Diff. = +5)
















TABLE 208







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
20
20


pinoxaden
20
50


A1-3 + pinoxaden
20 + 20
85 (Ec = 60, Diff. = +25)
















TABLE 209







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
20


pinoxaden
5
10


A1-3 + pinoxaden
20 + 5
50 (Ec = 28, Diff. = +22)
















TABLE 210







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
0


pinoxaden
20
50


A1-3 + pinoxaden
5 + 20
60 (Ec = 50, Diff. = +10)
















TABLE 211







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
0


pinoxaden
5
10


A1-3 + pinoxaden
5 + 5
15 (Ec = 10, Diff. = +5)
















TABLE 212







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
20
5


pinoxaden
20
0


A1-3 + pinoxaden
20 + 20
35 (Ec = 5, Diff. = +30)
















TABLE 213







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
5


pinoxaden
5
0


A1-3 + pinoxaden
20 + 5
15 (Ec = 5, Diff. = +10)
















TABLE 214







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
0


pinoxaden
20
0


A1-3 + pinoxaden
5 + 20
20 (Ec = 0, Diff. = +20)
















TABLE 215







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
40


pinoxaden
20
0


A1-3 + pinoxaden
5 + 20
50 (Ec = 40, Diff. = +10)
















TABLE 216







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
30


pinoxaden
20
0


A1-3 + pinoxaden
5 + 20
35 (Ec = 30, Diff. = +5)
















TABLE 217







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
10


pinoxaden
20
0


A1-3 + pinoxaden
20 + 20
40 (Ec = 10, Diff. = +30)
















TABLE 218







Efficacy against POLCO, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-3
20
10


pinoxaden
5
0


A1-3 +
20 + 5
40 (Ec = 10,


pinoxaden

Diff. = +30)
















TABLE 219







Efficacy against POLCO, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-3
5
0


pinoxaden
20
0


A1-3 +
5 + 20
40 (Ec = 0,


pinoxaden

Diff. = +40)
















TABLE 220







Efficacy against POLCO, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-3
5
0


pinoxaden
5
0


A1-3 +
5 + 5
20 (Ec = 0,


pinoxaden

Diff. = +20)
















TABLE 221







Efficacy against AVEFA, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
10
35


mesosulfuron-methyl
10
5


A1-13 +
10 + 10
60 (Ec = 38.25,


mesosulfuron-methyl

Diff. = +21.75)
















TABLE 222







Efficacy against PHAMI, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
10
30


mesosulfuron-methyl
10
5


A1-13 +
10 + 10
40 (Ec = 33.5,


mesosulfuron-methyl

Diff. = +6.5)
















TABLE 223







Efficacy against PHAMI, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
10
30


mesosulfuron-methyl
2.5
0


A1-13 +
10 + 2.5
40 (Ec = 30,


mesosulfuron-methyl

Diff. = +10)
















TABLE 224







Efficacy against PHAMI, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
2.5
30


mesosulfuron-methyl
10
5


A1-13 +
2.5 + 10
40 (Ec = 33.5,


mesosulfuron-methyl

Diff. = +6.5)
















TABLE 225







Efficacy against POAAN, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-13
10
40


mesosulfuron-methyl
10
40


A1-13 +
10 + 10
70 (Ec = 64,


mesosulfuron-methyl

Diff. = +6)
















TABLE 226







Efficacy against POAAN, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
2.5
20


mesosulfuron-methyl
10
40


A1-13 +
2.5 + 10
70 (Ec = 52,


mesosulfuron-methyl

Diff. = +18)
















TABLE 227







Efficacy against POAAN, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-13
2.5
20


mesosulfuron-methyl
2.5
15


A1-13 +
2.5 + 2.5
40 (Ec = 32,


mesosulfuron-methyl

Diff. = +8)
















TABLE 228







Efficacy against GALAP, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]





A1-13
10
50


mesosulfuron-methyl
10
30


A1-13 +
10 + 10
75 (Ec = 65,


mesosulfuron-methyl

Diff. = +10)
















TABLE 229







Efficacy against GALAP, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
10
50


mesosulfuron-methyl
2.5
30


A1-13 +
10 + 2.5
70 (Ec = 65,


mesosulfuron-methyl

Diff. = +5)
















TABLE 230







Efficacy against MATIN, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
10
40


mesosulfuron-methyl
10
0


A1-13 +
10 + 10
70 (Ec = 40,


mesosulfuron-methyl

Diff. = +30)
















TABLE 231







Efficacy against MATIN, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
10
40


mesosulfuron-methyl
2.5
0


A1-13 +
10 + 2.5
65 (Ec = 40,


mesosulfuron-methyl

Diff. = +25)
















TABLE 232







Efficacy against MATIN, 14 days after application









Active
Dosage
Efficacy


ingredient
[g of a.i./ha]
[%]












A1-13
2.5
30


mesosulfuron-methyl
10
0


A1-13 +
2.5 + 10
40 (Ec = 30,


mesosulfuron-methyl

Diff. = +10)
















TABLE 233







Efficacy against BROST, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
50
10


iodosulfuron-methyl-sodium
2
15


A1-34 + iodosulfuron-
50 + 2
30 (Ec = 23.5, Diff. = +6.5)


methyl-sodium
















TABLE 234







Efficacy against LOLMU, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
200
30


iodosulfuron-methyl-sodium
2
30


A1-34 + iodosulfuron-methyl-sodium
200 + 2
60 (Ec = 51, Diff. = +9)
















TABLE 235







Efficacy against LOLMU, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
200
30


iodosulfuron-methyl-sodium
0.5
0


A1-34 + iodosulfuron-
200 + 0.5
40 (Ec = 30, Diff. = +10)


methyl-sodium
















TABLE 236







Efficacy against LOLMU, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
50
5


iodosulfuron-methyl-sodium
0.5
0


A1-34 + iodosulfuron-methyl-sodium
50 + 0.5
15 (Ec = 5, Diff. = +10)
















TABLE 237







Efficacy against PHAMI, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
200
60


iodosulfuron-methyl-sodium
0.5
10


A1-34 + iodosulfuron-methyl-sodium
200 + 0.5
70 (Ec = 64, Diff. = +6)
















TABLE 238







Efficacy against POAAN, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
200
85


iodosulfuron-methyl-sodium
2
20


A1-34 + iodosulfuron-methyl-sodium
200 + 2
93 (Ec = 88, Diff. = +5)
















TABLE 239







Efficacy against POAAN, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
200
85


iodosulfuron-methyl-sodium
0.5
0


A1-34 + iodosulfuron-
200 + 0.5
95 (Ec = 85, Diff. = +10)


methyl-sodium
















TABLE 240







Efficacy against GALAP, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
50
50


iodosulfuron-methyl-sodium
0.5
30


A1-34 + iodosulfuron-methyl-sodium
50 + 0.5
70 (Ec = 65, Diff. = +5)
















TABLE 241







Efficacy against POLCO, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
200
30


iodosulfuron-methyl-sodium
2
30


A1-34 + iodosulfuron-methyl-sodium
200 + 2
60 (Ec = 51, Diff. = +9)
















TABLE 242







Efficacy against POLCO, 14 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-34
200
30


iodosulfuron-methyl-sodium
0.5
15


A1-34 + iodosulfuron-
200 + 0.5
60 (Ec = 40.5, Diff. = +19.5)


methyl-sodium
















TABLE 243







Efficacy against BROST, 14 days after application












Dosage




Active ingredient
[g of a.i./ha]
Efficacy [%]















A1-14
10
3



pyrasulfotole
25
0



A1-14 + pyrasulfotole
10 + 25
10 (Ec = 3, Diff. = +7)

















TABLE 244







Efficacy against BROST, 14 days after application












Dosage




Active ingredient
[g of a.i./ha]
Efficacy [%]















A1-14
2.5
0



pyrasulfotole
25
0



A1-14 + pyrasulfotole
2.5 + 25
10 (Ec = 0, Diff. = +10)

















TABLE 245







Efficacy against LOLMU, 14 days after application












Dosage




Active ingredient
[g of a.i./ha]
Efficacy [%]















A1-14
10
0



pyrasulfotole
100
0



A1-14 + pyrasulfotole
10 + 100
20 (Ec = 0, Diff. = +20)

















TABLE 246







Efficacy against LOLMU, 14 days after application












Dosage




Active ingredient
[g of a.i./ha]
Efficacy [%]















A1-14
2.5
0



pyrasulfotole
100
0



A1-14 + pyrasulfotole
2.5 + 100
15 (Ec = 0, Diff. = +15)

















TABLE 247







Efficacy against LOLMU, 14 days after application












Dosage




Active ingredient
[g of a.i./ha]
Efficacy [%]















A1-14
2.5
0



pyrasulfotole
25
0



A1-14 + pyrasulfotole
2.5 + 25
15 (Ec = 0, Diff. = +15)

















TABLE 248







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
10
25


pyrasulfotole
100
5


A1-14 + pyrasulfotole
10 + 100
40 (Ec = 28.75, Diff. = +11.25)
















TABLE 249







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
100
5


A1-14 + pyrasulfotole
2.5 + 100
30 (Ec = 5, Diff. = +25)
















TABLE 250







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
25
0


A1-14 + pyrasulfotole
2.5 + 25
10 (Ec = 0, Diff. = +10)
















TABLE 251







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
10


pyrasulfotole
100
0


A1-14 + pyrasulfotole
2.5 + 100
25 (Ec = 10, Diff. = +15)
















TABLE 252







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
10


pyrasulfotole
25
0


A1-14 + pyrasulfotole
2.5 + 25
20 (Ec = 10, Diff. = +10)
















TABLE 253







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
10
60


pyrasulfotole
100
15


A1-14 + pyrasulfotole
10 + 100
80 (Ec = 66, Diff. = +14)
















TABLE 254







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
10
60


pyrasulfotole
25
0


A1-14 + pyrasulfotole
10 + 25
70 (Ec = 60, Diff. = +10)
















TABLE 255







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
50


pyrasulfotole
100
15


A1-14 + pyrasulfotole
2.5 + 100
70 (Ec = 57.5, Diff. = +12.5)
















TABLE 256







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
10
20


pyrasulfotole
100
60


A1-14 + pyrasulfotole
10 + 100
85 (Ec = 68, Diff. = +17)
















TABLE 257







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-14
10
20


pyrasulfotole
25
50


A1-14 + pyrasulfotole
10 + 25
95 (Ec = 60, Diff. = +35)
















TABLE 258







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
20


pyrasulfotole
100
60


A1-14 + pyrasulfotole
2.5 + 100
75 (Ec = 68, Diff. = +7)
















TABLE 259







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
20


pyrasulfotole
25
50


A1-14 + pyrasulfotole
2.5 + 25
65 (Ec = 60, Diff. = +5)
















TABLE 260







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
15


flurtamone
320
15


A1-36 + flurtamone
10 + 320
40 (Ec = 27.75, Diff. = +12.25)
















TABLE 261







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
15


flurtamone
80
0


A1-36 + flurtamone
10 + 80
30 (Ec = 15, Diff. = +15)
















TABLE 262







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
0


flurtamone
320
15


A1-36 + flurtamone
2.5 + 320
30 (Ec = 15, Diff. = +15)
















TABLE 263







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
0


flurtamone
80
0


A1-36 + flurtamone
2.5 + 80
15 (Ec = 0, Diff. = +15)
















TABLE 264







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
0


flurtamone
320
10


A1-36 + flurtamone
2.5 + 320
15 (Ec = 0, Diff. = +5)
















TABLE 265







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
0


flurtamone
80
0


A1-36 + flurtamone
2.5 + 80
15 (Ec = 0, Diff. = +15)
















TABLE 266







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
3


flurtamone
80
30


A1-36 + flurtamone
10 + 80
60 (Ec = 32.1, Diff. = +27.9)
















TABLE 267







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
30


flurtamone
320
50


A1-36 + flurtamone
10 + 320
75 (Ec = 65, Diff. = +10)
















TABLE 268







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
30


flurtamone
80
40


A1-36 + flurtamone
10 + 80
65 (Ec = 58, Diff. = +7)
















TABLE 269







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
0


flurtamone
320
50


A1-36 + flurtamone
2.5 + 320
85 (Ec = 50, Diff. = +35)
















TABLE 270







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
25


flurtamone
320
80


A1-36 + flurtamone
10 + 320
100 (Ec = 85, Diff. = +15)
















TABLE 271







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
25


flurtamone
80
40


A1-36 + flurtamone
10 + 80
60 (Ec = 55, Diff. = +5)
















TABLE 272







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
5


flurtamone
80
40


A1-36 + flurtamone
2.5 + 80
70 (Ec = 43, Diff. = +27)
















TABLE 273







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
40


flurtamone
320
50


A1-36 + flurtamone
10 + 320
97 (Ec = 70, Diff. = +27)
















TABLE 274







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
40


flurtamone
80
50


A1-36 + flurtamone
10 + 80
97 (Ec = 70, Diff. = +27)
















TABLE 275







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
15


flurtamone
320
50


A1-36 + flurtamone
2.5 + 320
90 (Ec = 57.5, Diff. = +32.5)
















TABLE 276







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
15


flurtamone
80
50


A1-36 + flurtamone
2.5 + 80
80 (Ec = 57.5, Diff. = +22.5)
















TABLE 277







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
0


flurtamone
320
30


A1-36 + flurtamone
2.5 + 320
40 (Ec = 30, Diff. = +10)
















TABLE 278







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
 0


flurtamone
80
50


A1-36 + flurtamone
2.5 + 80
70 (Ec = 50, Diff. = +20)
















TABLE 279







Efficacy against AVEFA, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]







A2-1
50
0



fluroxypyr
80
0



A2-1 + fluroxypyr
50 + 80
20 (Ec = 0, Diff. = +20)

















TABLE 280







Efficacy against AVEFA, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A2-1
12.5
0



fluroxypyr
80
0



A2-1 + fluroxypyr
12.5 + 80
15 (Ec = 0, Diff. = +15)

















TABLE 281







Efficacy against BROST, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A2-1
12.5
0



fluroxypyr
80
0



A2-1 + fluroxypyr
12.5 + 80
15 (Ec = 0, Diff. = +15)

















TABLE 282







Efficacy against LOLMU, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]







A2-1
50
0



fluroxypyr
80
0



A2-1 + fluroxypyr
50 + 80
20 (Ec = 0, Diff. = +20)

















TABLE 283







Efficacy against LOLMU, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A2-1
12.5
0



fluroxypyr
80
0



A2-1 + fluroxypyr
12.5 + 80
20 (Ec = 0, Diff. = +20)

















TABLE 284







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
12.5
15


fluroxypyr
80
15


A2-1 + fluroxypyr
12.5 + 80
35 (Ec = 27.75, Diff. = +7.25)
















TABLE 285







Efficacy against POAAN, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A2-1
12.5
15



fluroxypyr
20
 0



A2-1 + fluroxypyr
12.5 + 20
20 (Ec = 15, Diff. = +5)

















TABLE 286







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
50
70


fluroxypyr
20
70


A2-1 + fluroxypyr
50 + 20
100 (Ec = 91, Diff. = +9)
















TABLE 287







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
 0


glufosinate-ammonium
100
25


A1-55 + glufosinate-
2.5 + 100
40 (Ec = 25, Diff. = +15)


ammonium
















TABLE 288







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
2.5 + 25
10 (Ec = 0, Diff. = +10)


ammonium
















TABLE 289







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
 5


glufosinate-ammonium
100
15


A1-55 + glufosinate-ammonium
2.5 + 100
40 (Ec = 19.25,




Diff. = +20.75)
















TABLE 290







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-55
10
15


glufosinate-ammonium
25
 0


A1-55 + glufosinate-
10 + 25
20 (Ec = 15, Diff. = +5)


ammonium
















TABLE 291







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
 0


glufosinate-ammonium
100
25


A1-55 + glufosinate-
2.5 + 100
40 (Ec = 25, Diff. = +15)


ammonium
















TABLE 292







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
2.5 + 25
15 (Ec = 0, Diff. = +15)


ammonium
















TABLE 293







Efficacy against PHAMI, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-55
10
25



glufosinate-ammonium
100
15



A1-55 + glufosinate-
10 + 100
65 (Ec = 36.25,



ammonium

Diff. = +28.75)

















TABLE 294







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
25


glufosinate-ammonium
25
0


A1-55 + glufosinate-
10 + 25
50 (Ec = 25,


ammonium

Diff. = +25)
















TABLE 295







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
15


A1-55 + glufosinate-
2.5 + 100
65 (Ec = 15,


ammonium

Diff. = +50)
















TABLE 296







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
2.5 + 25
40 (Ec = 0,


ammonium

Diff. = +40)
















TABLE 297







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
20


glufosinate-ammonium
100
0


A1-55 + glufosinate-
10 + 100
40 (Ec = 20,


ammonium

Diff. = +20)
















TABLE 298







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
5


glufosinate-ammonium
100
0


A1-55 + glufosinate-
2.5 + 100
30 (Ec = 5,


ammonium

Diff. = +25)
















TABLE 299







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
30


glufosinate-ammonium
25
0


A1-55 + glufosinate-
10 + 25
60 (Ec = 30,


ammonium

Diff. = +30)
















TABLE 300







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
2.5 + 25
30 (Ec = 0,


ammonium

Diff. = +30)
















TABLE 301







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
30


glufosinate-ammonium
100
30


A1-55 + glufosinate-
10 + 100
95 (Ec = 51,


ammonium

Diff. = +44)
















TABLE 302







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
30


glufosinate-ammonium
25
0


A1-55 + glufosinate-
10 + 25
95 (Ec = 30,


ammonium

Diff. = +65)
















TABLE 303







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
30


A1-55 + glufosinate-
2.5 + 100
80 (Ec = 30,


ammonium

Diff. = +50)
















TABLE 304







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
2.5 + 25
70 (Ec = 0,


ammonium

Diff. = +70)
















TABLE 305







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
0


glufosinate-ammonium
100
25


A1-55 + glufosinate-
10 + 100
50 (Ec = 25,


ammonium

Diff. = +25)
















TABLE 306







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-55
10
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
10 + 25
70 (Ec = 0,


ammonium

Diff. = +70)
















TABLE 307







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
25


A1-55 + glufosinate-
2.5 + 100
50 (Ec = 25,


ammonium

Diff. = +25)
















TABLE 308







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
2.5 + 25
15 (Ec = 0,


ammonium

Diff. = +15)
















TABLE 309







Efficacy against AVEFA, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-57
50
0



aclonifen
800
0



A1-57 + aclonifen
50 + 800
50 (Ec = 0, Diff. = +50)

















TABLE 310







Efficacy against AVEFA, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-57
50
0



aclonifen
200
0



A1-57 + aclonifen
50 + 200
20 (Ec = 0, Diff. = +20)

















TABLE 311







Efficacy against AVEFA, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-57
12.5
0



aclonifen
800
0



A1-57 + aclonifen
12.5 + 800
35 (Ec = 0, Diff. = +35)

















TABLE 312







Efficacy against AVEFA, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-57
12.5
0



aclonifen
200
0



A1-57 + aclonifen
12.5 + 200
5 (Ec = 0, Diff. = +5)

















TABLE 313







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
40


aclonifen
800
0


A1-57 + aclonifen
50 + 800
50 (Ec = 40, Diff. = +10)
















TABLE 314







Efficacy against BROST, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-57
12.5
0



aclonifen
800
0



A1-57 + aclonifen
12.5 + 800
40 (Ec = 0, Diff. = +40)

















TABLE 315







Efficacy against BROST, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-57
12.5
0



aclonifen
200
0



A1-57 + aclonifen
12.5 + 200
10 (Ec = 0, Diff. = +10)

















TABLE 316







Efficacy against LOLMU, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-57
50
35



aclonifen
800
0



A1-57 + aclonifen
50 + 800
40 (Ec = 35, Diff. = +5)

















TABLE 317







Efficacy against LOLMU, 14 days after application











Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]















A1-57
12.5
0



aclonifen
800
0



A1-57 + aclonifen
12.5 + 800
10 (Ec = 0, Diff. = +10)

















TABLE 318







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
70


aclonifen
200
0


A1-57 + aclonifen
50 + 200
85 (Ec = 70, Diff. = +15)
















TABLE 319







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
50


aclonifen
800
40


A1-57 + aclonifen
12.5 + 800
85 (Ec = 70, Diff. = +15)
















TABLE 320







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
50


aclonifen
200
0


A1-57 + aclonifen
12.5 + 200
60 (Ec = 50, Diff. = +10)
















TABLE 321







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
50


aclonifen
800
30


A1-57 + aclonifen
50 + 800
85 (Ec = 65, Diff. = +20)
















TABLE 322







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
50


aclonifen
200
0


A1-57 + aclonifen
50 + 200
80 (Ec = 50, Diff. = +30)
















TABLE 323







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
15


aclonifen
800
30


A1-57 + aclonifen
12.5 + 800
70 (Ec = 40.5, Diff. = +29.5)
















TABLE 324







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
15


aclonifen
200
 0


A1-57 + aclonifen
12.5 + 200
45 (Ec = 15, Diff. = +30)
















TABLE 325







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-57
 50
60


aclonifen
200
20


A1-57 + aclonifen
50 + 200
80 (Ec = 68, Diff. = +12)
















TABLE 326







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
30


aclonifen
200
20


A1-57 + aclonifen
12.5 + 200
65 (Ec = 44, Diff. = +21)
















TABLE 327







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-57
 50
85


aclonifen
800
 0


A1-57 + aclonifen
50 + 800
95 (Ec = 85, Diff. = +10)
















TABLE 328







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
60


aclonifen
800
 0


A1-57 + aclonifen
12.5 + 800
93 (Ec = 60, Diff. = +33)
















TABLE 329







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
60


aclonifen
200
 0


A1-57 + aclonifen
12.5 + 200
75 (Ec = 60, Diff. = +15)
















TABLE 330







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
65


aclonifen
800
10


A1-57 + aclonifen
12.5 + 800
85 (Ec = 68.5, Diff. = +16.5)
















TABLE 331







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
65


aclonifen
200
 0


A1-57 + aclonifen
12.5 + 200
85 (Ec = 65, Diff. = +20)
















TABLE 332







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2.5
15


saflufenacil
2
 0


A1-7 + saflufenacil
2.5 + 2
20 (Ec = 15, Diff. = +5)
















TABLE 333







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2.5
 0


saflufenacil
8
10


A1-7 + saflufenacil
2.5 + 8
15 (Ec = 10, Diff. = +5)
















TABLE 334







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2.5
0


saflufenacil
2
0


A1-7 + saflufenacil
2.5 + 2
10 (Ec = 0, Diff. = +10)
















TABLE 335







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-7
10
25


saflufenacil
 8
10


A1-7 + saflufenacil
10 + 8
80 (Ec = 32.5, Diff. = +47.5)
















TABLE 336







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-7
10
25


saflufenacil
 2
 0


A1-7 + saflufenacil
10 + 2
75 (Ec = 25, Diff. = +50)
















TABLE 337







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2.5
10


saflufenacil
8
10


A1-7 + saflufenacil
2.5 + 8
93 (Ec = 19, Diff. = +74)
















TABLE 338







Efficacy against POLCO, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2.5
10


saflufenacil
2
0


A1-7 + saflufenacil
2.5 + 2
75 (Ec = 10, Diff. = +65)
















TABLE 339







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
0


isoproturon
1600
35


A1-60 + isoproturon
10 + 1600
50 (Ec = 35, Diff. = +15)
















TABLE 340







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
0


isoproturon
400
0


A1-60 + isoproturon
10 + 400
50 (Ec = 0, Diff. = +50)
















TABLE 341







Efficacy against AVEFA, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
400
0


A1-60 + isoproturon
2.5 + 400
15 (Ec = 0, Diff. = +15)
















TABLE 342







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
15


isoproturon
1600
5


A1-60 +
10 + 1600
60 (Ec = 19.25, Diff. = +40.75)


isoproturon
















TABLE 343







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
15


isoproturon
400
0


A1-60 + isoproturon
10 + 400
40 (Ec = 15, Diff. = +25)
















TABLE 344







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
1600
5


A1-60 + isoproturon
2.5 + 1600
20 (Ec = 5, Diff. = +15)
















TABLE 345







Efficacy against BROST, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
400
0


A1-60 + isoproturon
2.5 + 400
15 (Ec = 0, Diff. = +15)
















TABLE 346







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
0


isoproturon
1600
15


A1-60 + isoproturon
10 + 1600
50 (Ec = 15, Diff. = +35)
















TABLE 347







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
0


isoproturon
400
0


A1-60 + isoproturon
10 + 400
30 (Ec = 0, Diff. = +30)
















TABLE 348







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
1600
15


A1-60 + isoproturon
2.5 + 1600
25 (Ec = 15, Diff. = +10)
















TABLE 349







Efficacy against LOLMU, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
400
0


A1-60 + isoproturon
2.5 + 400
15 (Ec = 0, Diff. = +15)
















TABLE 350







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
25


isoproturon
1600
80


A1-60 + isoproturon
10 + 1600
95 (Ec = 85, Diff. = +10)
















TABLE 351







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
25


isoproturon
400
35


A1-60 + isoproturon
10 + 400
85 (Ec = 51.25, Diff. = +33.75)
















TABLE 352







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
10


isoproturon
400
35


A1-60 + isoproturon
2.5 + 400
50 (Ec = 41.5, Diff. = +8.5)
















TABLE 353







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
10


isoproturon
1600
80


A1-60 + isoproturon
10 + 1600
90 (Ec = 82, Diff. = +8)
















TABLE 354







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
10


isoproturon
400
60


A1-60 + isoproturon
10 + 400
95 (Ec = 64, Diff. = +31)
















TABLE 355







Efficacy against POAAN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
 0


isoproturon
1600
80


A1-60 + isoproturon
2.5 + 1600
85 (Ec = 80, Diff. = +5)
















TABLE 356







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
30


isoproturon
1600
20


A1-60 + isoproturon
10 + 1600
65 (Ec = 44, Diff. = +21)
















TABLE 357







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
30


isoproturon
400
10


A1-60 + isoproturon
10 + 400
65 (Ec = 37, Diff. = +28)
















TABLE 358







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
25


isoproturon
1600
20


A1-60 + isoproturon
2.5 + 1600
65 (Ec = 40, Diff. = +25)
















TABLE 359







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
25


isoproturon
400
10


A1-60 + isoproturon
2.5 + 400
60 (Ec = 32.5, Diff. = +27.5)
















TABLE 360







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
10
30


indaziflam
40
10


A1-13 + indaziflam
10 + 40
60 (Ec = 37, Diff. = +23)
















TABLE 361







Efficacy against PHAMI, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
30


indaziflam
40
10


A1-13 + indaziflam
2.5 + 40
70 (Ec = 37, Diff. = +33)
















TABLE 362







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
10
50


indaziflam
40
60


A1-13 + indaziflam
10 + 40
95 (Ec = 80, Diff. = +15)
















TABLE 363







Efficacy against GALAP, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
40


indaziflam
10
50


A1-13 + indaziflam
2.5 + 10
75 (Ec = 70, Diff. = +5)
















TABLE 364







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
10
40


indaziflam
10
30


A1-13 + indaziflam
10 + 10
70 (Ec = 58, Diff. = +12)
















TABLE 365







Efficacy against MATIN, 14 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
30


indaziflam
10
30


A1-13 + indaziflam
2.5 + 10
70 (Ec = 51, Diff. = +19)
















TABLE 366







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
 5


pinoxaden
5
30


A1-3 + pinoxaden
20 + 5
40 (Ec = 33.5, Diff. = +6.5)
















TABLE 367







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
 0


pinoxaden
20
80


A1-3 + pinoxaden
5 + 20
90 (Ec = 80, Diff. = +10)
















TABLE 368







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
5


pinoxaden
20
20


A1-3 + pinoxaden
20 + 20
80 (Ec = 24, Diff. = +56)
















TABLE 369







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
5


pinoxaden
5
10


A1-3 + pinoxaden
20 + 5
20 (Ec = 14.5, Diff. = +5.5)
















TABLE 370







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
20
3


pinoxaden
20
0


A1-3 + pinoxaden
20 + 20
20 (Ec = 3, Diff. = +17)
















TABLE 371







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
0


pinoxaden
20
0


A1-3 + pinoxaden
5 + 20
15 (Ec = 0, Diff. = +15)
















TABLE 372







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
20
5


pinoxaden
20
0


A1-3 + pinoxaden
20 + 20
30 (Ec = 5, Diff. = +25)
















TABLE 373







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
5


pinoxaden
5
0


A1-3 + pinoxaden
20 + 5
30 (Ec = 5, Diff. = +25)
















TABLE 374







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
5
5


pinoxaden
20
0


A1-3 + pinoxaden
5 + 20
20 (Ec = 5, Diff. = +15)
















TABLE 375







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-3
20
5


pinoxaden
20
0


A1-3 + pinoxaden
20 + 20
15 (Ec = 5, Diff. = +10)
















TABLE 376







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-3
20
5


pinoxaden
5
0


A1-3 + pinoxaden
20 + 5
15 (Ec = 5, Diff. = +10)
















TABLE 377







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
10
3


mesosulfuron-methyl
10
0


A1-13 + mesosulfuron-methyl
10 + 10
15 (Ec = 3, Diff. = +12)
















TABLE 378







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
0


mesosulfuron-methyl
10
0


A1-13 + mesosulfuron-methyl
2.5 + 10
15 (Ec = 0, Diff. = +15)
















TABLE 379







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
10
5


mesosulfuron-methyl
10
0


A1-13 + mesosulfuron-methyl
10 + 10
20 (Ec = 5, Diff. = +15)
















TABLE 380







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
0


mesosulfuron-methyl
10
0


A1-13 + mesosulfuron-methyl
2.5 + 10
35 (Ec = 0, Diff. = +35)
















TABLE 381







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
2.5
0


mesosulfuron-methyl
2.5
0


A1-13 + mesosulfuron-methyl
2.5 + 2.5
20 (Ec = 0, Diff. = +20)
















TABLE 382







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
10
5


mesosulfuron-methyl
10
15


A1-13 + mesosulfuron-methyl
10 + 10
35 (Ec = 19.25,




Diff. = +15.75)
















TABLE 383







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
10
20


mesosulfuron-methyl
10
5


A1-13 + mesosulfuron-methyl
10 + 10
40 (Ec = 24,




Diff. = +16)
















TABLE 384







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
15


mesosulfuron-methyl
10
5


A1-13 + mesosulfuron-methyl
2.5 + 10
30 (Ec = 19.25,




Diff. = +10.75)
















TABLE 385







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
15


mesosulfuron-methyl
2.5
0


A1-13 + mesosulfuron-methyl
2.5 + 2.5
20 (Ec = 15, Diff. = +5)
















TABLE 386







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
10


mesosulfuron-methyl
10
40


A1-13 + mesosulfuron-methyl
2.5 + 10
60 (Ec = 46,




Diff. = +14)
















TABLE 387







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
10
0


mesosulfuron-methyl
10
0


A1-13 + mesosulfuron-methyl
10 + 10
15 (Ec = 0, Diff. = +15)
















TABLE 388







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
0


mesosulfuron-methyl
10
0


A1-13 + mesosulfuron-methyl
2.5 + 10
10 (Ec = 0, Diff. = +10)
















TABLE 389







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
200
5


iodosulfuron-methyl-sodium
2
5


A1-34 + iodosulfuron-methyl-sodium
200 + 2
15 (Ec = 9.75,




Diff. = +5.25)
















TABLE 390







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
200
35


iodosulfuron-methyl-sodium
2
0


A1-34 + iodosulfuron-methyl-sodium
200 + 2
40 (Ec = 35,




Diff. = +5)
















TABLE 391







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
50
15


iodosulfuron-methyl-sodium
2
0


A1-34 + iodosulfuron-methyl-sodium
50 + 2
20 (Ec = 15,




Diff. = +5)
















TABLE 392







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
200
40


iodosulfuron-methyl-sodium
2
25


A1-34 + iodosulfuron-methyl-sodium
200 + 2
70 (Ec = 55,




Diff. = +15)
















TABLE 393







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
50
20


iodosulfuron-methyl-sodium
0.5
0


A1-34 + iodosulfuron-methyl-sodium
50 + 0.5
40 (Ec = 20,




Diff. = +20)
















TABLE 394







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
50
50


iodosulfuron-methyl-sodium
0.5
70


A1-34 + iodosulfuron-methyl-sodium
50 + 0.5
90 (Ec = 85,




Diff. = +5)
















TABLE 395







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
50
0


iodosulfuron-methyl-sodium
2
0


A1-34 + iodosulfuron-methyl-sodium
50 + 2
15 (Ec = 0,




Diff. = +15)
















TABLE 396







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-34
50
0


iodosulfuron-methyl-sodium
0.5
0


A1-34 + iodosulfuron-methyl-sodium
50 + 0.5
15 (Ec = 0,




Diff. = +15)
















TABLE 397







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
10
0


pyrasulfotole
100
0


A1-14 + pyrasulfotole
10 + 100
5 (Ec = 0, Diff. = +5)
















TABLE 398







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
100
0


A1-14 + pyrasulfotole
2.5 + 100
30 (Ec = 0, Diff. = +30)
















TABLE 399







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
25
0


A1-14 + pyrasulfotole
2.5 + 25
20 (Ec = 0, Diff. = +20)
















TABLE 400







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
100
0


A1-14 + pyrasulfotole
2.5 + 100
15 (Ec = 0, Diff. = +15)
















TABLE 401







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
25
0


A1-14 + pyrasulfotole
2.5 + 25
15 (Ec = 0, Diff. = +15)
















TABLE 402







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-14
10
15


pyrasulfotole
25
40


A1-14 + pyrasulfotole
10 + 25
60 (Ec = 49, Diff. = +11)
















TABLE 403







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
25
40 


A1-14 + pyrasulfotole
2.5 + 25
50 (Ec = 40, Diff. = +10)
















TABLE 404







Efficacy against MATIN, 21 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-14
2.5
30


pyrasulfotole
100
3


A1-14 + pyrasulfotole
2.5 + 100
40 (Ec = 32.1, Diff. = +7.9)
















TABLE 405







Efficacy against POLCO, 21 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]





A1-14
10
3


pyrasulfotole
100 
30 


A1-14 + pyrasulfotole
10 + 100
70 (Ec = 32.1, Diff. = +37.9)
















TABLE 406







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-14
10
3


pyrasulfotole
25
0


A1-14 + pyrasulfotole
10 + 25
80 (Ec = 3, Diff. = +77)
















TABLE 407







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
100
30


A1-14 + pyrasulfotole
2.5 + 100
60 (Ec = 30, Diff. = +30)
















TABLE 408







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-14
2.5
0


pyrasulfotole
25
0


A1-14 + pyrasulfotole
2.5 + 25
50 (Ec = 0, Diff. = +50)
















TABLE 409







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
15


flurtamone
320
0


A1-36 + flurtamone
10 + 320
40 (Ec = 15, Diff. = +25)
















TABLE 410







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-36
10
15


flurtamone
80
 0


A1-36 + flurtamone
10 + 80
30 (Ec = 15, Diff. = +15)
















TABLE 411







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
10


flurtamone
320
0


A1-36 + flurtamone
2.5 + 320
30 (Ec = 10, Diff. = +20)
















TABLE 412







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
10


flurtamone
80
0


A1-36 + flurtamone
2.5 + 80
20 (Ec = 10, Diff. = +10)
















TABLE 413







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
 5


flurtamone
320
10


A1-36 + flurtamone
2.5 + 320
20 (Ec = 14.5, Diff. = +5.5)
















TABLE 414







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
 5


flurtamone
80
 0


A1-36 + flurtamone
2.5 + 80
15 (Ec = 5, Diff. = +10)
















TABLE 415







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-36
10
 0


flurtamone
80
20


A1-36 + flurtamone
10 + 80
60 (Ec = 20, Diff. = +40)
















TABLE 416







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-36
10
20


flurtamone
80
40


A1-36 + flurtamone
10 + 80
80 (Ec = 52, Diff. = +28)
















TABLE 417







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
25


flurtamone
320
70


A1-36 + flurtamone
10 + 320
95 (Ec = 77.5, Diff. = +17.5)
















TABLE 418







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-36
10
25


flurtamone
80
 0


A1-36 + flurtamone
10 + 80
60 (Ec = 25, Diff. = +35)
















TABLE 419







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
 0


flurtamone
80
 0


A1-36 + flurtamone
2.5 + 80
70 (Ec = 0, Diff. = +70)
















TABLE 420







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
15


flurtamone
320
30


A1-36 + flurtamone
10 + 320
97 (Ec = 40.5, Diff. = +56.5)
















TABLE 421







Efficacy against MATIN, 21 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]





A1-36
10
15


flurtamone
80
25


A1-36 + flurtamone
10 + 80
98 (Ec = 36.25, Diff. = +61.75)
















TABLE 422







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
 0


flurtamone
320
30


A1-36 + flurtamone
2.5 + 320
80 (Ec = 30, Diff. = +50)
















TABLE 423







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
2.5
 0


flurtamone
80
25


A1-36 + flurtamone
2.5 + 80
60 (Ec = 25, Diff. = +35)
















TABLE 424







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-36
10
 3


flurtamone
320
30


A1-36 + flurtamone
10 + 320
40 (Ec = 32.1, Diff. = +7.9)
















TABLE 425







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-36
10
 3


flurtamone
80
 0


A1-36 + flurtamone
10 + 80
30 (Ec = 3, Diff. = +27)
















TABLE 426







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
50
 0


fluroxypyr
80
 0


A2-1 + fluroxypyr
50 + 80
15 (Ec = 0, Diff. = +15)
















TABLE 427







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
12.5
 0


fluroxypyr
80
 0


A2-1 + fluroxypyr
12.5 + 80
15 (Ec = 0, Diff. = +15)
















TABLE 428







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
50
0


fluroxypyr
80
0


A2-1 + fluroxypyr
50 + 80
15 (Ec = 0, Diff. = +15)
















TABLE 429







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
50
0


fluroxypyr
80
0


A2-1 + fluroxypyr
50 + 80
10 (Ec = 0, Diff. = +10)
















TABLE 430







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
50
15


fluroxypyr
80
 0


A2-1 + fluroxypyr
50 + 80
30 (Ec = 15, Diff. = +15)
















TABLE 431







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
12.5
0


fluroxypyr
80
0


A2-1 + fluroxypyr
12.5 + 80
20 (Ec = 0, Diff. = +20)
















TABLE 432







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
12.5
0


fluroxypyr
80
10


A2-1 + fluroxypyr
12.5 + 80
15 (Ec = 10, Diff. = +5)
















TABLE 433







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
12.5
0


fluroxypyr
20
0


A2-1 + fluroxypyr
12.5 + 20
10 (Ec = 0, Diff. = +10)
















TABLE 434







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
50
85


fluroxypyr
80
50


A2-1 + fluroxypyr
50 + 80
98 (Ec = 92.5, Diff. = +5.5)
















TABLE 435







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
50
85


fluroxypyr
20
20


A2-1 + fluroxypyr
50 + 20
95 (Ec = 88, Diff. = +7)
















TABLE 436







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
12.5
80


fluroxypyr
80
50


A2-1 + fluroxypyr
12.5 + 80
95 (Ec = 90, Diff. = +5)
















TABLE 437







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
12.5
80


fluroxypyr
20
20


A2-1 + fluroxypyr
12.5 + 20
93 (Ec = 84, Diff. = +9)
















TABLE 438







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A2-1
50
60


fluroxypyr
20
80


A2-1 + fluroxypyr
50 + 20
100 (Ec = 92, Diff. = +8)
















TABLE 439







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A2-1
12.5
20


fluroxypyr
20
80


A2-1 + fluroxypyr
12.5 + 20
90 (Ec = 84, Diff. = +6)
















TABLE 440







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
10


glufosinate-ammonium
100
20


A1-55 + glufosinate-
10 + 100
40 (Ec = 28, Diff. = +12)


ammonium
















TABLE 441







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
20


A1-55 + glufosinate-
2.5 + 100
35 (Ec = 20, Diff. = +15)


ammonium
















TABLE 442







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-55
10
10


glufosinate-ammonium
25
 0


A1-55 + glufosinate-
10 + 25
20 (Ec = 10, Diff. = +10)


ammonium
















TABLE 443







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
15


A1-55 + glufosinate-
2.5 + 100
20 (Ec = 15, Diff. = +5)


ammonium
















TABLE 444







Efficacy against LOLMU, 21 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-55
10
10


glufosinate-ammonium
100
15


A1-55 + glufosinate-
10 + 100
30 (Ec = 23.5, Diff. = +6.5)


ammonium
















TABLE 445







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
15


A1-55 + glufosinate-
2.5 + 100
20 (Ec = 15, Diff. = +5)


ammonium
















TABLE 446







Efficacy against PHAMI, 21 days after application










Dosage



Active ingredient
[g of a.i./ha]
Efficacy [%]












A1-55
10
5


glufosinate-ammonium
100
10


A1-55 + glufosinate-
10 + 100
40 (Ec = 14.5, Diff. = +25.5)


ammonium
















TABLE 447







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-55
10
5


glufosinate-ammonium
25
0


A1-55 + glufosinate-
10 + 25
20 (Ec = 5, Diff. = +15)


ammonium
















TABLE 448







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
10


A1-55 + glufosinate-
2.5 + 100
40 (Ec = 10, Diff. = +30)


ammonium
















TABLE 449







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
2.5 + 25
20 (Ec = 0, Diff. = +20)


ammonium
















TABLE 450







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
0


glufosinate-ammonium
100
5


A1-55 + glufosinate-
10 + 100
15 (Ec = 5, Diff. = +10)


ammonium
















TABLE 451







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
5


A1-55 + glufosinate-
2.5 + 100
15 (Ec = 5, Diff. = +10)


ammonium
















TABLE 452







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
15


glufosinate-ammonium
25
0


A1-55 + glufosinate-
10 + 25
30 (Ec = 15, Diff. = +15)


ammonium
















TABLE 453







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
20


glufosinate-ammonium
100
15


A1-55 + glufosinate-
10 + 100
90 (Ec = 32, Diff. = +58)


ammonium
















TABLE 454







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
20


glufosinate-ammonium
25
0


A1-55 + glufosinate-
10 + 25
80 (Ec = 20, Diff. = +60)


ammonium
















TABLE 455







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
100
15


A1-55 + glufosinate-
2.5 + 100
70 (Ec = 15, Diff. = +55)


ammonium
















TABLE 456







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
2.5
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
2.5 + 25
40 (Ec = 0, Diff. = +40)


ammonium
















TABLE 457







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-55
10
0


glufosinate-ammonium
100
5


A1-55 + glufosinate-
10 + 100
15 (Ec = 5, Diff. = +10)


ammonium
















TABLE 458







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-55
10
0


glufosinate-ammonium
25
0


A1-55 + glufosinate-
10 + 25
20 (Ec = 0, Diff. = +20)


ammonium
















TABLE 459







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
0


aclonifen
800
0


A1-57 + aclonifen
12.5 + 800
15 (Ec = 0, Diff. = +15)
















TABLE 460







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
15


aclonifen
800
0


A1-57 + aclonifen
50 + 800
20 (Ec = 15, Diff. = +5)
















TABLE 461







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
0


aclonifen
800
0


A1-57 + aclonifen
12.5 + 800
10 (Ec = 0, Diff. = +10)
















TABLE 462







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
20


aclonifen
800
15


A1-57 + aclonifen
12.5 + 800
40 (Ec = 32, Diff. = +8)
















TABLE 463







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
20


aclonifen
200
0


A1-57 + aclonifen
12.5 + 200
30 (Ec = 20, Diff. = +10)
















TABLE 464







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
35


aclonifen
800
10


A1-57 + aclonifen
50 + 800
85 (Ec = 41.5, Diff. = +43.5)
















TABLE 465







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
35


aclonifen
200
0


A1-57 + aclonifen
50 + 200
60 (Ec = 35, Diff. = +25)
















TABLE 466







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
10


aclonifen
800
10


A1-57 + aclonifen
12.5 + 800
40 (Ec = 19, Diff. = +21)
















TABLE 467







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
40


aclonifen
800
20


A1-57 + aclonifen
50 + 800
70 (Ec = 52, Diff. = +18)
















TABLE 468







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
50
80


aclonifen
800
0


A1-57 + aclonifen
50 + 800
85 (Ec = 80, Diff. = +5)
















TABLE 469







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-57
12.5
50


aclonifen
200
0


A1-57 + aclonifen
12.5 + 200
60 (Ec = 50, Diff. = +10)
















TABLE 470







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
10
5


saflufenacil
8
5


A1-7 + saflufenacil
10 + 8
15 (Ec = 9.75, Diff. = +5.25)
















TABLE 471







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
10
10


saflufenacil
8
0


A1-7 + saflufenacil
10 + 8
60 (Ec = 10, Diff. = +50)
















TABLE 472







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
10
10


saflufenacil
2
0


A1-7 + saflufenacil
10 + 2
40 (Ec = 10, Diff. = +30)
















TABLE 473







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2.5
0


saflufenacil
8
0


A1-7 + saflufenacil
2.5 + 8
80 (Ec = 0, Diff. = +80)
















TABLE 474







Efficacy against POLCO, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-7
2.5
0


saflufenacil
2
0


A1-7 + saflufenacil
2.5 + 2
50 (Ec = 0, Diff. = +50)
















TABLE 475







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
5


isoproturon
1600
15


A1-60 +
10 + 1600
40 (Ec = 19.25, Diff. = +20.75)


isoproturon
















TABLE 476







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
5


isoproturon
400
0


A1-60 + isoproturon
10 + 400
40 (Ec = 5, Diff. = +35)
















TABLE 477







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
400
0


A1-60 + isoproturon
2.5 + 400
10 (Ec = 0, Diff. = +10)
















TABLE 478







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
5


isoproturon
1600
0


A1-60 + isoproturon
10 + 1600
30 (Ec = 5, Diff. = +25)
















TABLE 479







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
5


isoproturon
400
0


A1-60 + isoproturon
10 + 400
15 (Ec = 5, Diff. = +10)
















TABLE 480







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
3


isoproturon
1600
0


A1-60 + isoproturon
10 + 1600
30 (Ec = 3, Diff. = +27)
















TABLE 481







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
3


isoproturon
400
0


A1-60 + isoproturon
10 + 400
15 (Ec = 3, Diff. = +12)
















TABLE 482







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
20


isoproturon
400
15


A1-60 + isoproturon
10 + 400
80 (Ec = 32, Diff. = +48)
















TABLE 483







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
400
15


A1-60 + isoproturon
2.5 + 400
20 (Ec = 15, Diff. = +5)
















TABLE 484







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
20


isoproturon
400
30


A1-60 + isoproturon
10 + 400
80 (Ec = 44, Diff. = +36)
















TABLE 485







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
0


isoproturon
1600
0


A1-60 + isoproturon
10 + 1600
40 (Ec = 0, Diff. = +40)
















TABLE 486







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
0


isoproturon
400
0


A1-60 + isoproturon
10 + 400
50 (Ec = 0, Diff. = +50)
















TABLE 487







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
1600
0


A1-60 + isoproturon
2.5 + 1600
40 (Ec = 0, Diff. = +40)
















TABLE 488







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
400
0


A1-60 + isoproturon
2.5 + 400
40 (Ec = 0, Diff. = +40)
















TABLE 489







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
10
40


isoproturon
400
90


A1-60 + isoproturon
10 + 400
100 (Ec = 94, Diff. = +6)
















TABLE 490







Efficacy against MATIN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-60
2.5
0


isoproturon
400
90


A1-60 + isoproturon
2.5 + 400
100 (Ec = 90, Diff. = +10)
















TABLE 491







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
10
3


indaziflam
40
10


A1-13 + indaziflam
10 + 40
20 (Ec = 12.7, Diff. = +7.3)
















TABLE 492







Efficacy against AVEFA, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
0


indaziflam
40
10


A1-13 + indaziflam
2.5 + 40
30 (Ec = 10, Diff. = +20)
















TABLE 493







Efficacy against BROST, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
10
5


indaziflam
10
0


A1-13 + indaziflam
10 + 10
10 (Ec = 5, Diff. = +5)
















TABLE 494







Efficacy against LOLMU, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
10
5


indaziflam
10
0


A1-13 + indaziflam
10 + 10
10 (Ec = 5, Diff. = +5)
















TABLE 495







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
10
20


indaziflam
40
10


A1-13 + indaziflam
10 + 40
40 (Ec = 28, Diff. = +12)
















TABLE 496







Efficacy against PHAMI, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
2.5
15


indaziflam
40
10


A1-13 + indaziflam
2.5 + 40
40 (Ec = 23.5, Diff. = +16.5)
















TABLE 497







Efficacy against POAAN, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]












A1-13
10
20


indaziflam
10
0


A1-13 + indaziflam
10 + 10
40 (Ec = 20, Diff. = +20)
















TABLE 498







Efficacy against GALAP, 21 days after application









Active ingredient
Dosage [g of a.i./ha]
Efficacy [%]





A1-13
10
60


indaziflam
40
35


A1-13 + indaziflam
10 + 40
85 (Ec = 74, Diff. = +11)








Claims
  • 1. A herbicidal composition comprising (A) one or more compounds of formula (I) or salts thereof as component A
  • 2. The herbicidal composition as claimed in claim 1 comprising (A) one or more compounds of formula (I) or salts thereof as component A in which (1) A is CY, R is methoxymethyl, X is methyl, Y is SO2CH3, and Z is trifluoro-methyl,(2) A is CY, R is methyl, X is chlorine, Y is SO2CH2CH3, and Z is trifluoromethyl,(3) A is CY, R is methyl, X is methyl, Y is SO2CH3, Z is trifluoromethyl,(4) A is CY, R is methyl, X is chlorine, Y is SOCH3, and Z is trifluoromethyl,(5) A is CY, R is cyclopropyl, X is methyl, Y is SOCH3, Z is trifluoromethyl,(6) A is CY, R is methyl, X is chlorine, Y is SO2CH3, and Z is trifluoromethyl, or(7) A is CY, R is methyl, X is chlorine, Y is OCH2CH2F, and Z is SO2CH3,and(B) synergistically effective amounts of one or more herbicides selected from the group consisting of B1, B2, B4, B5, B8, and B11 as component B: B1 1,3-diketo compounds selected from the group consisting of tembotrione and pinoxaden at a weight ratio of component A to the 1,3-diketo compound of from 1:4 to 8:1,B2 (sulfon)amides selected from the group consisting of foramsulfuron, iodo-sulfuron-methyl-sodium, mesosulfuron-methyl, and thiencarbazone-methyl at a weight ratio of component A to the (sulfon)amide of from 1:10 to 400:1,B4 azoles selected from the group consisting of pyrasulfotole, and isoxaflutole at a weight ratio of component A to the azole of from 1:40 to 1:1.25,B5 an herbicide that is flurtamone at a weight ratio of component A to flurtamone of from 1:128 to 1:8,B8 phenyl ethers selected from the group consisting of aclonifen and fenoxaprop-P-ethyl at a weight ratio of component A to the phenyl ether of from 1:64 to 1:2.5, and B11 a triazine selected from the group consisting of indaziflam and metribuzin at a weight ratio of component A to the triazine of from 1:200 to 1:4.
  • 3. The herbicidal composition as claimed in claim 1 additionally comprising, as component C, one or more safeners selected from the group consisting of benoxacor, cloquintocet-mexyl, cyprosulfamide, dichlormid, fenclorim, fenchlorazole, furilazole, isoxadifen-ethyl, mefenpyr-diethyl, 4-(dichloroacetyl)-1-oxa-4-azaspiro [4.5] decane, and 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine.
  • 4. A method of controlling harmful plants in crops, comprising applying a herbicidally active amount of a herbicidal composition as claimed in claim 1 to the harmful plants, plants, plant seeds or an area on which plants grow.
  • 5. The method as claimed in claim 4, wherein the plants are selected from the group consisting of sugar cane, corn, wheat, rye, barley, oats, rice, sorghum, cotton and soya.
  • 6. The method as claimed in claim 4, wherein the plants have been genetically modified.
Priority Claims (1)
Number Date Country Kind
13190182 Oct 2013 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2014/072645 10/22/2014 WO 00
Publishing Document Publishing Date Country Kind
WO2015/059187 4/30/2015 WO A
US Referenced Citations (6)
Number Name Date Kind
4902340 Hubele Feb 1990 A
6251827 Ziemer et al. Jun 2001 B1
6914035 Ziemer et al. Jul 2005 B2
8404618 Plant et al. Mar 2013 B2
8551918 Polge Oct 2013 B2
20140080705 Koehn et al. Mar 2014 A1
Foreign Referenced Citations (9)
Number Date Country
2004000767 Apr 2004 CH
00049071 Apr 1982 EP
9847356 Oct 1998 WO
02060255 Aug 2002 WO
03022050 Mar 2003 WO
2004014138 Feb 2004 WO
2005055716 Jun 2005 WO
2005104848 Nov 2005 WO
2012126932 Sep 2012 WO
Non-Patent Literature Citations (45)
Entry
International Search Report of PCT/EP2014/072645 dated Jan. 13, 2015.
Owen “Herbicidal Compositions”, Declaration of Dr. Michael D.K. Owen, (Mar. 26, 2013), pp. 1-71.
Owen “Professor and Weed Science Extension Specialist”, Resume, pp. 1-118.
Polge “Herbicidal Compositions”, U.S. Appl. No. 60/527,061, (Dec. 4, 2003), pp. 1-22.
Owen et al. “Evaluation of preemergence applications of KIH-485, s-metolachlor & CGA-154281, and s-metolachlor & atrazine & CGA-154281 for crop phytotoxicity and weed control in corn, Nashua, IA, 2003,” (2003), NCWSS Research Report, vol. 60, pp. 51-52 (2003).
Joanna Davies “Herbicide Safeners—Commercial Products and Tools for Agrochemical Research”, Pesticide Outlook, The Royal Society of Chemistry, (Feb. 2001) pp. 10-15.
Fedtke et al. “Synergistic Activity of the Herbicide Safener Dichlormid with Herbicides Affecting Photosynthesis”, Zeitschrift Für Naturforschung, Section C, Biosciences 1990 vol. 45 No. 5 pp. 565-56.
Sprague et al. “Enhancing the Margin of Selectivity of RPA 201772 in Zea mays with Antidotes”, Weed Science, vol. 47, No. 5, pp. 492-497 (Sep.-Oct. 1999).
Leuschen et al. “Effects of a Seed-Applied Safener on Corn Injury From Clomazone, Imazaquin and Imazethapyr”, University of Minnesota Southern Experiment Station Research Report, pp. 72-73 (1989).
Pyroxasulfone (KIH-485) chemical structure, Wildlife International, Ltd., pp. 1-7.
“Corn Injury from Balance Herbicide”, University of Illinois Extension Publication (May 28, 1999), pp. 1-5.
“Herbicide Manual for Agricultural Professionals”, Iowa State University Manual for Agricultural Professionals (2004).
Friesen et al. “The Influence of Temperature and Soil Moisture on the Phytotoxicity of Dicamba, Picloram, Bromoxynil, and 2,4-D Ester”, Can. J. Plant Sci. (1966); vol. 46: pp. 653-660.
“Herbicide Injury Symptoms on Corn and Soybean”, Purdue Extension Publication, printed (Apr. 13, 2017), pp. 1-17.
David W. Cudney “Why Herbicides are Selective”, California Exotic Pest Plant Council (1996) Symposium Proceedings, pp. 1-3.
J.D. Burton et al. “Sulfonylurea Selectivity and Safener Activity in Landmark and ‘Merit’ Sweet Corn”, Pesticide Biochem. and Physiol. (1994); vol. 48(3): pp. 163-172.
Maxwell et al. “Crop response from corn herbicides on two sweet corn varieties”. Urbana, Illinois, (2004). NCWSS Research Report, vol. 61, pp. 8-10.
Gunsolus et al. “Herbicide Mode of Action and Injury Symptoms”, North Central Regional Publication 377: (2002) pp. 1-19.
O'Sullivan et al. “Sweet corn (Zea mays) cultivar tolerance to primisulfuron”, Can. J. Plant Sci. (2001); pp. 261-264.
Hwang et al. “Mode of Safening Action of Naphthalic Anhydride Against Injury of Sulfonylurea and Imidazolinone Herbicides in Maize”, Council of the Australasian Weed Soc. Inc., 10th Australian Weeds Conference/14th Asian-Pacific Weed Science Society Conference 1993.
Rowe et al. I., Efficacy and Mode of Action of CGA-154281, A Protectant for Corn (Zea mays) from Metolachlor Injury. Weed Science. 1991; 39:78-82.
Zidua Herbicide Label from BASF.
Ritter et al., First Year Experiences with KIH-485. NEWSS 58:18 (2004) http://www.newss.org/proceedings/proceedings_2004_vol58.pdf., pp. 1-5.
Zollinger et al. “Crop Response to KIH-485 carryover”. NCWSS Research Report, vol. 61, pp. 34-35 (2004).
Mallory-Smith et al. “Revised Classification of Herbicides by Site of Action for Weed Resistance Management Strategies”, Weed Technology. (2003); vol. 17: pp. 605-619.
Wicks et al. “Isoxaflutole (Balance) Herbicide Injury to Corn in Nebraska”, pp. 1-8.
Dewell et al. “Preemergence weed control in corn with s-metolachlor&atrazine&mesotrione and s-metolachlor&mesotrion premixes. Wanatah, IN, 2003”, (2003), NCWSS Research Report, vol. 60, pp. 70-71.
Nelson et al. “Safening of Isoxaflutole in Corn”, NCWSS Research Report, vol. 56, p. 76 (2001).
Steckel et al. “Soil Factor Effects on Isoxaflutole Plus Flufenacet Phytotoxicity in Two Corn Hybrids”. NCWSS Research Report, vol. 56, p. 145 (2001).
Kelley et al. “Soybean Response to Plant Growth Regulatory Herbicides”, NCWSS Research Report, vol. 56, p. 100 (2001).
Ditmarsen et al. “Crop Tolerance and Efficacy of Flumetsulam + Clopyralid Tank Mixed With Reduced Rates of Dicamba + Diflufenzopyr in Field Corn”, NCWSS Research Report, vol. 56, p. 218 (2001).
Wyk et al. “Maize Cultivars Differ in Tolerance to Imazethapyr”, South African Journal of Plant and Soil (2000); 17:2, p. 86-89.
Curran et al. “Herbicide Injury-Photosynthetic Inhibitors and Contact Herbicides”, University of Illinois Extension.
Phatak et al. “Chapter 13: Growth Regulators, Fungicides and other Agrochemicals as Herbicide Safeners”, Crop Safeners for Herbicides (1989) pp. 299-315.
Owen et al. “Evaluation of Crop Phytotoxicity and Weed Control in Corn With Postemergence Applied Nicosulfuron & Rimsulfuron, Atrazine, Mesotrione and others, Ames, IA, 2002,” (2002), NCWSS Research Report, vol. 59, p. 108-109.
Trower “Sweet Corn Tolerance to Postemergence Applications of Formasulfuron” (2003) NCWSS Research Report, vol. 60, pp. 16-17.
Johnson et al. “Nicosulfuron, Primisulfuron, Imazethapyr and DPX-PE350 Injury to Succeeding Crops” (1993), Weed Tech.; vol. 7(3): 641-644.
Striegel et al. “Formasulfuron + Isoxadifen—Success and Lessons Learned from a Launch Year”, North Central Weed Science Proceedings, vol. 57: 225 (2002).
DuPont Web Printout explaining “Q” herbicides, “Safened Sulfonylurea Herbicides Reduce Risk of Corn Injury”, Pioneer, printed (Apr. 14, 2007), pp. 1-6.
Schultz et al. “A Comparison of Safeners for Metolachlor on Corn”, North Central Weed Science Proceedings, vol. 59:11 (2004), pp. 1-2.
Rowe et al. “Factors Affecting Chloroacetanilide Injury to Corn” (Zea mays). Weed Technology. 1990; 4(4): 904-906.
“Postemergence Control of Grass Weeds in field Corn” Purdue Weed Science, Publication (May 21, 2003), pp. 1-3.
David Hest “Mixing It Up”, Farm Industry News (Jan. 1, 2003), pp. 1-10.
Hartzler et al. “2005 Iowa State University Manual for Agricultural Professionals” (1996-2006) pp. 1-115.
“Isoxaflutole” chemical structure, Phenomenex Applications; printed (Apr. 26, 2017). pp. 1-2.
Related Publications (1)
Number Date Country
20160242419 A1 Aug 2016 US